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Abstract 
 
The investigation of the chemical characteristics of siderophores has been of 
interest for many years, for both the understanding of their fundamental 
chemistry and exploiting the design features of these natural compounds for 
novel applications. 
 
Within the present project, the properties of a biomimetic model of the 
tetradentate siderophore known as the enterobactin linear dimer was 
investigated, followed by those of the enterobactin linear dimer itself.  Both 
compounds were chemically synthesised, with an overall yield of 52% in four 
steps for the biomimetic, and 26% in seven-step convergence synthesis for the 
linear dimer.  Investigation of the coordination chemistry, showing both can 
form complexes with a ligand-to-metal ratios of 3:2 and 1:1 in solution.  This 
was followed up by X-ray diffraction investigations of the ferric-complexes with 
the periplasmic binding protein CeuE.  Both ferric-complexes bound to CeuE in 
a novel mode, with conserved tyrosine and histidine residues binding directly to 
the iron(III) centre to complete the octahedral coordination of the metal.  Both 
complexes have a Λ metal centre configuration when bound to CeuE.  The 
dissociation constants of CeuE with ferric-4-LICAM and ferric-linear dimer 
were determined to be 29.3 ± 11.7 nM and 8.4 ± 4.3 nM for the ferric-4-LICAM 
and ferric-linear dimer, respectively. 
 
In addition, selected applications of siderophores were investigated.  Firstly, a 
synthetic route to a novel hexadentate siderophore mimic possessing a chemical 
linking group was developed, in an eight-step synthesis with an overall yield of 
10.5%.  Secondly, the natural hydroxamate siderophore ferricrocin was labelled 
with an Alexa Fluor® 488 fluorophore.  Total internal reflection fluorescence 
microscopy was used to demonstrate that the resulting conjugate binds to E. coli 
cells that possess the ferricrocin outer membrane receptor protein FhuA. 
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1.1 Overview 
 
This thesis is concerned with the synthesis, characterisation and investigation of 
siderophores and analogues, with a view to providing further insight into the 
mechanism by which iron uptake occurs.  This chapter provides an overview of 
the background to the project and puts the work within this thesis into context 
with regard to previous research within the field. 
 
Throughout the thesis, the indicated  protonation states of compounds only refer 
to those protons that dissociate upon iron chelation, protons from other 
functional groups e.g. backbone carboxylic acids, are not included. 
 
1.2 Iron in Biology 
 
Iron is an essential element for nearly all living organisms on Earth.
1
  The redox 
chemistry and high affinity for oxygen make this abundant element ideal for a 
number of biological processes.  In aqueous media, the most common oxidation 
states are iron(II) and iron(III).  The redox potential between these states is such 
that the metal can perform a wide variety of biologically relevant reactions.
1-2
 
 
While iron is vital for most forms of life, it is also toxic in excess, due to its 
ability to perform a redox cycle with molecular oxygen, resulting in highly 
reactive oxygen-derived free radicals.
3-5
  Due to this toxicity, biological systems 
have developed sophisticated solutions for iron uptake, storage, transport and 
distribution.
3
 
 
Despite iron being one of the most abundant elements in the Earth's crust, it is 
predominately found as iron(III), due to the oxidising atmosphere.
6
  This has the 
consequence of the free iron concentration in the environment varying from 10
-
18
 to 10
-24
 mol dm
-3
.
7-8
  As a result micro-organisms in particular have developed 
specialised strategies for the uptake of this crucial element from the surrounding 
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environment.
9
  These can be categorised into two different iron uptake 
mechanisms, direct or indirect.  Direct uptake of iron is the ability of an 
organism to acquire iron from a natural source, e.g. haem when located within 
the human body.  This specialised direct iron uptake mechanism requires a 
specific receptor for each different iron source which is a disadvantage when the 
organism is located in different environments.
1
  This is thought to be the main 
reason why indirect iron uptake mechanisms are more widespread and diverse, 
with the use of siderophores being one of the most common examples.
1-2, 7
 
 
1.3 Siderophores 
 
Siderophores are small strong chelating molecules that are used to bind and 
solubilise iron(III) to aid iron uptake.  They are required to have a selectivity for 
iron(III) over other abundant metal ions found within the environment, achieved 
by matching the preferred coordination characteristics of the metal centre with 
the coordination ability of the siderophore.  Iron(III) is a 'hard' ion with a d
5
 
electronic configuration and thus prefers to coordinate in a octahedral geometry, 
surrounded by charge dense, negatively charged donor atoms.
10-11
  To 
complement this, the donor atoms of the siderophore chelating groups are 
dominated by the presence of negatively charged oxygen atoms, usually 
arranged to form a hexadentate ligand that forms a highly thermodynamically 
stable complex.
11
  While there are not many biologically important 'hard' ions 
that can compete with iron(III), siderophores must also be selective for iron(III) 
in the presence of environmentally abundant trivalent cations such as 
aluminium(III).  The binding moieties of siderophores are generally comprised 
of bidentate units, which are predisposed to have an ideal bite angle for the 
coordination of iron(III) (ionic radius of 0.65 Å) over other abundant metals 
(e.g. ionic radius of aluminium(III) is 0.54 Å).
2, 12
 
 
There are over 500 known siderophores, with a wide variety of different 
structural motifs for the backbone.
2
  Despite this, there is a reliance on relatively 
few coordination groups, presumably due to the limitation of the coordination 
chemistry of iron(III).
2
  Siderophores are classified by these coordinating  
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groups, with the three most common iron-chelating units being catecholates, 
hydroxamates and α-hydroxycarboxylates (Figure 1). 
 
 
Figure 1 - Representative examples of siderophores with different iron chelating 
moieties highlighted.  *Protonation state of citric acid can differ due to different binding 
modes available. 
 
Each of these three coordinating  groups possess the charge dense oxygen atoms 
required for strong iron(III) binding.  Under neutral conditions, the catechol 
group deprotonates twice (pKa values 9.2, 13.0), to form two phenolate atoms 
which coordinate to the metal centre, whereas the hydroxamate (pKa 9.0) and α-
hydroxycarboxylate (pKa 3.0, 14.5) groups are only required to deprotonate 
once, with the latter's carboxylates already deprotonated under neutral 
conditions.
2
  This results in the catecholate complexes being more sensitive to 
pH conditions. 
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As a result of this, the catechol group is often observed in siderophores as the 
related catecholamide group.  When the amide is in the adjacent position to 
provide the 2,3-catecholamide functionality, the resulting hydrogen bonding 
network reduces the pKa of the ortho-phenolate to 7.2-7.4.
13
  The hydrogen 
bonding network around the catecholamide groups also affects the rotation of 
the catecholamide with respect to the backbone of the siderophore.  For 
example, in the fully protonated form, the hydrogen bonding network of the 
ortho-phenolate involves the carbonyl of the amide group, whereas upon 
deprotonation, the network reverses and the proton of the amide group forms a 
hydrogen bond to the ortho-phenolate.
14
  This reversal has the consequence of 
rotating the catecholamide group, which is also observed upon iron(III) 
chelation.  It is postulated that this mechanism is utilised by the tris-catecholate 
siderophore enterobactin for orientating the catecholamide groups in an 
'outwardly' facing direction when fully protonated, and upon iron(III) binding 
the catecholamide group rotates, pulling the metal centre into the central binding 
position (Figure 2).
7
  For many siderophores the amide functionality has been 
shown to be important for recognition by the binding proteins during iron 
uptake.
15
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Figure 2 - Schematic diagram demonstrating the hydrogen bonding network and 
conformational change of enterobactin upon A) single deprotonation; B) iron 
complexation.  Figure adapted from Proc. Natl. Acad. Sci., 2003, 100, (7), 3584-3588.  
Copyright 2003 National Academy of Sciences, USA. 
 
Enterobactin is one of the most widely studied siderophores.  It contains three 
catecholamide moieties connected via a cyclic tri-ʟ-serine backbone (Figure 1).  
Enterobactin comprises of three dihydroxybenzoylserine (DHBS) units, which 
are arranged to form a cyclic ester.  As such, enterobactin is prone to hydrolysis 
under certain conditions and can form three distinct hydrolysis products; the 
linear trimer, linear dimer and DHBS monomer.  Each hydrolysis product has 
been shown to promote bacterial growth, demonstrating that siderophores are 
not required to be hexadentate to function as iron scavengers (Figure 3).
16-17
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Figure 3 - Chemical structures of the enterobactin hydrolysis products.   
 
There are a number of examples of siderophores with 'low' denticity (Figure 4).  
While some of these could be perceived as biological precursors to their 
hexadentate counterparts, e.g. azotochelin and the enterobactin linear dimer are 
formally fragments of protochelin and enterobactin, respectively, others are only 
structurally related and are a siderophore in their own right, e.g. rhodotorulic 
acid and pyochelin.
18
  It is still not clear why some organisms purposely 
synthesise siderophores with a lower denticity.  One possibility is their 
involvement in the uptake of other biologically important ions, and thus the 
selectivity requirement of the siderophore is less strict.
18-20
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Figure 4 - Chemical structures of a selection of 'low' dentate siderophores.   
 
It has been shown that the stereochemistry of siderophores is greatly important 
for iron uptake.
21-24
  As siderophores are usually comprised of three bidentate 
units coordinating to the metal centre in a octahedral geometry, they have a 
metal-centred chirality, in addition to any ligand-based chirality.  This allows the 
possibilty of two alternate configurations; a left-handed propeller (Λ-
configuration), or a right-handed propeller (Δ-configuration, Figure 5).25   
 
 
Figure 5 - Λ-configuration and Δ-configuration of a tris-bidentate octahedral complex. 
 
Asymmetric binding moieties also give rise to cis- and trans-complexes, 
depending on the orientation of the binding unit with respect to the other 
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coordinating groups.  If there is no chiral or steric induction from the 
siderophore backbone, these optical isomers form racemic mixtures in solution.  
As the majority of siderophores are derived from amino acids, and hence are 
often optically active, racemic siderophore complexes are rare.  The most 
common isomers formed with siderophores are Λ-cis complexes, although 
enterobactin has been shown to have a preference to form a Δ-cis complex.2, 21 
 
Siderophore Mimics 
 
Due to their remarkable iron(III) chelating chemistry, there has been much focus 
on the fundamental study of the iron binding ability and physical properties of 
siderophores.  In order to study different aspects of siderophores and their 
uptake pathways, many siderophore mimics have been synthesised and used in 
various investigations. 
 
While enterobactin is one of the most widely studied siderophores, due to its  
hydrolytically unstable tri-lactone backbone, a number of hydrolytically stable 
mimetic systems have been developed.  The most successful were designed to 
keep the key structural features of enterobactin, namely the three bidentate 
catecholamide units, positioned on a backbone with three-fold rotational 
symmetry, and five-atomic unit spacers between the binding moieties (Figure 
6).
26-29
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Figure 6 - A selection of structures of biomimetic hexadentate catecholamide 
siderophores and enterobactin, all possessing high affinity for iron(III).
26-29
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As with natural siderophores, the preorganisation of the catecholamide 
functional groups correlates with the strength of the iron(III) binding.  
Enterobactin fulfils this requirement for preorganisation via the chirality of the 
tri-serine backbone, as well as the hydrogen-bonding network formed by the 
catecholamide functionality.
7
 
 
Catecholamide preorganisation for iron binding has also been demonstrated with 
siderophore mimics.  Stack et al. have shown that (Et)3MECAM
6-
 binds iron(III) 
with a formation constant of Kf ≈ 10
47 
M
-1
, an increase of 10
4
 compared with 
MECAM
6-
 (Kf ≈ 10
43
 M
-1
).
29
  This increase was attributed to the predisposition 
of the catecholamide rings to be preferentially on one side of the central 
aromatic ring.  This is due the adjacent groups avoiding steric interactions by 
alternating above (a) and below (b) the central ring in a (ababab) conformation 
with three-fold symmetry.  In (Et)3MECAM
6-
, the neighbouring groups of the 
methylene-catecholamide and the ethyl groups are both large enough to form the 
ababab conformation, whereas in MECAM protons occupy the neighbouring 
positions, hence only minimal steric interactions occur, leading to a weaker 
preference for the ababab conformation, (Figure 7).
29
 
 
 
Figure 7 – Illustration of the preorganised ababab configuration of (Et)3MECAM (A) 
compared to MECAM (B). 
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The flexibility of the siderophore backbone has also been investigated.  Tse et 
al. synthesised compounds H6-1-3 (Figure 6) and showed that conformational 
flexibility of the siderophore mimics had a direct impact on the strength of 
iron(III) binding.
27
  Compound H6-1 has a linear backbone, allowing rotational 
freedom, and hence can act as a control compound to highlight the effects of a 
lack of preorganisation in a hexadentate chelator.  Compound H6-2 has a cyclic 
backbone, restricting its rotational freedom, but, its catechol rings are not forced 
into a particular direction.  However, in the most rigid compound, H6-3, the 
catechol rings are all preorganised to be positioned on one side of the 
macrocycle.  Compound 3
6-
 has a formation constant upon binding to iron(III) of 
Kf ≈ 10
49
 M
-1
, rivalling that of enterobactin
6-
, whereas that of the most flexible 
mimic 1
6-
 was Kf ≈ 10
45
 M
-1
, closer to that of the linear trimer (Table 1).
27
 
 
Compound ≈log10Kf
* 
Reference 
Enterobactin
6-
 49 
13
 
Linear Trimer
7- ǂ 43 30 
MECAM
6-
 43 
29
 
Et-MECAM
6-
 47 
29
 
TRENCAM
6-
 44 
26
 
3,4,3-CYCAM
6-
 40 
31
 
1
6-
 45 
27
 
2
6-
 47 
27
 
3
6-
 49 
27
 
Table 1 - Formation constants reported for the ferric complexes of the indicated tris-
catecholamide ligands. * log10Kf refers to fully deprotonated ligand forming a 1:1 
complex with iron(III). ǂ The fully deprotonated charge of the linear trimer includes the 
six catechol protons and the carboxylic acid on the backbone. 
 
As well as being used in investigations of iron(III) chelation, siderophore 
mimics have also been used to investigate the iron uptake system of various 
micro-organisms, and as biomimetic systems for the investigation of substrate-
protein interactions.
22, 24, 32-37
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Rastetter et al. reported a total synthesis of enterobactin, and its enantiomer, 
enantioenterobactin, which has a ᴅ-serine-based backbone.  The ᴅ-enantiomer 
has been used in iron(III) uptake studies and was shown not to support bacterial 
growth.
24
  While initially the lack of growth was attributed to stereospecificity of 
the outer membrane receptor towards the metal-centred chirality,
21
 it was later 
shown that the stereospecificity must be further along the iron uptake or release 
mechanism.
22
 
 
1.4 Siderophore Mediated Iron Uptake 
Gram-negative bacteria 
 
As well as synthesising siderophores, micro-organisms have developed 
sophisticated iron-uptake systems in order to retrieve iron-siderophore 
complexes.  These uptake systems are specific to each organism.  For Gram 
negative bacteria, such as E. coli, there are two cell membranes that the iron-
siderophore complex must pass through to enter the cytoplasm of the cell.  The 
outer membrane comprises of a lipid bilayer, which contains outer membrane 
receptors that internalise the iron-siderophore complex into the volume between 
the two membranes layers, the periplasm.  Within the periplasm, there are 
periplasmic binding proteins (PBPs) that bind to the iron-siderophore complex, 
allowing it to be transported to an inner membrane ABC transport complex, 
which transfers it into the cytoplasm (Figure 8).
9
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Figure 8 - Schematic diagram of the iron-uptake mechanism for a Gram-negative 
bacterium. 
 
Outer membrane receptors for iron-siderophore complexes generally consist of 
22 β-sheets that form a barrel through which the iron-siderophore complex is 
transported (Figure 9).  The extracellular loops that connect the β-sheets can 
extend up to 40 Å above the membrane surface and have importance in 
preventing the binding of unwanted species, as well as providing the initial 
interaction with the siderophore complex.
38-40
  The second key feature of these 
receptors is the N-terminus occupying the central barrel, known as the 'cork 
domain'.  This domain interacts with the bound complex and the periplasmic 
spanning protein TonB, which provides the energy for internalisation.
40-42
  It is 
still unclear how the complex circumvents this cork domain, but it is generally 
accepted that the domain is partially displaced to allow the iron siderophore 
complex to pass through.  Full displacement of the domain is considered 
unlikely, as this would involve breaking approximately 50 hydrogen bonds, thus 
having an energy barrier too high to overcome.
38, 43-45
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Figure 9 - Ribbon representation of the ferric enterobactin outer membrane receptor 
FepA, shown from: A) Side on; B) Top down (from the extracellular space); C) Beneath 
(from periplasmic space)  Key: Barrel domain (light blue), Cork domain (red). PDB 
code: 1FEP.
38 
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Once the iron-siderophore complex has been transported into the periplasm, it is 
bound by a PBP, which escorts the associated siderophores to the correct ABC 
transport complex.  There are many different PBPs, as a result they are classified 
depending on their ligands.  One class binds organic metal ion complexes.  The 
sequence identity of PBPs varies greatly, and can be as low as 10%, yet they 
retain a similar tertiary structure (Figure 10).
9
  PBPs are bi-lobal in structure, 
with the two domains connected via a long -helix, with the cleft between the 
two lobes acting as the binding pocket. 
9, 35, 46
 
 
Figure 10 - Ribbon representation of PBPs: A) VctP (PDB code: 3TEF)47; B) FhuD 
bound to desferral (PDB code: 1K2V)
46
; C) CeuE bound to ferric-MECAM (PDB code: 
2CHU)
35
.  Key: PBP (light blue), ligands shown as spheres; grey - carbon, blue - 
nitrogen, red - oxygen, coral - iron. 
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Once the iron-siderophore complex has bound to the PBP, it must be transferred 
to the ABC transport complex to be shuttled across the inner membrane.  
Conserved glutamate and arginine residues on the PBP and the ABC transport 
complex, respectively, allow the two proteins to dock together, allowing 
exchange of the iron-siderophore complex.  Unlike the outer membrane 
receptors, the ABC transport complexes are usually an assembly of proteins, 
rather than a single polypeptide.  The ferric-enterobactin and the vitamin B12 
ABC transport complexes in E. coli both consist of a dimer of dimers, FepC2D2 
and BtuC2D2, respectively.  In comparison, in the ferric-hydroxamate ABC 
transport complex in E. coli, one of the dimers is fused forming a FhuBC2 
complex.  The only structurally characterised complexes of these transporters 
are BtuC2D2
48-50
 and the molybdate transporter ModB2C2,
51-52
 which are 
assumed to look similar to the ferric-siderophore uptake proteins (Figure 11). 
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Figure 11 - Ribbon representation of BtuC2D2F (PDB code 2QI9)
49
: A) Dimer of 
BtuC2 (protomers shown in white and grey); B) Dimer of BtuD2 (protomers shown in 
light blue and coral); C) Complex of BtuC2D2F.  Key: BtuC2 (white and grey), BtuD2 
(blue and coral), BtuF (gold) key docking residues shown as spheres; red - arginine, 
green - glutamate. 
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Gram-positive bacteria 
 
Compared to their Gram-negative analogues, there is relativity little research 
published for iron-siderophore uptake mechanisms used by Gram-positive 
bacteria, with the majority of research focusing on B. subtilis.
36, 53-55
  Gram-
positive bacteria do not possess an outer membrane, and hence contain no 
periplasm.  The uptake system therefore resembles that of the inner membrane 
transport system for Gram-negative bacteria.  The PBP equivalent, a lipoprotein, 
is bound to the membrane via a membrane anchor.
53
  These lipoproteins are 
structurally similarity to PBPs, and are assumed to interact with an ABC 
transporter in a similar fashion to that of Gram-negative bacteria (Figure 12).  
 
Figure 12 - A schematic diagram for a simplified overview of the iron-uptake 
mechanism for Gram-positive bacteria. 
 
Iron release 
 
As ferric-siderophore complexes are highly thermodynamically stable, specific 
mechanisms for iron release are required.  Bacteria can employ a number of 
different strategies to access siderophore bound iron.  Most involve transporting 
the iron-siderophore complex into the cytoplasm which gives access to enzymes 
capable of removing the iron from the siderophore.  However, the release 
mechanisms for some siderophores, such as pyoverdine, has been shown to 
occur in the periplasm.
56
  One of the most widely used mechanisms is the 
reduction of the coordinated iron(III) to iron(II).
57
  This greatly reduces the 
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stability of the iron complex, allowing iron transfer.  This mechanism is not 
available for the tris-catecholate siderophores, due to the extremely low redox 
potential (enterobactin E½ = -750 mV).
2
  As a result, the release mechanisms 
from these siderophores has been widely debated.  There is now a consensus that 
the major release pathway of the iron is via siderophore degradation.
2, 7, 34, 37, 58-61
  
Studies with siderophore mimics such as H6-MECAM, that are not prone to the 
action of an esterase, have shown that iron is still delivered to the cell, though at 
reduced rates (~5%), thus indicating the possibilty of a secondary release 
pathway.
33
 
 
The secondary pathway has been proposed to be an acid-mediated release via 
change in coordination from the catecholate to the salicylate mode of binding 
(Figure 13).
59
  This mode of binding weakens the affinity of the siderophore for 
the metal centre, and hence raises the redox potential, allowing reduction of the 
iron(III) to iron(II) and extraction of the metal as before.  Details of this 
secondary release pathway are still unclear. 
 
 
Figure 13 - Schematic diagram demonstrating the pH dependence of the catecholate 
and salicylate binding modes of the catecholamide group. 
 
Regulation of Iron Uptake 
 
The accumulation of excess iron can be just as hazardous to biological life as 
iron starvation.  Consequently, the production of iron uptake and related proteins 
is highly regulated by the repressor protein Fur (ferric-iron uptake regulation).
62-
64
  Over 90 genes from different E. coli strains have been shown to be regulated 
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by Fur including siderophore biosynthesis, transporter systems and also 
oxidative-stress response systems (Table 2).
62
 
 
Regulated Genes Function Reference 
fepA-entD Enterobactin synthesis and transport 
65
 
fes-entF Enterobactin synthesis and release 
65
 
fhuACDB Ferrichrome transport 
62
 
iucBCD Biosynthesis of aerobactin 
64
 
sodB Iron-dependent superoxide dismutase 
66
 
acnA Biosynthesis of isocitrate 
67
 
Table 2 - Selected examples of Fur regulated genes from E. coli with a brief 
description of their function. 
 
Fur comprises of two domains; a helix-turn-helix domain, and the carboxy-
terminus domain which contains two metal-binding sites.  In E. coli, one of 
these sites is occupied by a zinc(II) ion, while the other binds to iron(II) and 
regulates activity.
68
  A dimer of iron loaded Fur binds to a specific 19 bp DNA 
sequence known as the 'Fur Box', which is located within the promoter of the 
regulated genes.  The affinity of Fur towards iron(II) is balanced so as to allow 
the accumulation of iron within the cell, but if the intracellular concentration 
becomes too high, Fur becomes loaded with iron, and binds to the Fur Box 
which represses further iron uptake, helping to prevent toxic concentrations of 
iron accumulating within the cell (Figure 14).
63
 
 
Figure 14 - A schematic diagram demonstrating the general mechanism of action of 
Fur. 
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Campylobacter jejuni 
 
C. jejuni is a Gram-negative, microaerobic bacterium.
69
  It is the most prevalent 
cause of gastroenteritis worldwide, and is a major cause of food-borne diarrhoeal 
illness in humans,
70
 with iron acquisition demonstrated to be an important 
virulence determinant.
71-73
  The importance of iron for C. jejuni is suggested by 
the relatively large number of genes associated with iron uptake and regulation 
in the genome.
74
  As a Gram-negative bacterium, it has an iron uptake system 
similar to that discussed above.  C. jejuni is thought to be incapable of 
synthesising its own siderophores, however, most strains have been shown to 
utilise siderophores such as enterobactin, produced by other bacteria.
69, 75
  The 
major iron uptake pathways for C. jejuni are based on enterobactin, haem and 
transferrin proteins (Figure 15).
71, 74
 
 
 
 
Figure 15 - Schematic representation of the three major iron uptake systems of C. 
jejuni.  
 
Currently, the only structurally characterised protein from the enterobactin 
uptake system of C. jejuni is the PBP CeuE.
35
  Müller et al. co-crystallised CeuE 
with ferric-MECAM and found it to form an unusual dimer complex.  The 
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interactions between the two proteins are minimal, suggesting that the driving 
force for dimerisation is due to the ligand.  The overall complexation is 
stabilised by favourable hydrophobic interactions, as the methylene group of one 
of the MECAM ligands is directly above the other MECAMs aromatic ring 
(Figure 16). 
 
Figure 16 - The structure of the {CeuE2[Fe2MECAM2]} complex (PDB code: 
2CHU).
35
  A) CeuE chain A (light blue), CeuE chain B (gold), ligands shown as 
spheres; B) The MECAM molecules shown as cylinders.  Key: grey - carbon, blue - 
nitrogen, red - oxygen, coral - iron. 
 
The formation of dimerised PBP using ferric-MECAM also offers an 
explanation for ferric-MECAM reportedly becoming trapped within the 
periplasm.
33
  Ferric-MECAM has also been co-crystallised with the Gram-
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positive binding protein FeuA, and was found to form the 'usual' 1:1:1 complex, 
thus demonstrating that ferric-MECAM does not dimerise all binding proteins.
36
 
 
1.5 Applications of Siderophores 
Siderophores in Supramolecular Chemistry 
 
As stated above, not all siderophores are hexadentate and hence different 
stoichiometries with metal ions are possible.  By utilising the preferred 
coordination requirements of metals and ligands it is possible to use metal-
ligand interactions to drive the formation of molecular assemblies.
76-78
  One of 
the smallest assemblies is the triple helicate (M2L3), which forms when three 
ligands bridge between two metal centres of the same chirality.  If the chirality is 
reversed at the metal centres, then it is referred as a triple mesocate (Figure 
17).
79
 
 
Figure 17 - Schematic diagram of a triple helicate and triple mesocate. 
 
Both triple helicate and mesocate systems with catechol containing ligands have 
been reported with gallium(III), cobalt(III), aluminium(III), iron(III) and 
titanium(IV).
76, 80-85
  The key design features are a C2 symmetric bis(bidentate) 
ligand and a metal ion with pseudo-octahedral coordination.  The ligands usually 
possess a rigid linker that directs the formation of an M2L3 system, although it is 
still possible to form these systems with flexible linkers (Figure 18).
76
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Figure 18 - Example bis(catechol) ligands that have been shown to form triple 
helicates.
76
 
 
Simple bis(catecholamide) ligands with short spacer units such as H4-2-LICAM, 
which possesses an ethylene, was found to form a dinuclear 3:2 helicate, as well 
as a dinuclear 2:2 hydroxo-bridged dimer (Figure 19).
86
  The naturally occurring 
bis(catecholamide) siderophore, which possesses a spermidine linker, was also 
investigated and shown to also form a 3:2 helicate.  There was no evidence of 
formation of a hydroxo-bridged dimer with this ligand, showing linker length 
and type has a profound affect on complexation.
86
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Figure 19 - Structures of the two complexes 2-LICAM4- forms with iron(III), [Fe2L3]
6-
 
and [Fe2L2OH2]
4-
. 
 
Studies of similar tetradentate ligands with hydroxamate binding groups have 
identified both mononuclear complexes with a ligand-to-metal ratio of 1:1, 
dinuclear, 2:2 complexes and dinuclear 3:2 triple stranded helicates forming 
with a dependence on linker length.
87
  Even 3:2 complexes that adopt a mono-
bridged dinuclear structure have been reported with the bis-hydroxamate 
siderophore alcaligin (Figure 20).
88
   
 
 
Figure 20 - Structures of the natural siderophores rhodotorulic acid and alcaligin and 
schematic diagrams of their dinuclear six-coordinate iron complexes. 
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The ligand H4-3-LICAM was studied with gallium(III) using 
1
H NMR 
spectroscopy, which suggested 3-LICAM
4-
 coordinates to gallium(III) in a 3:2 
triple stranded fashion.
80
  H4-5-LICAM was crystallised with Ni
2+
 forming a 
mononuclear 1:1 complex in a square planar geometry.
89
  H4-5-LICAM was also 
crystallised with a cis-dioxomolybdenum(VI) unit (MoO2
2+
), which also requires 
only four coordinating atoms.  However, unlike nickel, the molybdenum formed 
a dinuclear complex, where two 5-LICAM
4- 
ligands bridged two MoO2 
centres.
90
  A follow-up study using a xylene linker found that a dinuclear system 
could again be formed, which can be converted to the mononuclear system upon 
heating.
91
  Many other ligands have been shown to form triple stranded 
helicates,
92-93
 and larger molecular cages,
76, 79, 94
 which have been widely 
observed and reviewed.
77-78, 95-97
  
 
Medicinal Applications of Siderophores 
 
A major research area for applications of siderophores is the development of 
new chelation therapeutics, particularly for the treatment of iron overload.
3, 28, 98-
99
  Iron overload is the accumulation of iron within the body, which can impair 
organ function and if left unchecked, can lead to multiple organ failure.  This 
condition is either caused by genetic defects, known as haemochromatosis, or as 
an indirect result from other conditions, such as treatment for β-thalassaemia, 
known as siderosis.
100-101
 
 
In designing suitable chelators for clinical applications, many of the design 
principles can be mimicked from siderophores, such as metal selectivity and 
complex stability.  For chelators targeting iron(III), the same binding moieties 
can be used to achieve selectivity over other biologically important ions.  For 
chelation therapies targeting other ions, the coordination chemistry of the ligand 
can be tailored to suit the requirements of the metal centre.  For example, Weitl 
et al. developed actinide chelators based on four catecholamide units, which 
show selectivity for the larger actinide ions over iron(III).
102
  One of the most 
widely used chelators for iron(III) currently in use, is the natural hydroxamate 
siderophore desferrioxamine-B (DFO).
101
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Another consideration required for chelation therapy, is the stability of the iron-
complex towards the uptake systems of micro-organisms.  An adverse side 
effect in the use of siderophores as iron-chelating therapeutics is the increase in 
micro-organism growth, resulting in an increased risk of infection.
103-104
  
Therefore, it would be advantageous to use siderophore mimics which cannot 
transport iron into micro-organisms. 
 
Other areas of research rely on siderophores for targeting, rather than 
exclusively for their metal chelating properties.  The Trojan Horse Strategy, for 
example, involves covalently attaching known anti-microbial agents to 
siderophores to produce siderophore-conjugates.  These conjugates can 
coordinate iron(III), and hence the siderophore uptake system of the targeted 
micro-organism should actively transport the conjugate into the cell.
105-108
  It is 
purposed that this strategy would evade certain aspects of anti-microbial 
resistance mechanisms.  This strategy was inspired by a range of natural 
compounds, known as sideromycins, which operate by the same method.
108
  
Albomycin is the most commonly studied of the sideromycins, and consists of a 
tris-hydroxamate siderophore unit linked via an amide bond to a thioribosyl 
pyrimidine tRNA synthetase inhibitor.
108-109
  In the cytoplasm of E. coli, the 
amide linkage is cleaved by peptidase N, releasing the antibiotic required for 
anti-microbial activity. 
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Since the discovery of sideromycins, synthetic and semi-synthetic Trojan Horse 
conjugates have been made, and their anti-microbial activity evaluated with 
varying degrees of success.
110-116
  Key design features required for all Trojan 
Horse siderophore systems are; recognition of the siderophore group, to allow 
active transport through the iron uptake system, and the availability of a 
chemical linking group to allow the covalent linkage to the anti-microbial group. 
 
Other Applications of Siderophores 
 
An area related to the Trojan Horse strategy is the delivery of chemical 'cargo' 
into micro-organisms using siderophores.  Enterobactin was modified by Zheng 
et al. for evaluation of delivering different cargos.
112
  Interestingly, the point of 
modification to attach the cargo was the C5 position on the catechol ring.  This 
position has been modified by nature through the addition of a glucose ring, 
forming a class of siderophores known as salmochelins.
117
  Salmochelins (mono- 
or di-substituted glucosylated enterobactin and associated hydrolysis products) 
evolved in response to the human immune system recognising and binding 
ferric-enterobactin, using proteins known as siderocalins.
118-120
  While the 
addition of the glucose ring in the C5 position has no adverse effect on substrate 
binding for the iron(III) uptake proteins, it inhibits binding by the siderocalins.  
The structure of these salmochelins inspired the addition of chemical linkers on 
the C5 position, for the study developing H6-9 (Figure 21).
112
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Figure 21 - Chemical structures of DGE, one of the salmochelins and H6-9 designed 
and synthesised by Zheng et al.
112
 
 
The modified enterobactin H6-9 was recognised and transported into E. coli and 
P. aeruginosa.  Small cargos, such as Boc, cyclohexyl, napthyl and 
phenylmethylbenzyl groups, were shown to be recognised and transported into 
the cell.  Conjugates with larger cargos, such as coumarin, were actively 
transported into P. aeruginosa but not E. coli, presumably due to the different 
iron uptake systems.
112
 
 
Modification of a natural siderophore with a fluorescent tag for the development 
of targeted probes has been demonstrated by Noël et al.
121
  Pyochelin is one of 
two major siderophores produced by P. aeruginosa, an opportunistic Gram-
negative bacterium, which cause severe lung infections that can be fatal for 
cystic fibrosis patients.
121
  Pyochelin can either be a tridentate or tetradentate 
siderophore which was shown to bind to not only iron(III) with high affinity but 
also zinc(II), copper(II), cobalt(II), nickel(II) vanadium(IV), molybdenum(VI), 
gallium(III) and terbium(III).
18-20, 45, 122-123
  These metal-chelates are 
predominantly bound in a 2:1 ligand-to-metal ratio.
18
  Only metal complexes of 
iron(III), cobalt(II), nickel(II), gallium(III) and molybdenum(VI) are transported 
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through the pyochelin uptake pathway but at a reduced rate compared to the 
iron(III) complex.
19-20
  
 
 
 
The ferric-pyochelin complex is recognised by the outer membrane protein, 
FptA which transports it into the periplasm of the cell.
18
  Due to the wide range 
of metals that pyochelin is able to chelate and deliver to the bacterium, the exact 
role of this siderophore during infection and its interactions with other biological 
ions remains unclear. 
 
In response to this challenge, Noël et al. designed and synthesised two pyochelin 
conjugates as molecular tools for the investigation of the pyochelin-dependent 
iron uptake pathway.
121
  Pyochelin was covalently linked to the (4-nitro-
benzo[1,2,5]oxadiazole) fluorophore using two different linkers, a short succinic 
linker and a longer spacer to minimise steric clashes with uptake proteins.  The 
conjugates were shown to be recognised by the pyochelin-specific outer 
membrane receptor, by selectivity labelling cells that expressed the receptor over 
cells that did not (Figure 22). 
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Figure 22 - Chemical structure of fluorescently-labelled Pyochelin.121 
 
Another important application of siderophore chemistry is the development of 
novel sensors.  The most obvious example is the detection of iron(III) utilising 
naturally emissive siderophores such as pyoverdine.
124
 
 
 
 
Pyoverdine is produced by all fluorescent pseudomonads, with the exact 
structure varying between strains.  Pyoverdine is a mixed-type siderophore, 
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forming hexacoordinate complexes with iron(III), binding through one 
catecholate and the two hydroxamate groups.  The unusual catechol group is 
incorporated as part of the dihydroxyquinoline group, which acts as the 
chromophore, with the rest of the siderophore made up of both ᴅ- and ʟ-amino 
acids.
125
  Immobilisation of pyoverdine in a porous structure of either silica or 
sol-gel glass, allowed the development of fluorescent sensors for the 
determination of trace iron(III) levels.
126-128
 
 
1.6 Project Aims 
 
The overall aim of this project was the investigation of interactions between 
iron-siderophore complexes with selected binding proteins involved in iron(III) 
uptake.  The investigations can be divided into three distinct areas.  The first 
involves the study of tetradentate siderophores interacting with iron(III) in the 
absence and presence of the periplasmic binding protein CeuE (Chapters 2 and 
3).  The second is the development of a novel hexadentate siderophore mimic to 
be used for the attachment of secondary chemical functional groups (Chapter 4).  
The third involves the modification of a natural siderophore with a fluorescent 
unit, for use as a novel fluorescent probe for investigating integral membrane 
proteins and their movements with the outer cell membrane (Chapter 5). 
 
 
  
 
Chapter 2: Tetradentate 
Siderophores, a Biomimetic 
Approach 
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Project Aims 
 
The aim of this chapter was the investigation of a biomimetic model of the 
enterobactin linear dimer interacting with iron(III) in the absence and presence 
of the periplasmic binding protein CeuE.  Characterisation of possible binding 
stoichiometries of the iron(III)-ligand complex under biologically relevant 
conditions; and the determine of the type and strength of interactions of this 
complex system with CeuE. 
 
2.1 Introduction 
 
As outlined in Chapter 1, enterobactin is comprised of a hydrolytically unstable 
tri-lactone backbone.  Hence, enterobactin is prone to degradation in aqueous 
medium and can form three distinct enterobactin fragments, the linear trimer, 
linear dimer and DHBS, each of which mediates iron uptake into bacteria.
1-2
  It 
was therefore of interest to investigate how hydrolysis products, such as the 
tetradentate linear dimer, interact with iron.  In addition, the binding of the 
resulting iron-complex(es) with their cognate iron-uptake proteins was 
investigated. 
 
Due to the chemical complexity of the linear-dimer derived from enterobactin, a 
simplified biomimetic model was used initially to study the potential 
interactions of the linear dimer with metal ions and the periplasmic binding 
protein CeuE.  The LICAM (LInear Catechol AMide) series of compounds was 
selected for this purpose due to their simple chemical structure, which consists 
of two catechol amide groups attached via a linear alkanediyl linker. 
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A number of ligands of this series, 2-,4-,6-LICAM, was prepared previously by 
Weitl et al.
3
  In addition, 3-,5-,8-,9-,10-,12-LICAM were prepared by Bhargava 
et al.
4
, focusing on metal coordination for chelation therapy.  Subsequently, the 
LICAM series of compounds was used for the investigation of binding modes in 
combination with divalent metal centres, such as nickel(II), cobalt(II) and also 
the cis-dioxomolybdenum(VI) unit (MoO2
2+
),
5-7
 as well as the trivalent metal 
centres gallium(III) and iron(III).
8-9
  In order to mimic the enterobactin linear 
dimer successfully, the alkanediyl linker between the two catecholamide 
functional groups should have a similar length as the linear dimer; therefore a 
butylene linker was used first. 
 
H4-4-LICAM 
 
The bis-catecholamide ligand H4-4-LICAM, is comprised of two catechol-
amides linked via a butylene linker.  Compared with the enterobactin linear 
dimer, H4-4-LICAM avoids the chemically complexity of the functional side 
chains, the chiral centres and the chemically unstable ester backbone. 
 
 
 
H4-4-LICAM was first synthesised by Weitl et al. as a precursor for the 
investigation of actinide sequestering agents based on sulfonated catechol 
ligands.
3
  Subsequently, it was investigated as part of a series of tetradentate 
catechol ligands that form five-coordinate organoarsenic complexes.
10-11
  H4-4-
LICAM, along with other similar ligands, was also investigated for chloride 
binding to demonstrate the importance of the hydrogen bonding network around 
the catechol functionality towards anion binding.
12
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Previous synthetic routes towards H4-4-LICAM involve linking 2,3-
dimethoxybenzoyl chloride to 1,4-diaminobutane, followed by deprotection of 
the methyl ethers using boron tribromide.  In some cases, the deprotection was 
reported to work in excellent yields,
3
 however, yields have also been reported to 
be as low as 15%, suggesting that deprotection and/or purification is not 
straightforward.
12
  In addition to the uncertain yields, boron tribromide is a toxic 
reagent.  To avoid these issues a different synthetic route was devised.  
 
2.2 Synthesis of H4-4-LICAM 
 
The synthesis was carried out according to literature procedures with the 
exception of altering the catechol protecting groups from methyl ethers to benzyl 
ethers.
3, 13-15
  This change was made due to the ease of benzyl deprotection 
utilising benzyl hydrogenolysis compared to methyl ether deprotection requiring 
boron tribromide.  
 
The catechol-amide groups were synthesised from 2,3-dihydroxybenzaldehyde.  
First the phenolate oxygen atoms were protected as benzyl ethers, using benzyl 
chloride,
13
 followed by oxidation of the aldehyde group to the corresponding 
carboxylic acid with sodium chlorite and sulfamic acid.
14
  The carboxylate 
functionality was then activated as a succinic ester for the amide coupling, as 
previously reported.
15
  Compound 13 was then reacted with half an equivalent of 
1,4-diaminobutane, yielding the benzyl protected 4-LICAM.  This novel 
compound was characterised using 
1
H, 
13
C NMR and infra-red spectroscopy, 
mass spectrometry, and elemental analysis.  The benzyl ether protecting groups 
were removed using hydrogen over a palladium catalyst, resulting in the 
formation of the final compound H4-4-LICAM, the characterisation data of 
which are consistent with the literature (Scheme 1).
3, 12
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Scheme 1 – Synthesis of H4-4-LICAM.  (a) i) Benzyl chloride, K2CO3, EtOH  ii) 
NaClO2, H3NSO3, acetone/water, 79%; (b) N-hydroxysuccimide, DCC, 1,4-dioxane, 
71%; (c) 1,4-diaminobutane (0.5 eq), NEt3, acetone, 94%; (d) H2, Pd-C 10%, EtOH, 
99%.  Overall yield 52%. 
 
2.3 Ligand-Metal Interactions 
 
Due to the mismatch between the preferred coordination number of iron(III) and 
the denticity of H4-4-LICAM (six and four respectively), it was of interest to 
investigate the speciation of the complexes formed in solution (see Chapter 1).   
 
The literature suggests that many of these ligands can form a range of complexes 
with different binding stoichiometries.  Based on these literature reports, there 
would appear to be three possible structures in which H4-4-LICAM could 
interact with a iron(III) centre.  These are a mononuclear 1:1 complex, a 
dinuclear 2:2 complex, both with solvent molecules filling the vacant 
coordination sites on the metal centre, or a dinuclear triple standard 3:2 complex 
(Figure 23).   
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Figure 23 - Possible iron(III)-4-LICAM complexes that could form in solution. 
 
Stoichiometric Ratio Determination of H4-4-LICAM and Iron(III) using the 
Continuous Variation Method 
 
In order to determine the composition of the ligand-metal complexes formed in 
solution, the method of continuous variation (Job plot) was applied to H4-4-
LICAM and iron.  This method varies the concentrations of metal ([M]) and 
ligand ([L]) whilst allowing the sum of their concentrations to remain constant.  
The evaluation of a unique signal arising from complexation allows the 
determination of the ratio of components within a complex.
16
  
 
The development of a Job plot based on UV-visible spectra, allows the 
monitoring of catecholamide-iron(III) speciation via the ligand-to-metal charge 
transfer (LMCT) band arising from the catechol-iron(III) interaction, under 
biologically relevant conditions once the system has reached equilibrium.
17-19
  
The measurements required for the Job plot were carried out in buffered aqueous 
solution at pH 7.5. Due to the limited solubility of H4-4-LICAM in water, 
DMSO was added.  To ensure consistency, the concentration of DMSO was kept 
to 5% for all samples under investigation. 
 
Initial studies showed that the ferric iron that was added to the samples resulted 
in the formation of insoluble ferric hydroxide species within eight hours.  Only 
in the presence of excess ligand was the iron held in solution by complexation.  
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However, with excess of iron, a visible precipitate would form, which had to be 
prevented as it would alter the final concentration of iron in solution, and hence 
affect the result of the Job plot.  Measuring the UV-visible absorbance of freshly 
prepared samples, before precipitate formation occurred, would not reflect the 
species distribution at equilibrium. 
 
In aqueous conditions at neutral pH, iron(III) readily hydrolyses and 
precipitates, initiated by the formation of small inorganic polymers.  These 
polymers are able to grow into larger clusters, eventually forming colloidal sized 
hydroxide solids of various compositions (Fe
3+
, Fe(OH)
2+
, Fe(OH)2
+
, 
Fe(OH)3(aq)
0
 and Fe(OH4)
-
).
20
 
 
To avoid iron precipitate formation in the samples where an excess of iron is 
required, a second iron chelating ligand had to be introduced to compete with 
the hydroxide ligand.  Nitrilotriacetic acid, (NTA), has previously been used to 
solubilise iron(III) in solution and was reported not to effect the results obtained 
from spectrophotometric titrations.
21-22
  The first investigation, by Scarrow et 
al., examined the complex formation between iron and enterobactin hydrolysis 
products.  The absorbance arising from the LMCT band due to the iron-catechol 
interaction was plotted against the equivalents of iron per ligand.  The resulting 
plot showed that of the enterobactin hydrolysis products DHBS and the linear 
dimer could coordinate to one and two iron centres per ligand respectively.
21
  
 
 
 
The second investigation by Ma et al. was focused on developing a 
fluorescence-based method for pFe
3+
 determination.  The fluorophore chelated 
iron(III) with a well characterised binding constant, while competing ligands 
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were introduced to remove the iron(III) from the fluorophore.  The removal of 
iron(III) would lead to an increase of the fluorescent signal, which could be used 
to calculate the affinity of the ligands for iron(III).
22
  Both studies reported that 
NTA did not interfere to a significant extent with the results, instead it rapidly 
and completely delivered iron to the ligands with catecholate and 3-
hydroxypyridin-4-ones binding moieties.
21-22
 
 
The formation constants of NTA with various metal cations have been 
previously determined.
23
  The reaction of Fe
3+
 with NTA gives FeL, with only 
limited formation of a FeL2 species.  The 1:1 complex was reported to have a 
logK value of 16, while for the formation constant of the 1:2 complex logK was 
8.5.  However, this value was been questioned due to the formation of ferric 
hydroxide under the experimental conditions.
23
  The formation constant of a 
single catechol towards Fe
3+
 is reported to have a logK of 20.  Therefore it 
would be expected that NTA should have minimal competition with catechol 
binding; however, it would still be able to compete with any hydroxide ions to 
stop precipitate formation.
24
  
 
Additional control experiments were carried out to experimentally establish the 
effect of NTA under the experimental conditions used for the Job plot analysis.  
A catecholamide control compound was used to investigate if NTA is competing 
to a significant extent with the catechol functionality for iron and to ensure that 
NTA inhibits iron precipitation under the chosen conditions. 
 
Thus N-ethyl-2,3-dihydroxybenzamide H2-15 was synthesised to act as the 
control.  The bidentate ligand H2-15 was chosen to investigate if a single 
catecholamide unit can displace NTA under the conditions used to form the 
coordinatively saturated mononuclear 3:1 complex, plus potentially, 
coordinatively unsaturated 2:1 and 1:1 complexes.  The presence of the amide 
functionality should keep the electronic and hydrogen bonding properties of the 
catechol ring similar to that of H4-4-LICAM and other natural catecholate 
siderophores.   
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The synthesis utilised the benzyl protected activated succinic ester catechol unit 
(13), which was coupled to ethylamine.
25
  The benzyl protecting groups were 
removed using catalytic hydrogenation.  The product was purified by 
sublimation, to give product H2-15 in an overall yield of 53%. The 
characterisation data are consistent with literature data (Scheme 2).
26
  The 
synthesis, characterisation and Job plot analysis of H2-15 was completed by BSc 
project student Bethany Peeters under my supervision (2012-2013). 
 
 
 
Scheme 2 – Synthesis of H2-15.  (a) 2.0 M ethylamine, NEt3, THF, 72%; (b) H2, Pd-C 
10%, EtOH, 74%.  Overall yield 53%. 
 
The stoichiometric ratio of compound H2-15 and iron(III) was then determined 
in the presence and absence of NTA, using either a 10 mM Fe(NO3)3 + 10 mM 
NTA aqueous stock solution, or a 10 mM Fe(NO3)3 aqueous stock solution with 
no NTA present as the iron source.  The samples were prepared with the iron 
solution being introduced last to minimise precipitation for the samples with no 
NTA.  The samples were thoroughly mixed, and the absorbance reading taken 
within a minute to minimise precipitate formation in the samples with no NTA.  
Data points are the average of duplicate runs, with the standard deviation used as 
the error of the data points (Figure 24).  
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Figure 24 - Job plot for the binding of H2-15 to iron (III), obtained by following the 
absorbance at 512 nm in the presence (red diamonds) and absence (blue triangles) of 
NTA.  The absorbance values are averages of two experiments and the error bars 
indicate the differences between the runs.  Plot recorded in 0.1 M TrisHCl pH 7.5, 5% 
DMSO.   
 
The maximum of the Job plot obtained indicates a ligand-to-metal ratio of 3:1 in 
both cases, as expected for a bidentate ligand that coordinates to a metal centre 
with a preferred coordination number of six.  Visual inspection of the samples 
confirmed that the presence of NTA prevented the iron from precipitating, which 
together with the similarity between the two plots indicates that NTA does not 
interfere with the coordination of 15
2-
 to a ferric metal centre. It was therefore 
concluded that NTA is a suitable additive.  
 
The formation of more than one species becomes apparent when examining the 
whole set of UV-visible spectra obtained (Figure 25).  The maximum initially 
observed at 512 nm first increases in intensity, then shifts to 560 nm.  The 
maximum at 560 nm is indicative of a bis(catechol)iron(III) species, as reported 
previously.
17, 24, 27
  The bathochromic shift continues until the maximum is 
located at 592 nm, which is still within the quoted range for 
bis(catechol)iron(III) complexes.  There is no evidence of a 
mono(catechol)iron(III) complex, which has a reported λmax of 680-700 nm.
27-28
 
         Chapter 2 
          66 
 
0
0.2
0.4
0.6
0.8
1
190 270 350 430 510 590 670 750
Wavelength / nm
A
b
s
o
rb
a
n
c
e
Ligand
90:10
75:25
60:40
30:70
10:90
 
Figure 25 – Selected UV-visible absorbance spectra of H2-15 and Fe
III
(NTA), 
recorded in the presence of NTA.  Spectra recorded in 0.1 M TrisHCl pH 7.5, 5% 
DMSO.  Spectra ordered from black (H2-15) to light blue ordered by ligand to metal 
ratio. 
 
Job Plot Analysis of H4-4-LICAM and Iron(III) Nitrate in the Presence of 
NTA 
 
A Job plot investigation with H4-4-LICAM was carried out under analogous 
conditions as H2-15.  However, this time NTA was always present in equimolar 
amounts to iron to allow the solutions time to equilibrate without the formation 
of iron precipitate.  When preparing the samples for the UV-visible 
spectroscopic investigation, it was observed that at close to a 1:1 metal-to-ligand 
ratio the solutions were initially red but then the colour darkened progressively 
over time, giving a final colour of purple.  To characterise the colour change in 
more detail, a kinetic experiment was conducted, monitoring the change in 
absorbance at 498 nm and 552 nm over time.  Samples with H4-4-LICAM to 
iron(III) ratios of 3:2, 1:1 and 1:2 were monitored over 6 minutes at 5 °C (Figure 
26). 
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Kinetic Run of 3:2 H4-4-LICAM and Fe(III) at 5°C
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Figure 26 - Kinetic traces recorded for 1:2, 1:1 and 3:2 ratios of H4-4-LICAM and 
Fe
III
(NTA), following the absorbance at 498 nm (red diamonds) and 552 nm (blue 
triangles) over 6 minutes.  Spectra recorded every 6 seconds, solution containing 0.1 M 
TrisHCl pH 7.5, 5% DMSO at 5 °C.  Concentration of H4-4-LICAM; 1.3x10
-4
 M; 
2.0x10
-4
 M; 2.4x10
-4 
M for 1:2; 1:1 and 3:2 samples. 
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Solutions with ratios of 1:1 and 1:2 showed a change from red to purple over 
time, due to the increase of absorbance at 552 nm and a decrease in the 
absorbance at 498 nm, whilst the solution with a ratio of 3:2 showed no colour 
change.  These kinetic runs show that the equilibration of the solution is 
essentially complete after 6 minutes at 5 °C, yet there are clearly at least two 
different chemical species within the solution, possessing different λmax 
absorbance values.  Therefore the Job plot samples are required to stand for a 
minimum of 5 minutes at room temperature in order to ensure that the samples 
are at equilibrium before UV-visible absorbance spectra are recorded. 
 
The Job plot of H4-4-LICAM and iron(III) in the presence of NTA was then 
conducted as previously stated, with the samples now left to reach equilibrium 
before the absorbance values were recorded.  The UV-visible data revealed that 
there are two species present in solution with characteristic λmax values of 498 
nm and 552 nm (Figure 27).  Job plot analysis carried out at these two 
wavelengths indicates two binding ratios.  The absorbance at 498 nm indicates a 
3:2 binding ratio, whilst the absorbance at 552 nm shows 1:1 binding (Figure 
28).  This is consistent with the maximum absorbance values of approx 500 nm 
for a tris(catechol)iron(III) and 550 nm for the bis(catechol)iron(III) 
complexes.
17, 24, 27, 29
  The kinetic data suggests that in samples between the 3:2 
and 1:1 ligand-to-metal ratio that a tris(catechol)iron(III) complex forms prior to 
the bis(catechol)iron(III) complex, before reaching equilibrium (Figure 29). 
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Figure 27 - Selected UV-visible absorbance spectra of H4-4-LICAM and Fe
III
(NTA), 
used for the Job plot analysis.  Spectra recorded in 0.1 M TrisHCl pH 7.5, 5% DMSO.  
Spectra ordered from black (H4-4-LICAM) to light blue ordered by ligand to metal 
ratio; (95:5, 85:15, 78:22, 68:32, 60:40, 50:50, 46:54, 30:70, 10:90).  [M] + [L] = 0.4 
mM. 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0 20 40 60 80 100
Ligand to Metal Ratio
A
b
s
o
rb
a
n
c
e
498 nm
552 nm
1:4                3:2              2:3        4:1
A
b
s
o
rb
a
n
c
e
 
Figure 28 - Job plot for the binding of H4-4-LICAM and Fe
III
(NTA), obtained by 
following the absorbance at both 498 nm (red diamonds) and 552 nm (blue triangles).  
The absorbance values are averages of two experiments and the error bars indicate the 
differences between the runs.  Plot recorded in 0.1 M TrisHCl pH 7.5, 5% DMSO. 
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Figure 29 - Purposed schematic mechanism of formation of different 
(catechol)iron(III) complexes within samples for Job plot analysis.  Actual speciation 
cannot be determined from these experiments. 
 
In conclusion these results suggest that two species can form in solution and this 
process is dependant on relative concentrations of H4-4-LICAM and iron(III).  
One has a ligand to metal ratio of 3:2, with a maximum absorbance for the 
LMCT band at 498 nm, consistent with a tris(catechol)iron(III) complex;  the 
other has a ligand to metal ratio of 1:1 and a maximum absorbance value for the 
LMCT band of 552 nm, consistent with a bis(catechol)iron(III) complex.  These 
results only show that the species present have a ligand to metal ratio of 3:2 and 
1:1, and the speciation cannot be distinguished between species with the same 
stoichiometry, such as an m(M2L3) or an n(M2L3) structure. 
 
1
H NMR Spectroscopic Analysis of H4-4-LICAM and Gallium(III) Nitrate 
 
To study speciation in solution in more detail, 
1
H NMR spectroscopy was 
utilised.  Due to the paramagnetic nature of iron(III), gallium(III) was used as a 
diamagnetic substitute, as it has similar coordination chemistry and physical 
properties to iron(III).
30
  By preparing samples at known ratios of H4-4-LICAM 
and Ga(NO3)3 and by comparing the aromatic region of the 
1
H NMR spectrum 
of H4-4-LICAM, different species were identifiable.  To avoid competition from 
the protons that dissociate upon metal binding, four equivalents of sodium 
hydroxide with respect to H4-4-LICAM were added to each sample.  Due to the 
low sensitivity of the NMR technique, higher concentrations of H4-4-LICAM 
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were required than for the UV-visible experiments.  This required the percentage 
of d6-DMSO to be increased, hence the experiments were conducted in a solvent 
mixture of 5:1 d6-DMSO:D2O.  In order to ensure equilibrations, the spectra 
were recorded after 2 days and again after 30 days from sample preparation; the 
samples were kept at room temperature (Figure 30). 
 
Figure 30 - Aromatic region of the 1H NMR spectra of 4-LICAM4- in a mixture of d6-
DMSO/D2O with varying amounts of Ga(NO3)3 present, with 4 equivalents of NaOH 
with respect to H4-4-LICAM; (●) 4-LICAM
4-; (○) Complex A; (♦) Complex B. 
 
The aromatic region of the 
1
H NMR spectrum of 4-LICAM
4-
 shows the triplet 
(5.93 ppm) and the two doublets (6.24 ppm and 6.73 ppm).  The doublets have 
lost the defined splitting pattern and are observed as two broad signals, 
potentially as a result of delocalisation of charge due to the deprotonated 
catechol moiety.  The 
1
H NMR spectrum of the solution of H4-4-LICAM and 
gallium(III) present in a 3:2 ratio, recorded after two days, show the formation 
of species A (complex A, ○), with the signals arising from free 4-LICAM4- (●) 
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still present.  The signals for complex A are shifted downfield compared to those 
of 4-LICAM
4-
, showing that the aromatic protons are deshielded.  After 30 days, 
the signals due to free 4-LICAM
4-
 are absent, with only the signals due to 
complex A remaining.  In comparison, a solution containing a 1:1 ratio of H4-4-
LICAM and gallium(III) show only signals for complex A after 2 days whereas 
30 days later, a second set of signals appear, which is assigned as complex B (♦).  
The resonances are found further downfield to those of both complex A and free 
4-LICAM
4-
.  In the solution containing a 2:3 ratio of H4-4-LICAM and 
gallium(III) solution, the signal for complex A is still present, and the signals 
associated with complex B are also present, with little change occurring over 30 
days. 
 
The aromatic triplet signals arising from complexes A and B appear upfield 
compared to H4-4-LICAM, and downfield when compared to 4-LICAM
4-
.  This 
is consistent with a shielding effect on the aromatic protons due to additional 
electron density on the ring system, when comparing to H4-4-LICAM.
31-32
  
Therefore it can be concluded that complex A has a higher negative charge per 
catechol than complex B, as it is further upfield compared to complex B.  This 
suggests that complex A is the species with 3:2 ligand to metal ratio and 
complex B is the species with a 1:1 ratio, due to the higher charge density of the 
3:2 complex compared to the 1:1 complex (Table 3). 
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1
H NMR shift of 
aromatic triplet / ppm 
Species Formal Charge per 
Catechol 
5.93 4-LICAM
4- 
-2 
6.09 Complex A, m(M2L3)
6- 
-1* 
6.22 Complex B, m(ML)
- 
-0.5* 
6.67 H4-4-LICAMǂ 0 
 
Table 3 - Comparison of 1H NMR shifts for the aromatic triplet recorded in 5:1 d6-
DMSO : D2O. * Charge per catechol calculated assuming complex A has a 3:2 ligand to 
metal ratio and complex B has a ligand to metal ratio of 1:1, with neutral donors in 
vacant coordination sites. ǂ H4-4-LICAM was recorded in d6-DMSO. 
 
The hypothesis that complexes A and B have a 3:2 and a 1:1 ligand to metal 
ratio, respectively, is also supported by the change in the relative ratio of 
complexes A and B over time in both the 3:2 and 1:1 samples.  Complex A is 
shown to slowly equilibrate to form a clean spectrum in the 3:2 sample, 
suggesting that it possesses a 3:2 stoichiometry.  
 
The 1:1 appears to yield a clean spectrum, however, after allowing the sample to 
equilibrate, signals arising from complex B also become apparent.  The resulting 
clean spectrum in the 1:1 sample after 2 days suggests that all the 4-LICAM 
must be bound in the form of complex A as there are no other signals.  This 
suggests there must be 'free' gallium(III) within the sample, however, as the 
gallium source is Ga(NO3)3 it possesses no detectable protons to be observed in 
the 
1
H NMR spectrum.  This 'free' gallium(III) is presumably the driving force 
for the slow equilibration, dissociating some of the complex A to form complex 
B.  The fact that the 2:3 sample possesses signals for both complex A and 
complex B, rather than forming solely a 1:1 complex as the UV-visible data 
would suggest, shows that the equilibrium between complex A and B is clearly 
altered from that of the UV-visible experiment, likely due to the change in the 
solvent and pH of the system. 
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To confirm the assignment of complex A possessing a 3:2 ligand to metal ratio 
and to determine whether complex B is the 1:1 complex or the 2:2 complex, a 
diffusion-ordered spectroscopy (DOSY) experiment was carried out (Figure 31).  
The DOSY NMR experiment is a pseudo 2D technique, which presents 
chemical shifts against diffusion coefficients of the chemical species in solution.  
The diffusion coefficients can be determined from the NMR signal intensity 
decay, in a sequence of 1D spectra recorded with increasing amplitudes of 
pulsed field gradients.  This can be used to map the translational behaviour of 
the species within solution, which can then be used to calculate the diffusion 
coefficients of the species within solution.
33-34
 
 
Figure 31 - 1H DOSY NMR spectrum of the 1:1 sample recorded after 1 month of 
equilibration in 5:1 d6-DMSO : D2O. Representations: (○) Complex A; (♦) Complex B. 
 
The DOSY NMR shows that there are only two species that have a defined 
hydrodynamic radius.  The larger set of peaks, which originates from complex 
A, has a diffusion coefficient of 0.65 x 10
-10
 m
2
 s
-1
, which is approximately half 
the value of the smaller set of signals with a diffusion coefficient of 1.1 x 10
-10
 
m
2
 s
-1
.  As the diffusion coefficient is related to the size of the complex via the 
Stokes-Einstein equation (Equation 1), the diffusion coefficients indicate that 
complex A is approximately double the size of complex B.
35
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D = (1/6r)kT 
Equation 1 - Stokes-Einstein equation. Key;  - viscosity, r - radius of a spherical 
particle, k - Boltzmann constant, T - temperature. 
 
The DOSY spectrum was recorded at 295 K, in a DMSO : D2O 5:1 mixture, 
which has a viscosity () close to 2.6 x 10-3 Pa s.36  Due to the hydroscopic 
nature of d6-DMSO, the actual ratio of DMSO to D2O may differ from the 
quoted 5:1 ratio and therefore an error of ± 10% on the viscosity value has been 
calculated and the estimated values for the radii of complexes A and B can be 
calculated to be 11.6-14.2 Å and 6.8-8.4 Å, respectively. 
 
For comparison, an estimation of the radii of the proposed complexes can be 
obtained through molecular modelling using the computer program Avogadro 
(Figure 32).
37
  The models were built and energy minimised to get an estimation 
of molecular size.  It is uncertain which ligands are occupying the available 
coordination sites in the 1:1 complex.  DMSO molecules have been modelled in 
to represent coordinating solvent.  Avogadro was then used to calculate the 
centre of mass for the modelled complexes.  The centre of mass can be used to 
estimate the radius of the complexes by measuring the distance from the centre 
of mass to the outer atom, which will correspond to the overall radii of the 
complexes when tumbling in solution.  The estimations for a mononuclear 1:1 
complex and a 3:2 triple helicate are 6.0 Å and 10.5 Å, respectively.  These radii 
are slightly lower than those calculated from the DOSY experiment, as expected 
since the modelling does not account for solvation effects, which have an 
important effect on diffusion coefficients.
38
  The 2:2 complex has an estimated 
radius of 9.2 Å when modelled using Avogadro, which is larger than the DOSY 
experiment for complex B.  This does not include any solvation effects, which 
would increase the complex radius, suggesting that complex B is a 1:1, rather 
than a 2:2 complex. 
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Figure 32 - Models of the proposed 3:2 triple helical [Fe2(4-LICAM)3]
6-
 and 1:1 
mononuclear [Fe(4-LICAM)]
- 
complexes, showing the centre of mass calculated by 
Avogadro and distance to the outer most atom. Key; grey - carbon, blue - nitrogen, red - 
oxygen, yellow - sulphur, white - hydrogen, coral sphere - iron, light blue - centre of 
mass. 
 
In conclusion, the Job plot analysis shows that H4-4-LICAM can adopt two 
binding stoichiometries with iron(III), depending on the relative concentration of 
H4-4-LICAM and iron(III) in solution.  A similar dependence on relative 
concentrations can be seen in the 
1
H NMR spectra with gallium(III), with two 
complexes observed under different conditions.  These complexes are likely to 
be a complex with 3:2 ligand to metal ratio and a complex with 1:1 ligand to 
metal ratio.  The DOSY NMR experiment indicates that the 3:2 complex is 
approximately twice the size of the 1:1 complex, with analysis of the diffusion 
coefficients suggesting that the approximate size of the complexes fit the 
assignment of the complexes as a 3:2 triple helicate and a 1:1 monomeric 
complex. 
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2.4 CeuE-Complex Interactions 
 
As shown previously a range of different ferric-siderophore complexes can be 
formed in solution.  The aim of this study was to clarify which of these 
structures interact with the ferric-siderophore transport PBP’s, and to 
characterise these ferric-siderophore-protein interactions.  As outlined in 
Chapter 1, the PBP for the enterobactin uptake system in C. jejuni is CeuE.
39-40
  
 
The initial sequence identification of CeuE was taken from Uniprot (code 
Q0P8Q4).
41
  As CeuE is located in the periplasm it has a signal peptide at the 
start of the sequence in order to transport the protein into the periplasm of the 
organism.  The signal peptide by signal peptide prediction programs; SignalP 
4.0
42
, Signal-3L
43
 and LipoP
44
 suggest the signalling peptide is 20 amino acids 
long.  Therefore the CeuE sequence numbering relates to the mature protein, 
omitting the first 20 amino acids from the full sequence (Cysfull21 → Cysmature1) 
(Figure 33). 
 
 
 
Figure 33 - Full sequence of CeuE with the predicted signalling peptide highlighted as 
the black triangles. Image produced using ESPript.
45 
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Expression and Purification 
 
In previous work conducted by Axel Müller, it was shown that the first 23 amino 
acids of the mature CeuE are disordered and removal of this disordered region 
via limited proteolysis was required before crystals were able to be grown.
39
  
Therefore a new construct of CeuE was designed to start at Leu24 and was 
successfully amplified from genomic C. jejuni DNA.  The primers used to 
perform PCR are shown in Table 4. 
 
Forward Primer Reverse Primer 
5’CCAGGGACCAGCAATGTTGCCT
ATTAGTATGAGCGATGAG3’ 
5’GAGGAGAAGGCGCGTTATTATT
TTACAGCGTTTTTGATTTC3’ 
Table 4 - Primers used for gene amplification. 
 
The PCR product was then inserted into the pET-YSBLic system yielding a 
recombinant plasmid, which was subsequently transferred and grown in the 
expression strain BL21 E. coli.  Once expressed, purification was completed 
over three steps.  First, CeuE was purified using nickel affinity column 
chromatography utilising the cleavable His-tag that was introduced by the pET-
YSBLic vector.  The His-tag was then removed using C-protease in a 100:1 ratio 
in a dialysis bag for 48 hours at 4 °C to remove any imidazole in the buffer, as 
well as removing the His-tag.  SDS PAGE analysis revealed that only half of the 
His-tags had been removed (Figure 34). 
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Figure 34 - SDS PAGE analysis of CeuE protein, after 48 hours at 4 °C with C-
protease in a 100:1 ratio.  Lane 1: Before treatment with C-protease; Lanes 2 and 3: 
CeuE after treatment of C-protease; Lanes 4-8: Cut out work not relating to this project; 
Lane 9: Ladder.  
 
The protein was therefore subjected to a second C-protease digestion, this time 
in a 50:1 ratio for 18 hours at 4 °C.  SDS PAGE analysis then confirmed the 
removal of almost all of the histidine tags.  This allowed the second step of 
purification to be completed, using nickel affinity column chromatography to 
separate the His-tag free CeuE from other nickel binding proteins.  The final 
step was size exclusion chromatography to yield pure CeuE.  Fractions were 
checked by SDS PAGE analysis and pooled (lanes 6 and 7 in Figure 35).  The 
sample was concentrated to 18 mg/mL, and divided into 50 μL samples and 
flash frozen in liquid nitrogen and stored at -80 °C until required with the total 
protein produced being 19.8 mg from one litre of culture (see section 7.3). 
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Figure 35 – A) UV-visible trace of final gel-filtration column monitoring at 280 nm 
and 254 nm.  B) Final SDS PAGE analysis of CeuE, before and after the gel filtration 
step.  Lane 1: Before Gel filtration column; Lanes 2-8: Fractions from gel filtration 
column; Lane 9: Molecular weight ladder.  Pure CeuE in lanes 6 and 7 are associated 
with peak at 65 mL in UV-visible trace. 
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Crystallisation of apo-CeuE 
 
Initial crystallisation trials were conducted on apo-CeuE, using 96 well, sitting 
drop, PACT and Hampton commercial crystallisation screens.  A suitable crystal 
was selected from well B2 in the PACT screen (0.1 M MIB buffer, pH 5, 25% 
(w/v) PEG 1500), and a data set was collected at Diamond synchrotron beamline 
i03.  The structure was solved by means of molecular replacement with 
MOLREP
46
 using one of the CeuE peptide chains from the ferric-MECAM 
structure as a model (PDB code: 2CHU)
40
.  Refinement was completed using 
REFMAC5
47
 and Coot.
48
  The crystal was in the space group P1, with three 
CeuE monomers in the asymmetric unit.  The structure is that of a typical PBP 
with two domains linked by a -helical backbone (Figure 36). 
 
Figure 36 - Ribbon representation of apo-CeuE with colours blended from cyan, N-
terminus, to dark blue, C-terminus. 
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 CeuE {CeuE[Fe(4-LICAM)]} 
Data collection   
Diffraction Source DLS Beamline i03 DLS Beamline i24 
Wavelength / Å 0.976 0.978 
Temperature / K 100 100 
Crystal Data   
Space Group P1 P212121 
a, b, c / Å 56.95, 62.74, 67.98 60.42, 66.89, 67.30 
α, β, γ / ° 82.19, 76.74, 75.96 90, 90, 90 
Resolution / Å 65.93 - 1.69 44.96 - 1.61 
Unique Reflections 95173 28929 
Completeness / % 96.8 99.5 
Redundancy 2.4 5.7 
Rmerge 0.04 0.05 
Mean [I/σ (I)] 11.1 18.3 
Refinement 
Statistics 
  
Reflections, working 88200 20945 
Reflections, test 4647 1146 
Resolution Range / 
Å 
65.01 - 1.71 33.65-1.89 
R-factor 0.195 0.261 
Rfree 0.227 0.309 
Mean B Factors / Å
2
 29.4 19.5 
RMS deviation 
from ideal 
  
Bond length / Å 0.019 0.016 
Bond angles / ° 2.064 2.011 
PDB Code 3ZKW 3ZK3 
Table 5- Data collection and refinement statistics of apo-CeuE and {CeuE[Fe(4-
LICAM)]} structures. 
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As discussed in Chapter 1, a common feature of PBPs is the presence of two 
domains that are connected through either a long -helix or two or three -
strands, producing a bi-lobal structure.  The apo-CeuE model fits this description 
and has a long -helical backbone.  The cleft between the two lobes of the 
model is the known binding pocket of CeuE, which is dominated by a central 
positively charged electrostatic region (Figure 37).  The long connective -
helical backbone allows PBP’s to move the two domains towards each other for 
substrate binding.
49
  However, superimposition of the apo-CeuE structure with 
{CeuE2[Fe2MECAM2]} (PDB: 2CHU) shows little movement in CeuE upon 
substrate binding (RMS 0.72), possibly due to the main driving force for 
substrate binding being electrostatic, rather than coordinative (Figure 38). 
 
 
 
Figure 37 - Surface electrostatic representation of apo-CeuE, negative charge shown in 
red and positive charge in blue. 
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Figure 38 - Ribbon representation of apo-CeuE (PDB code 3ZKW) superimposed 
with the dimeric {CeuE2[Fe2MECAM2]} (PDB code 2CHU) structure.
40
  ProSMART 
analysis shows similar regions in yellow and regions of difference in red (white for 
unaligned).
50
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Crystallisation of the CeuE, Ferric-4-LICAM Structure 
 
The growth of apo-CeuE crystals and X-ray diffraction analysis to afford a 3D 
model structure provided the basis to determining how ferric 4-LICAM interacts 
with CeuE.  Co-crystallisation screens were set up in order to obtain single 
crystals for X-ray diffraction analysis.  A solution of ferric 4-LICAM was 
prepared from H4-4-LICAM and an aqueous solution of FeCl3 in methanol.  The 
solvent was removed to yield a purple solid, which subsequently was dissolved 
in DMF to produce a concentrated stock solution of ferric 4-LICAM.  This stock 
solution was mixed with the CeuE protein, and a purple precipitate formed.  The 
precipitate was removed by centrifugation, leaving a clear lightly purple 
solution, which was used for crystallisation using commercially available PACT 
and Hampton screens. 
 
Crystals grew in many of the crystallisation wells but few produced single 
crystals suitable for X-ray diffraction analysis.  A crystal found in well G5 of the 
PACT screen (0.2 M sodium nitrate, 0.1 M Bis Tris propane pH 7.5, 20% (w/v) 
PEG 3350) diffracted to approximately 2 Å resolution upon in-house testing on 
a Rigaku MicroMax 007HF generator with an MAR 345 imaging plate detector.  
The crystal was sent to the Diamond light source (DLS) synchrotron beamline 
i24 for full data collection.  The structure was solved as described for apo-CeuE 
(Figure 39).  The crystal was in the space group P212121, with one CeuE 
monomer in the asymmetric unit, however, the crystal was found to be twinned. 
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Figure 39 - Ribbon representation of {CeuE[Fe(4-LICAM)]} with colours blended 
from cyan, N-terminus, to dark blue, C-terminus.  His227, Tyr288 and Fe-4-LICAM 
shown as cylinders.  Key: binding residues, green - carbon, blue - nitrogen, red - 
oxygen; Fe-4-LICAM, grey - carbon, blue - nitrogen, red - oxygen; Fe - coral. 
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Figure 40 - Stereoview of the iron chelating ligands in the {CeuE[Fe(4-LICAM)]} 
with electron density map shown as 2Fobs-Fcalc, contoured at 1σ and chemical 
representation showing key interactions of Fe-4-LICAM.  Key: binding residues, green 
- carbon, blue - nitrogen, red - oxygen; Fe-4-LICAM, grey - carbon, blue - nitrogen, red 
- oxygen; Fe - coral. 
 
The {CeuE[Fe-4-LICAM]} complex is the first to offer structural insights into 
the binding of a tetradentate siderophore to a PBP.  The structure shows that 
ferric-4-LICAM has a 1:1 metal to ligand stoichiometry and binds to a single 
CeuE monomer.  This is in a similar fashion to the binding of ferric-
bacillibactin, ferric-enterobactin and ferric-MECAM to FeuA from B. subtilis.
51-
52
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The remaining two free coordination sites of the iron centre are occupied by the 
side chains of two amino acid residues, His227 and Tyr288.  The iron is bound 
in a distorted octahedral geometry (Figure 41).  The bond lengths are shown in 
Table 6 and range from 1.9 Å to 2.3 Å, consistent with previous known catechol 
iron bond lengths both in the absence of protein,
9
 and when bound to their 
respective proteins.
40, 51-53
  The iron-tyrosine and the iron-histidine bond lengths 
are 1.9 Å and 2.2 Å, respectively, which are typical for iron-complexes
54
 and 
match those in the structure of the ion transporter cFbpA from C. jejuni, in 
which Fe(III) is bound to four tyrosine and one histidine residues
55
 and also 
FbpA from H. influenzae in which Fe(III) is bound to two tyrosine and one 
histidine residues (PDB codes: 1Y4T, 3OD7).
56
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Figure 41 - Coordination of [Fe(4-LICAM)] in {CeuE[Fe(4-LICAM)]}.  Key; CeuE 
residues, green - carbon, blue - nitrogen, red - oxygen; 4-LICAM, grey - carbon, blue - 
nitrogen, red - oxygen; Fe - Coral sphere. 
 
Atom Bond Length / Å 
CatO23 - Fe 1.9 
CatO24 - Fe 2.0 
CatO25 - Fe 2.2 
CatO26 - Fe 2.3 
TyrO - Fe 1.9 
HisN - Fe 2.2 
 
Table 6 - Bond distances between coordinating atoms and the iron centre. 
 
The bond angles in the {CeuE[Fe(4-LICAM)]} crystal, Table 7, deviate from a 
perfectly octahedral geometry, consistent with other ferric-siderophores bound 
to their respective proteins.
40, 52
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Bond Bond Angle / ° Deviation from 
Ideal / ° 
CatO23-Fe-CatO24 113 23 
CatO23-Fe-CatO25 54 -36 
CatO23-Fe-CatO26 104 14 
CatO23-Fe-HisN 92 2 
CatO24-Fe-CatO26 93 3 
CatO24-Fe-HisN 101 11 
CatO25-Fe-CatO26 77 -13 
CatO25-Fe-HisN 94 4 
TyrO-Fe-CatO24 105 15 
TyrO-Fe-CatO25 88 -2 
TyrO-Fe-CatO26 77 -13 
TyrO-Fe-HisN 84 -6 
CatO23-Fe-TyrO 170 10 
CatO24-Fe-CatO25 161 -19 
CatO26-Fe-HisN 159 -21 
 
Table 7 - A comprehensive list of bond angles between coordinating atoms to the iron 
centre and their deviation from the ideal octahedral geometry. 
 
Superimposition of the apo-CeuE model onto {CeuE[Fe(4-LICAM)]}, shows 
that there is minimal structural change upon ligand binding (RMS 0.88), (Figure 
42).  The area of the largest structural change is around His227, which is the 
residue that binds to the iron centre.  His227 is located on a loop, which is not 
surrounded by major α-helices or β-sheets. 
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Figure 42 - Ribbon representation of apo-CeuE (PDB code 3ZKW) superimposed with 
the dimeric {CeuE[Fe(4-LICAM)]} (PDB code 3ZK3) structure.  ProSMART analysis 
shows similar regions in yellow and regions of difference in red (white for unaligned).
50
 
4-LICAM shown as cylinders- Grey, carbon - blue, nitrogen - red, oxygen; Fe - coral. 
 
In the {CeuE2[Fe2MECAM2]} structure the His227 loop is also disordered and 
was therefore excluded from the final model.  Unlike the histidine residue, 
which seems to be flexible, the tyrosine residues of the binding pockets of the 
two structures are found in the same location.  The main difference between the 
two is that in {CeuE2[Fe2MECAM2]}, Tyr288 donates a hydrogen bond to the 
complex, while in {CeuE[Fe(4-LICAM)]}, it coordinates directly to the iron 
centre. 
 
Sequence alignment of CeuE with the related ferric catecholate siderophore 
uptake proteins; YclQ, VctP and FetB, using T-coffee
57
 shows that the 
coordinating histidine and tyrosine residues are conserved among these proteins 
(Figure 43). 
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Figure 43 - Sequence alignment of selected PBPs: CeuE (C. jejuni), YclQ (B. subtilis), 
VctP (V. cholerae) and FetB (N. meningitidis), performed using T-coffee.
57
  Red block 
colours show fully conserved residues; red triangles show the position of basic triad of 
arginine residues; blue stars indicate position of coordinating histidine and tyrosine 
residues.  Image produced using ESPript.
45 
 
The full CeuE sequence can also be queried using a BLAST+
58
 search, which 
results in a large number of homologous proteins from a wide range of bacteria 
(Figure 44).  Both alignments show the histidine and tyrosine residues and the 
basic triad of arginine residues fully conserved.  The glutamic acid residues 
proposed for docking onto the inner membrane protein complex (E123 and 
E254), as outlined in Chapter 1, are present in all but one sequence (B. subtilis, 
YclQ).  In YclQ, the glutamic acid (E123) has mutated to an aspartic acid 
(D123), which presumably should be able to complete a similar role to the 
glutamic acid. 
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Continued… 
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Continued… 
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Figure 44 - BLAST+58 search results of homologous proteins to CeuE.  Aligned 
using T-Coffee
57
 and image produced using ESPript.
45
  Red block colours show fully 
conserved residues; red triangles show the position of basic triad of arginine residues; 
blue starts indicate position of coordinating histidine and tyrosine residues. 
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The His227 loop and Tyr288 positioning can also be compared with the 
structurally related proteins, VctP and YclQ, for which the apo-forms have also 
been structurally characterised.
59-60
  These structures both show the histidine and 
tyrosine in the same topological location as CeuE, with the YclQ structure 
showing reduced electron density around the histidine loop, which also supports 
that this histidine is flexible.  
 
The conservation of the histidine and tyrosine suggests a biological role in these 
proteins and hence could be part of a mechanism that enables certain PBPs to 
bind more than one type of ferric siderophore.  The flexible loop of the His227 
would enable this residue to coordinate if a tetradentate siderophore binds to the 
protein, but would also allow it to fold away from the binding pocket if a 
hexadentate siderophore is bound.  The Tyr288 residue is well placed for either 
hexadetante or tetradentate binding, either acting as a hydrogen bond donor or as 
a directly coordinating ligand towards the metal centre according to the type 
(hexa- or tetradentate) of ligand present (Figure 45).  This adaptor mechanism 
may give a biological advantage if it could enable the uptake of multiple iron-
complexes via a singular system. 
 
 
Figure 45 - Schematic diagram of a potential mechanism for both hexadentate and 
tetradentate binding in the binding pocket of CeuE. 
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Circular Dichroism and Fluorescence Biophysical Measurements 
 
Octahedral complexes with two cis-positioned bidentate ligands are chiral.
61
  
The chirality at the iron centre in the {CeuE[Fe(4-LICAM)]} crystal structure is 
Λ, as seen in other ferric siderophore bound proteins, such as 
{CeuE2[Fe2MECAM2]}, {FeuA[Fe(MECAM]}, {FeuA[Fe(enterobactin)]} and 
{FeuA[Fe(baillibactin)]} (Figure 46).
40, 52, 62
   
 
 
Figure 46 - Metal centre chirality in cis-bis(bidenate) complexes in comparison with 
the {CeuE[Fe(4-LICAM)]} crystal structure.  Key; CeuE residues, green - carbon, blue 
- nitrogen, red - oxygen; 4-LICAM, grey - carbon, red - oxygen; Fe - Coral sphere. 
 
To confirm that the Λ-configuration is preserved in solution, circular dichroism 
(CD) was used.  The CD spectra were recorded in the wavelength range of the 
LMCT band arising from the catechol-iron interaction, in aqueous TrisHCl 
buffer solution at pH 8 (Figure 47).  As expected, ferric-4-LICAM in the 
absence of CeuE does not preferentially absorb left or right polarised light, 
showing that there is a racemic mixture of both Λ and Δ-configured complexes 
in solution.  When CeuE is present the CD spectrum contains a broad negative 
band with a minimum at 400 nm and the positive band with a maximum at 595 
nm, giving an overall positive Cotton effect, a feature previously shown for 
catechol systems as being indicative of the Λ-configuration.31, 63-64  There is also 
a large negative feature in the spectrum at 320 nm, which is often part of the CD 
spectrum for iron-bound catecholamides, known to be a ligand based, n→ π* 
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transition.
21
  Due to the CD spectra of ferric-4-LICAM showing a racemic 
mixture, the preference of the Λ-configuration in the presence of CeuE must be 
due to the environment within the binding pocket of the protein.   
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Figure 47 - Circular dichroism spectra of CeuE with {CeuE[Fe(4-LICAM)]} in black 
and ferric 4-LICAM in the absence of CeuE (grey) recorded in 20 mM TrisHCl buffer, 
10 mM NaCl, 0.6% DMSO, pH 8. 
 
Taking account of the direct coordination of His227 and Tyr288, it is important 
to characterise the affinity of ferric-4-LICAM towards CeuE.  If binding affinity 
is very strong, it could indicate that this binding mode is not biologically 
relevant, as ferric-4-LICAM needs to dissociate from CeuE, and complex with 
the CeuBCD to be transported through the cytoplasmic membrane. 
 
The binding affinity between ferric-4-LICAM and CeuE was determined 
through the measure of intrinsic fluorescence quenching upon ligand binding, as 
previously for the ferric complexes of various catechol siderophore ligands 
binding to FeuA from B. subtilis
51-52, 65-67
, and FepB from E. coli.
68
 
 
CeuE contains a single tryptophan (Trp287) adjacent to the coordinating Tyr288, 
which can be exploited for fluorescence quenching analysis to determine a 
dissociation constant.  The experiments were all conducted in aqueous 40 mM 
TrisHCl pH 7.5, with 150 mM NaCl.  The sodium chloride ensured biologically 
relevant ionic strength of the solution, which could be an important factor in the 
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binding affinity, especially in the presence of electrostatic contributions.  To 
determine an accurate CeuE concentration, UV-vis absorbance was utilised, 
measuring the absorbance at 280 nm, and comparing it to the predicted molar 
absorbance coefficient (ε = 15930 mol-1 dm3 cm-1) of  the mature proteins 
sequence, using ProtParam.
69
 
 
The tryptophan was excited at 280 nm and the emission signal measured from 
295 to 415 nm.  The ferric-4-LICAM was complexed in situ by combining 
Fe(NTA) with H4-4-LICAM in equimolar amounts in a buffered sample to make 
a concentrated stock solution of complex which was allowed to stand 30 minutes 
before titration.  Control experiments showed that the buffer and the ferric-4-
LICAM stock solution had no detectable fluorescence signal within the relevant 
wavelength range.  A previous study involving the binding of ferric-
siderophores to FepB, showed that binding of a ligand to FepB occurs within 
seconds.
68
  To confirm that CeuE shows a similar kinetic behaviour, an initial 
titration was completed recording each data point at 1, 5 and 15 minutes (Figure 
48). This showed there is little difference on leaving the solution to stand for 
longer than one minute.   
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Figure 48 - Emission spectra of CeuE at 240 nM in 40 mM TrisHCl pH 7.5 150 mM 
NaCl, with various equivalents of Fe-4-LICAM, excitation at 280 nm.  Each spectrum 
was recorded after 1 minute (dark), 5 minutes (medium) and 15 minutes (light), shown 
as shades of starting colour.  Key; Black, 0 eq - blue, 0.4 eq - red, 0.8 eq - green, 2 eq - 
purple, 5 eq.  Emission intensity normalised to initial intensity. 
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A small hypsochromic shift in the emission maximum at 330 nm can be 
observed upon Fe-4-LICAM addition.  This indicates a change in the 
environment of the tryptophan residue, which can be expected due to its vicinity 
to the binding site.  To evaluate the emission quenching effect of Fe-4-LICAM, 
the integrated peak area of the emission band was determined from 305 to 380 
nm, in order to minimise the effect of the hypsochromic shift.  The data were 
recorded in triplicate and at two different concentrations, with each 
concentration originating from a different batch of CeuE.  The result of each 
titration experiment was plotted and fitted using DynaFit to calculate a 
dissociation constant via non-linear regression (Figure 49).
70
  The average 
dissociation constants were calculated using a weighted average using the 
method reported by Lyons (Equation 2, Table 8).
71
 
 
 
Figure 49 - Example fluorescence quenching analyses of PBP CeuE with ferric-4-
LICAM.  Titrations were carried out with 240 nM CeuE (red) and 170 nM CeuE (blue) 
in 40 mM TrisHCl pH 7.5, NaCl 150 mM.  Recorded data points shown as circles; lines 
give the non-linear least-squares calculated fits (DynaFit).
70 
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Equation 2 - Calculation of weighted average dissociation constant. 
 
 Dissociation Constant / nM 
Individual Average of Batch Overall Average 
Batch 1 
(240 nM) 
Run 1 25.1 ± 1.3 
27.7 ± 7.8 
29.3 ± 11.7 
Run 2 30.3 ± 0.9 
Run 3 14.9 ± 2.7 
Batch 2 
(170 nM) 
Run 1 44.9 ± 2.5 
40.5 ± 13.4 Run 2 40.8 ± 3.8 
Run 3 19.9 ± 5.3 
Table 8 - Calculated dissociation constants from non-linear regression analysis of the 
fluorescence quenching data of ferric-4-LICAM : CeuE titrations.  Error of individual 
Kd values are calculated from non-linear regression fit, and errors of overall and batch 
calculated from standard deviation of the different Kd values within that group. 
 
The calculated dissociation constants of the two batches of CeuE were found to 
be 27.7 ± 7.8 nM and 40.5 ± 13.4 nM.  The values are not significantly different 
but have larger error values associated with them compared to most other 
dissociation constants found in the literature for other PBP systems.  However, 
when comparing the same dissociation constant experimentally determined by 
different research groups, there is an inconsistency between the results and the 
level of error that is quoted.  For example, the dissociation constant of ferric-
bacillibactin and FeuA has been independently shown by separate groups to be 
15 ± 4 nM (Abergel et al.)
65
, 26.5 ± 1.4 nM (Miethke et al.)
66
 and 29 ± 22.5 nM 
(Peuckert et al.).
51
  All three of these results were obtained from different 
batches of FeuA, in separate laboratories, using fluorescence quenching to 
determine the dissociation constant.  The dissociation constants obtained by 
Abergel et al. and Miethke et al. both have small errors, however, the 
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dissociation constant obtained by Peuckert et al. shows a larger error.  Clearly 
there must be a larger error value than quoted by Abergel et al. and Miethke et 
al. due to the differences in the values obtained through basically the same 
experimental approach.  Peuckert et al. do not state whether  the results obtained 
in their experiments were results of difference batches of FeuA expressed and 
purified separately, but their dissociation constant appears to have a more 
realistic approximation of the error, given the other two results.  The 
discrepancy between batches is likely to be due to errors in the estimation of the 
true protein concentration, and these differences may provide a more realistic 
estimation of the error in the binding constants.  Therefore the dissociation 
constant of ferric-4-LICAM and CeuE was calculated from the average of all six 
titrations and is found to be 29.3 ± 11.7 nM. 
 
The dissociation constant of 29.3 ± 11.7 nM is comparable to those reported for 
other periplasmic binding proteins and their associated ferric-siderophore 
complexes.  Ferric-enterobactin has a dissociation constant of 19 ± 5 nM and 29 
± 1.4 nM for FeuA and FepB, respectively.
65, 68
  Ferric-bacillibactin has a 
dissociation constant of 15 ± 4 nM
65
, 26.5 ± 1.4 nM
66
 and 29 ± 22.5 nM,
51
 to 
FeuA and a structurally similar serine-glycine-catechol (SGC) found to be 52 ± 
8 nM.
65
  Interestingly, the enantiomers of enterobactin and SGC, which were 
found to form the Λ-configuration in solution rather than the Δ-configuration, 
have also been used for binding studies and show that these bind with a slightly 
increased strength.  Enantioenterobactin was shown to have a dissociation 
constant of 10 ± 2 nM for FeuA and 14.5 ± 1 nM for FepB, whereas ᴅ-serine-
glycine-catechol, was found to have a dissociation constant of 32 ± 4 nM, to 
FeuA, suggesting that both FeuA and FepB, may have a preference for the Λ-
configuration.
65, 68
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In conclusion, the CD spectroscopy shows that the ferric-4-LICAM is bound in 
the Λ-configuration in solution state as observed in the {CeuE[Fe(4-LICAM)]} 
crystal structure.  The observation that ferric-4-LICAM is achiral in the absence 
of CeuE shows that CeuE selectively binds the Λ-configuration.  The 
fluorescence quenching titration shows that the dissociation constant for ferric-
4-LICAM towards CeuE is within the biologically relevant range of similar 
proteins, suggesting that the coordination of the tyrosine and histidine residues 
observed in the {CeuE[Fe(4-LICAM)]} crystal structure may be of biological 
relevance. 
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2.5 Summary of Chapter 2 
 
The siderophore mimic H4-4-LICAM was synthesised, characterised and 
complexed to both iron(III) and gallium(III).  4-LICAM
4- 
forms complexes with 
3:2 and 1:1 ligand to metal ratios with these metal cations.  Which complex 
dominates in solution depends on the relative concentrations of both H4-4-
LICAM and metal.  For intermediate ligand to metal concentration ratios, 
between 3:2 and 1:1, the two complexes are in equilibrium.  With iron(III), 
equilibration occurs within minutes in aqueous buffer solution at pH 7.5.  In 
contrast, the equilibration is slower with gallium(III) in 5:1 d6-DMSO:D2O in 
the presence of sodium hydroxide. 
 
The PBP CeuE was over-expressed, purified and crystallised, both in the apo 
form and also as a co-crystal with ferric-4-LICAM.  Ferric-4-LICAM was found 
to be present in a unique binding mode in the binding pocket of CeuE, with 
residues His227 and Tyr288 coordinating directly to the metal centre.  Sequence 
alignment revealed that these two residues are conserved among related proteins 
from several bacteria, suggesting that they are part of a mechanism allowing 
these proteins to bind ferric-tetradentate as well as ferric-hexadentate 
siderophores, and facilitate the uptake of both species. 
 
The metal-centred chirality of the {CeuE[Fe(4-LICAM)]} structure was found to 
be Λ, both in the solid state (x-ray diffraction analysis) and in solution (CD 
spectroscopy), consistent with the previous {CeuE2[Fe2MECAM2]} structure.  
The dissociation constant was determined using intrinsic fluorescence quenching 
to be 29.3 ± 11.7 nM, consistent with those reported for other ferric-catecholate 
siderophores.  However, this study is the first time a tetradentate catecholate 
siderophore’s binding constant has been determined, and therefore cannot be 
directly compared to other tetradentate catecholate siderophore binding 
constants. 
 
 
 Chapter 3: Tetradentate 
Siderophores, a Natural 
Product Approach 
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Project Aims 
 
The work outlined within this chapter is a continuation of Chapter 2, following 
on from the biomimetic approach to characterisation of the enterobactin linear 
dimer, moving onto characterisation of the natural product itself. 
 
3.1 Introduction 
 
Following the study of the synthetic derivative H4-4-LICAM, described in 
Chapter 2, the next step in the study of tetradentate siderophores was to 
investigate a naturally occurring enterobactin fragment, namely the enterobactin 
linear dimer H4-17 (the quoted protonation state only refers to the catechol 
protons).  A key aim was to establish the coordination chemistry of a 
biologically relevant tetradentate siderophore both in free solution and in 
complex with an associated uptake protein. 
 
 
The linear dimer H4-17 can be considered as a segment of the hexadentate 
enterobactin molecule, with two catecholamide-based chelating groups on a 
backbone consisting of two L-serine units connected via an ester linkage. 
 
The biosynthesis of enterobactin is carried out by six enzymes, EntA-F, coded 
for by the genes entA-F.
1
  EntA and EntC synthesise 2,3-dihydroxybenzoic acid 
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(DHB) from chorismate, while EntD-F are involved in the assembly of the DHB 
and L-serine units into the trilactone.
1
  EntB is a bifunctional enzyme involved 
in both steps of the biosynthesis (Scheme 3).  
 
Scheme 3 - Biosynthetic pathway of enterobactin.2 
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It is not clear whether the enterobactin fragments are released from the 
biosynthetic pathway in order to act as siderophores in their own right, or are a 
result of the hydrolysis of enterobactin.
3
  A more detailed investigation of the 
EntF-catalysed elongation and cyclolactonisation step by Shaw-Reid et al. 
showed that only enterobactin was observed as a product when wild-type EntF 
was utilised, with no detectable amount of any enterobactin fragments using 
HPLC.
2
  On repeating the experiment with a mutation in EntF (S1138C), the 
catalytic turnover rate was dramatically reduced (100 min
-1
 to 0.9 min
-1
), and 
detectable amounts of the enterobactin fragments were observed using mass 
spectrometry.  The authors concluded that due to the absence of detectable 
amounts of fragments in the wild-type experiment it is likely that they are 
primarily hydrolysis degradation products.
2
 
 
After its identification and characterisation,
4-7
 the enterobactin linear dimer H4-
17 was used previously for several studies, including its coordination chemistry 
with iron(III)
8
 and gallium(III)
7
, growth studies of E. coli
9-10
 and various marine 
bacteria
11
, and other biological studies.
2, 12-15
  The majority of these 
investigations involved the isolation of H4-17 from growth media, while only 
one involved its synthesis as part of the total synthesis of enterobactin and 
enantioenterobactin.
16
 
 
There has been relatively little research involving the coordination chemistry 
and the biological importance of the linear dimer compared to enterobactin 
itself.  The aim of the work in this Chapter was its synthesis, determination of its 
coordination chemistry with iron(III) and the interactions of the ferric-complex 
of 17
4- 
with CeuE in solution and the crystal.   
 
Previous Synthetic Approaches 
 
The synthesis of enantiomerically pure H4-17 has not been described previously.  
In the total synthesis of enterobactin carried out by Rastetter et al., compound 
H4-17 was synthesised in a diastereomeric form.
16
  These authors encountered a 
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number of problems, including the racemisation of the serine backbone and 
various protecting group issues.  They outlined two approaches towards the total 
synthesis of enterobactin, the N-benzoyl monomer approach and the urethane-
protection route. These served as the basis of the methodology used in this 
chapter. 
 
The N-benzoyl Monomer Approach 
 
This method involves the synthesis of two differently protected N-[2,3-
bis(benzyloxy)-benzoyl]serine monomers followed by formation of the 
trilactone backbone in a step-wise fashion, yielding a protected linear dimer.  
Controlled deprotection and esterification of this dimer, with another N-benzoyl 
monomer yields the linear trimer, which could be cyclised to form enterobactin.  
When investigating the N-benzoyl monomer approach it was found that the 
esterification step yields diastereomeric products, due to racemisation of the 
activated form of the carboxylic acid, 18, when using DCC, DCC/HOBt or DCC 
and pyridine (Scheme 4).
16
   
 
 
Scheme 4 - The N-benzoyl monomer route when using X = DCC, DCC/HOBt or DCC 
and pyridine to activate the carboxylic acid for esterification. 
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The additive HOBt usually aids prevention of racemisation and deactivation by 
rapidly forming an activated aromatic ester with 20 before the competing acyl 
transfer can occur (Scheme 5).   
 
Scheme 5 - The use of HOBt to reduce the deactivation of the O-acylisourea mixed 
anhydride 20. 
 
The generated activated aromatic ester is still active enough to couple with a 
nucleophile, but because of its increased stability compared to the O-acylisourea 
mixed anhydride 20, slows the rate of oxazolone formation and hence, reduces 
racemisation (Scheme 6).
18-19
  Unusually, racemisation still occurred with the 
addition of HOBt in the esterification carried out by Rastetter et al., showing 
that the racemisation must have an extraordinarily high rate, or that the 
generated activated aromatic ester is still active enough to undergo oxazolone 
formation.
17
  Rastetter et al. attributed the high rate of racemisation to the 
electron-releasing nature of the benzyl groups on the catechol ring, which can 
promote the nucleophilicity of the benzamide carbonyl oxygen enhancing the 
rate of oxazolone formation.  Various other coupling reagents (Mitsunobu 
esterification, CDI coupling, N-methyl-2-chloropyridinium iodide) lead to 
dehydration of the monomer alcohol 19.
16
  The synthesis towards the linear 
dimer was continued and deprotection using zinc and acetic acid, followed by 
hydrogen over a palladium catalyst removes all the protecting groups, yielding 
the ʟ, ʟ -dimer and the ᴅ, ʟ -dimer. 
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Scheme 6 - Oxazolone-mediated racemisation during esterification. 
 
The N-benzoyl monomer approach for the total synthesis of enterobactin was 
abandoned due to these initial problems. 
 
The Urethane Protection Route 
 
The urethane protection route involves protection of the amine functionality of 
the serine units as a carbamate, followed by esterification, before urethane 
deprotection and introduction of the N-[2,3-bis(benzyloxy)-benzoyl] monomers.  
This route leads to successful formation of the ester linkage with no evidence for 
racemisation.  Rastetter et al. at this point continued the synthesis towards 
enterobactin rather than completing the synthesis of the linear dimer in an 
enantiomerically pure form.  The synthesis was completed by coupling the 
serine containing the free acid with the protected linear dimer to produce the 
protected linear trimer, which was then cyclised.  The benzyl protected catechol 
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units were added onto the cyclic trimer and subsequently deprotected, yielding 
enterobactin (ʟ-serine) or enantioenterobactin (ᴅ-serine) (Scheme 7).16 
 
 
Scheme 7 - The urethane protection route for the total synthesis of enterobactin 
outlined by Rastetter et al. 
 
The two routes towards the synthesis of the linear dimer both have advantages 
and disadvantages.  The N-benzoyl monomer approach is simpler with fewer 
steps, but it suffers from racemisation.  The urethane protection approach has the 
advantage of being proven to form the ester linkage without racemisation, but 
requires more synthetic steps.  Furthermore, the labile ester linkage has to be 
maintained during urethane deprotection, catechol coupling and catechol 
deprotection, whereas in the N-benzoyl monomer approach it only has to be 
maintained during catechol deprotection.  Therefore it was decided to investigate 
the N-benzoyl monomer approach first, as there have been advances in the 
development of peptide coupling reagents since Rastetter et al. published their 
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synthesis; the new reagents available were anticipated to prevent racemisation 
during the esterification step.
18-19
 
 
3.2 Synthesis 
Initial Approaches to the Synthesis of the Enterobactin Linear Dimer 
 
The work in this section was completed with the aid of Emily Brooke, a summer 
placement student working under my supervision (July-September 2012). 
 
As the electron donating properties of the protecting groups were linked to the 
racemisation of the serine during esterification, it was decided to replace the 
benzyl with tetrahydropyran (THP) ether, since this was used successfully by 
Rastetter et al. in the urethane-protection route.  Due to the limited availability 
of the 2-bromomethylanthraquinone (Maq-Br) starting material, the carboxylic 
protecting group had to be changed.  The alternative protecting group was 
required to possess orthogonal deprotection requirements to both the benzyl 
ethers (catalytic hydrogenation) of the catechol protecting groups and the THP 
ether (acid deprotection) of the alcohol protecting group; hence a base-labile 
methyl ester was chosen (Scheme 8).   
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Scheme 8 - Initial synthetic route towards the H4-17.  (a) NEt3; (b) NEt3; (c) THP, 
pyridinium p-toluenesulfonate;  (d) NaOH / NMe4OH; (e) DCC, HOBt, H
+
 workup; (f) 
H2, Pd-C 10%. 
 
Compound 22 was synthesised using commercially available ʟ-serine benzyl 
ester hydrochloride as the starting material.  Compound 13 was used to 
introduce the protected catechol scaffold, yielding amide 22 in a 91% yield.  The 
product was characterised using 
1
H and 
13
C NMR spectroscopy, infra red 
spectroscopy and ESI mass spectrometry.  The mass spectrum shows peaks at 
m/z 512.2063 and m/z 534.1867, corresponding to the protonated [M+H]
+
, and 
sodiated [M+Na]
+
, ions, consistent with a molecule of formula C31H29NO6.  A 
characteristic doublet at 8.86 ppm in the 
1
H NMR spectrum, which could be 
assigned to the amide proton, confirms formation of the amide bond.  The 
resonances due to the serine backbone consist of a doublet of doublet of doublets 
due to the proton on the α-carbon (Ha), and two roofed doublet of doublets 
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which are assigned as the two geminal protons on the β-carbon (Hb and Hc).  
Due to the chirality of the serine, the two geminal protons, Hb and Hc, are 
diastereotopic and both couple with Ha, and to the other geminal proton, arising 
to the two sets of doublet of doublets.  As the chemical shifts of these two 
signals are close, the two signals show a roof effect, which accounts for the 
profile of the signals (Figure 50). 
 
 
 
Figure 50 - 1H NMR spectrum of 22 in CDCl3 shown in the regions between 4.85-4.70 
ppm and 4.00-3.75 ppm.  The J-coupling splitting pattern is shown below, explaining 
the splitting for each of the three resonances.  *The assignment of H
b
 and H
c
 can be 
interchanged. 
 
Compound 24 was synthesised using ʟ-serine methyl ester hydrochloride and the 
catechol unit introduced and characterised as described for 22 (78% yield).  
Compound 24 was then treated with 3,4-dihydro-2H-pyran, using pyridinium p-
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toluenesulfonate in dichloromethane to introduce the THP protecting group.  The 
resulting compound 25 was obtained in 86% yield using the same methodology as 
Rastetter et al.16  Compound 25 was characterised using 
1
H and 
13
C NMR 
spectroscopy, infra-red spectroscopy and ESI mass spectrometry.  The mass 
spectrum showed a peak at m/z 542.2139 consistent with a [M+Na]
+ 
ion for a 
molecule with a formula of C30H33NO7.  The 
1
H and 
13
C NMR spectra 
confirmed the addition of THP, and also showed the doubling of all signals 
associated with the two diastereomers that form upon non-stereospecific 
introduction of the THP group. 
 
Deprotection of the methyl ester of 25 was attempted with sodium hydroxide in a 
methanol:dichloromethane mixture.  Monitoring the reaction via TLC and mass 
spectrometry indicated formation of the desired de-methylated product, however, the 
subsequent analysis of the product revealed that the THP protecting group was also lost, 
either during the reaction or during the work-up procedure.  Changes in solvent, 
reaction conditions, or base (from sodium hydroxide to tetramethylammonium 
hydroxide) did not result in selective deprotection of the methyl ester whilst maintaining 
the THP ether.  Due to these protecting group compatibility issues an alternative route 
that avoids THP as protecting group was developed. 
 
The second synthetic route involved protecting the alcohol and acid groups of 
the two serine backbone units as a benzyl ether or benzyl ester, respectively.  
The starting materials, ʟ-serine benzyl ester hydrochloride 21 and O-benzyl-ʟ-
serine 28, are commercially available (Scheme 9).  The N-benzoyl monomer 29 
was synthesised and characterised as described for compound 22. 
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Scheme 9 - Second synthetic route towards H4-17.  (a) NEt3; (b) NEt3; (c) 
Esterification, various conditions; (d) H2, Pd-C 10%. 
 
Various reaction conditions were investigated in order to obtain compound 30 in 
enantiomerically pure form.  Rastetter et al. reported the use of DCC/HOBt, 
CDI, N-methyl-2-chloropyridinium iodide
20-21
 and ethyl diazodicarboxylate, 
triphenylphosphine (Mitsunobu reaction).
22-23
  In the investigation to form 30, a 
range of conditions were applied in order to form the enantiomerically pure ester 
including DCC, EDC, HBTU, DCC/HOBt, EDC/HOBt, DCC/DMAP, activation 
using thionyl chloride or formation of an activated ester with N-
hydroxysuccinimide.  Of these, only DCC/HOBt gave an isolatable amount of 
product in 16% yield as a diastereomeric mixture of 30 (ʟ, ʟ and ᴅ,ʟ). 
 
Despite the formation of the diastereomeric mixture of compound 30, the 
catalytic hydrogenation for global benzyl deprotection was conducted in order to 
test the reaction and to form the diastereomeric mixture of compound H4-17.  
The reaction was performed and the product characterised in the same manner as 
for H4-4-LICAM described in Chapter 2.  Mass spectrometry showed that the 
ester linkage had been maintained during the reaction, with the peaks found at 
m/z 465.1142 and m/z 487.0985 corresponding to the [M+H]
+
 and [M+Na]
+
 ions 
for a molecular formula of C20H20N2O11 respectively.  The 
1
H and 
13
C NMR 
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spectra again showed the doubling of the signals associated with the two 
diastereomers in the sample, and the 
13
C NMR containing the ester linkage 
carbon signal, confirming the ester had not hydrolysed.  There was no evidence 
of transesterification with ethanol, used as the solvent for the reaction.  The 
reaction yielded a 94% of the diastereomeric mixture of compound H4-17 (ʟ, ʟ 
and ᴅ, ʟ). 
 
This reaction sequence confirmed that compound H4-17 can be synthesised 
using the outlined synthetic route, although the diastereomers would need to be 
separated before catalytic hydrogenation.  However, due to the low yield of the 
esterification reaction step, it was concluded that this route is not a viable option 
for scale-up to access larger quantities.  For this reason the route was abandoned. 
 
Synthesis of the Enterobactin Linear Dimer 
 
Due to the problems described above, the urethane protection approach outlined 
in section 3.2 was attempted.  Rastetter et al. investigated the use of both the N-
tert-butoxycarbonyl, and carboxybenzyl groups for the protection of the amino 
groups.  In both cases the esterification step was reported to proceed without 
racemisation.
16
 
 
Ultimately the carboxybenzyl group was used for amino protection in the 
synthesis of enterobactin, due to difficulties in the cyclisation step of the linear 
trimer when the N-tert-butoxycarbonyl group was used.  However, this issue 
does not need to be considered for the synthesis of the linear dimer.
16
  In the 
synthesis of the linear dimer, it is necessary for the alcohol and the carboxylic 
acid of the serine backbone to be protected to control the esterification step.  In 
order to simplify the deprotection procedure once the benzyl protected catechol 
moieties are coupled to the backbone, and hence to have a global benzyl 
deprotection, the protecting groups selected for the alcohol and the carboxylic 
acid were a benzyl ether and benzyl ester, respectively.  As the serine monomers 
have benzyl protecting groups attached, the amino protecting groups must be 
removed under orthogonal deprotection conditions compared to that of the 
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benzyl groups.  For this reason the carboxybenzyl group cannot be used, and 
therefore N-tert-butoxycarbonyl protecting group were chosen (Scheme 10). 
 
Scheme 10 - Third synthetic route towards H4-17.  (a) SOCl2; (b) Boc2O, NEt3; (c) 
Boc-O-benzyl-L-serine, EDC, HOBt, ; (d) TFA; (e) DIPEA; (f) H2, Pd-C 10%. 
 
Compound 32 was synthesised by reacting ʟ-serine benzyl ester hydrochloride 
with di-tert-butyl dicarbonate in the presence of triethylamine (98% yield).  
Compound 32 showed a characteristic singlet at 1.43 ppm in the 
1
H NMR 
spectrum which integrates to nine protons corresponding to the tert-butyl group.  
A broad doublet at 5.52 ppm of relative integration one, can be assigned to the 
carbamate proton, which couples to the proton on the alpha-carbon of the serine 
unit.  The NMR and mass spectrometry data are consistent with the literature, 
however, a previous synthesis reports the compound as a colourless oil, whereas 
a white waxy solid was obtained here (melting point 66.8-68.2 °C).
24
 
 
Initially, compound 33 was synthesised from 32 and commercially available 
Boc-O-benzyl-ʟ-serine using DCC as the coupling reagent and DMAP as an additive, 
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however, a DCC-derived impurity formed during the reaction.  The impurity could not 
be removed from the product despite numerous purification attempts.  Therefore the 
reaction was repeated using EDC as an alternative coupling reagent, with HOBt 
as the additive.  Compound 33 was easily purified via silica column 
chromatography, with no evidence of racemisation, to give compound 33 in 61% 
yield (characterisation data consistent with the literature).
25
 
 
Removal of the Boc-protecting groups was then achieved using trifluoroacetic 
acid in dichloromethane.
26
  The 
1
H NMR spectrum showed the absence of the 
two tert-butyl and the carbamate proton signals, while mass spectrometry and 
13
C NMR confirmed that the ester linkage had been maintained during Boc-
deprotection. 
 
To introduce the catechol functionality onto diamine 34, compound 13 was 
initially utilised in the same fashion as in the synthesis of H4-4-LICAM (see 
Chapter 2).  The reaction, however, was found to proceed in low yields; 
therefore an alternative method was designed.  Compound 12 was instead 
activated as the acid chloride, compound 31, prepared in accordance with the 
literature and used without isolation.
27
  Compound 31 was then reacted with 34 
in the presence of N,N-diisopropylethylamine in anhydrous dichloromethane 
under a dry nitrogen atmosphere in order to limit hydrolysis of the ester under 
basic conditions.  The coupling of the catechol units to 34 proceeded in 44% 
yield, lower than 61% reported by Rastetter et al. in the synthesis of 
enterobactin.
16
  A peak in the mass spectrum at m/z 1005.3922 was assigned as 
the [M+H]
+
 protonated molecular ion and the 
1
H and 
13
C NMR spectra both 
showed the addition of the benzyl protected catechol units on to compound 34 to 
form compound 30.  There was no evidence of the formation of diastereomers in 
the NMR spectra.  Elemental analysis was also used to confirm the purity of the 
sample. 
 
Compound 30 was deprotected using catalytic hydrogenation under an 
atmosphere of hydrogen in the presence of a 10% Pd-C catalyst, to obtain 
compound H4-17 in a quantitative yield.  Mass spectrometry, 
1
H, 
13
C NMR and 
elemental analysis confirmed the successful synthesis and purity of the product.  
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The characterisation data were consistent with literature data for H4-17 isolated 
from growth media (see section 7.2).
12
  To identify whether the chirality of the 
serine units had been affected during the synthesis, specific rotation of polarised 
light at the sodium line was measured in methanol, and was found to be []D = 
+15, in good agreement with the literature value of []D = +13.
12
 
 
3.3 Ligand-Metal Interactions 
 
As discussed in Chapter 2, the mismatch between the preferred coordination 
number of iron(III) and the denticity of the ligand required investigation of the 
speciation of the complexes formed in solution.  After the study of the ligand-
metal interaction with the biomimetic derivative 4-LICAM, the successful 
synthesis of the enterobactin linear dimer allowed this investigation to be 
completed. 
 
Enterobactin is one of the most widely studied siderophores,
28
 but little research 
has been conducted on the coordination chemistry of H4-17.  Two studies have 
investigated ligand-metal coordination chemistry, one by Scarrow et al. which 
investigated the iron(III) coordination of linear dihydroxyserine compounds 
derived from enterobactin,
8
 and the other by Bergstrom et al. which focused on 
NMR studies of 2,3-dihydroxyserine compounds, which also extended into 
coordination with gallium(III).
7
  
 
Scarrow et al. used UV-visible measurements of the LMCT band in a 
spectrophotometric titration.  Upon titrating H4-17 with iron(III), the absorbance 
at 590 nm increased.  Plotting the absorbance at this wavelength versus 
equivalents of iron(III), a linear change of absorbance was observed, with 
notable breaks at 1.0 and 2.0 equivalents of iron(III).  These changes were 
attributed to the formation of 1:1 and 1:2 ligand-to-metal complexes.  However, 
Scarrow et al. did not discuss an apparent bathochromic shift in the UV-visible 
data shown in the supplementary information.
8
  During the titration, the 
maximum absorption was initially at approximately 500 nm and then shifted to 
approximately 550 nm, between 0.5 and 1.0 equivalents of iron(III).  This 
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bathochromic shift indicates a change in coordination environment, from a 
tris(catechol)iron(III) to a bis(catechol)iron(III) complex (Figure 51). 
 
 
Figure 51 - Upper - Plot of the absorbance at 590 nm for solutions containing the 
DHBS monomer and linear dimer in the presence of increasing equivalents of Fe(III).  
Solutions were buffered at pH 9 and ferric ion was added as the NTA complex.  Lower - 
UV-visible spectra between 370-800 nm recorded during the linear dimer titration.  
Reprinted with permission from Inorg. Chem., 1991, 30 (5), 900-906.  Copyright 1991 
American Chemical Society.
8
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Scarrow et al. also noted that during a spectrophotometric titration of the 1:1 
ferric complex of H4-17 across pH ranges of 8.0-7.0 another bathochromic shift 
is observed from λmax of 500 nm at pH 8.0 to a λmax of 540 nm at pH 7.0 (Figure 
52).  This shift was explained by hydrolysis of one of the two coordinating water 
molecules assumed to be coordinating in the two remaining iron coordination 
sites.  This shift, which is associated with pH change, cannot be the cause of that 
seen in Figure 51, as the iron titration was buffered at pH 9.0, which would only 
allow for minimal pH change during the experiment.  The conclusion that H4-17 
only forms a 1:1 complex in the presence of iron(III) is likely to be an over-
simplification of the system. 
 
 
Figure 52 - Spectrophotometric titration of the 1:1 ferric complex of H4-17 in dilution 
corrected absorbance units.  Reprinted with permission from Inorg. Chem., 1991, 30 
(5), 900-906.  Copyright 1991 American Chemical Society.
8 
 
Another investigation of the coordination chemistry of H4-17 was conducted by 
Bergstrom et al., who explored the change in the 
1
H and 
13
C NMR signals of the 
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linear dimer upon chelation of gallium(III).  They showed that upon chelation of 
gallium by H4-17 (ratio not specified), a simple 
1
H NMR spectrum is observed, 
where the signals of the aromatic protons and the protons situated on the α- 
carbon all shift upfield, while the two diastereotopic, geminal protons situated 
on the β-carbon shift differently to each other, one upfield and the second 
downfield.
7
  The authors stated that it is not clear whether H4-17 forms a triple 
stranded 3:2 complex, similar to that formed by rhodotorulic acid
29
, rather than a 
3:2 mono-bridged dimer, such as that formed by alcaligin
30
 (Chapter 2), 
although the complex is more likely to have formed the triple stranded complex, 
due to the observation of a simple spectrum, indicating that the ligands are 
equivalent.
7
  The possibility of H4-17 forming a 1:1 complex was not addressed, 
assuming that H4-17 must form a 3:2 complex to satisfy the octahedral binding 
geometry of iron(III), although this contradicts the conclusion of Scarrow et al. 
who claim that H4-17 predominantly forms a 1:1 complex.
8
  It is still unclear 
which coordination complex the tetradentate bis(catecholate) ligand H4-17 
preferentially forms under biologically relevant conditions. 
 
The coordination chemistry of a structurally similar bis(catecholate) siderophore 
family known as the amonabactins has also been studied.
31
  The amonabactins 
are a series of bis(catecholate) siderophores that are composed of tri- or 
tetrapeptides with the general formula (gly)-(ʟ)-lys-(ʟ)-lys-(ᴅ)-aro, where the 
aromatic residue is either a tryptophan or phenylalanine (Figure 53).
32-33
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Figure 53 - Amonabactins.  Names refer to the aromatic amino acid constituent and 
molecular weight. 
 
This family of siderophores can interchange their coordination chemistry 
depending on pH and relative concentration of ligand to metal.
31
  At high pH 
with an excess of ligand a 3:2 ligand to metal complex dominates, whereas at 
neutral and low pH, they preferentially form 1:1 bis(catechol)iron(III) 
complexes.
31
  These studies by Scarrow et al.
8
 and Telford et al.
31
 highlight that 
the coordination chemistry of these bis(catechol) siderophores is non-trivial, and 
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a variety of complexes can form under different conditions.  This study will 
focus on the complexes formed by H4-17 with iron(III) at neutral pH and under 
biologically relevant conditions. 
 
Investigation of 17
5-
 to Iron(III) Ratios using the Continuous Variation 
Method 
 
The investigation of the coordination chemistry of H4-17 was carried out under 
the same conditions as those reported for H4-4-LICAM (Chapter 2).  A kinetic 
experiment was set up as for H4-4-LICAM, to investigate the time required for 
the samples obtained by mixing H4-17 with iron(III) in a 1:1 ratio to reach 
equilibrium.  H4-17 exhibited different behaviour to H4-4-LICAM and did not 
show a notable change in colour over time at close to a 1:1 metal-to-ligand ratio.  
The experiment showed a bathochromic shift in λmax (542 nm to 563 nm), with 
the intensity of the LMCT band increasing and then stabilising after 60 seconds 
(Figure 54).  The reason for the bathochromic shift in λmax is not clear.  As the 
system has not reached equilibrium, presumably there are coordination 
complexes with different speciation (particularly solvation) affecting the 
observed absorbance.  This showed that the equilibrium is reached relatively 
quickly which allowed the Job plot to be conducted in the same manner as for 
H4-4-LICAM.   
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Figure 54 - Upper - Selected UV-visible absorbance spectra recorded during the 
kinetic run with H4-17 (2.0x10
-4
 M) and iron(III) (1:1 ratio).  Spectra ordered from 
black (0 seconds) to light blue (60 seconds) for selected time intervals.  Lower - Kinetic 
trace of upper, following absorbance at 500 nm (red diamonds) and 560 nm (blue 
triangles) over 2 minutes.  Spectra recorded every 3 seconds, solution containing 0.1 M 
TrisHCl pH 7.5, 5% DMSO at 20 °C. 
 
The UV-visible spectra of ferric-17 (Figure 55) show two λmax values at 512 nm 
and 563 nm when varying the ligand to metal ratio, as found in the UV-visible 
data for ferric-4-LICAM.   
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Figure 55 - Selected UV-visible absorbance spectra of H4-17 and Fe
III
(NTA), used for 
the Job plot analysis   Spectra recorded in 0.1 M TrisHCl pH 7.5, 5% DMSO.  Spectra 
ordered from black (H4-17 excess) to light blue ordered by ligand to metal ratio; 90:10, 
70:30, 60:40, 50:50, 40:60, 30:70, 10:90).  [M] + [L] = 0.4 mM. 
 
Job plot analysis carried out at these two wavelengths (512 nm and 563 nm) 
indicates two different binding ratios, however, unlike ferric-4-LICAM, the 
ratios for ferric-17 are closer together (Figure 56).  The analysis at 563 nm 
shows the expected 1:1 ratio, however, the analysis for 512 nm shows a 
stoichiometry between the 3:2 and 1:1 ratios.  This shift suggests that 17
5-
 (extra 
charge due to deprotonated carboxylate group at pH 7.5) prefers a ligand-to-
metal binding ratio of 1:1, but is still capable of coordinating in the 3:2 mode if 
an excess of ligand is present.  The preference for the 1:1 complex could be 
influenced by a number of factors, such as the stereochemistry of the backbone, 
prearranging the catechol binding groups away from the linear arrangement 
required for triple helicate formation.  The nature of the backbone could also 
influence the binding ratio, as the linear dimer possesses a polar linker with the 
ester which can form hydrogen bonds in the aqueous solution, rather than a 
hydrophobic one, which could self assemble in order to reduce contact with the 
polar solvent, potentially favouring the 3:2 assembly.  The accumulation of 
negative charge could also disfavour the 3:2 complex for ferric-17, as the free 
carboxylate group on the backbone will also add negative charge to the complex, 
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with the resulting 3:2 complex of ferric-17 formally having a negative charge of 
nine rather than negative six for ferric-4-LICAM. 
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Figure 56 - Job plot for the binding of H4-17 and Fe
III
(NTA), obtained by following 
the absorbance at both 512 nm (red diamonds) and 563 nm (blue triangles).  The 
absorbance values are averages of two experiments and the error bars indicate the 
differences between the runs.  Plot recorded in 0.1 M TrisHCl pH 7.5, 5% DMSO. 
 
The Job plot shows that H4-17 can adopt two binding stoichiometries with 
iron(III), much like H4-4-LICAM, depending on the relative concentration of 
H4-17 and iron(III) in solution.  Unlike H4-4-LICAM, the Job plot of H4-17 
suggests that a 1:1 binding stoichiometry is preferred over 3:2, suggesting it has 
similar solution behaviour to the amonabactins, although they possess a much 
longer linker between the coordinating functional groups.   
 
Circular Dichroism Spectroscopic Study of the H4-17 and Iron(III) System 
 
Due to the chirality of the ligands (amonabactins, enterobactin and the 
enterobactin hydrolysis products), intramolecular chiral induction influences the 
metal-centred chirality of the complexes which can be examined using circular 
dichroism.  Enterobactin is known to form mainly Δ-configured complexes, with 
iron(III),
34
 chromium(III),
35
 vanadium(IV)
36-37
 and rhodium(III).
38
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Scarrow et al. investigated the coordination chemistry of the enterobactin 
hydrolysis products and showed that the linear trimer forms a iron(III) complex 
with Δ-configuration with a CD spectrum similar to that of ferric enterobactin.  
The linear dimer (1:1 ratio with iron(III)) was essentially featureless in the 
visible region, which was attributed to an equilibrium between equal amounts of 
Λ- and Δ-configured complexes (Figure 57).8  All three spectra produce a 
positive band due to a n→π* transition at approximately 320 nm, which was 
interpreted as a ligand-based transition that increases in intensity upon metal 
binding.   
 
 
 
Figure 57 - Circular dichroism spectra of the free ligands (left) and the iron(III) 
complexes (right) of enterobactin and the hydrolysis products in aqueous solution at pH 
7.5, 0.1 M HEPES buffer. Reprinted with permission from Inorg. Chem., 1991, 30 (5), 
900-906. Copyright 1991 American Chemical Society.
8
 
 
The CD spectra of the ferric-amonabactins have also been studied and show that 
the 1:1 ferric-amonabactins are present in a racemic mixture of Λ- and Δ-
configured complexes while the 3:2 ligand to metal ratio shows a weak 
preference for the Δ-configuration.31 
 
Job plot analysis suggests that the coordination chemistry behaviour of H4-17 is 
similar to that of the amonabactins, showing a change in coordination geometry 
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under different conditions, although the original study by Scarrow et al. did not 
record the CD spectrum of the H4-17 with iron(III) in a 3:2 ligand to metal ratio.  
 
To determine whether H4-17 behaves similarly to the amonabactins, the CD 
spectra of ferric H4-17 were recorded at ligand-to-metal ratios of 3:2, 1:1 and 
2:3.  Samples were prepared in the same manner as for the continuous variation 
experiments, (0.1 M TrisHCl pH 7.5, 5% DMSO).  The samples were given time 
to reach equilibrium before spectra were recorded (Figure 58). 
 
 
Figure 58 - Circular dichroism spectra of H4-17 and ferric-17 in key ligand-to-metal 
ratios in aqueous 0.1 M TrisHCl buffer, pH 7.5, 150 mM NaCl, 5% DMSO.  [L] + [M] 
= 0.4 mM. 
 
The CD spectrum of H4-17 in the near UV region shows a positive feature 
arising from an n→π* transition at approximately 320 nm, which grows in 
intensity upon metal binding.  When the ligand to metal ratio is 1:1 or 2:3, the 
spectra are consistent with that of the ferric linear dimer reported by Scarrow et 
al., with a large positive feature at 320 nm and a weak, broad, positive feature 
between 380-610 nm.
8
  When the ligand to metal ratio is 3:2, the large positive 
feature around 320 nm in H4-17 is shifted to 340 nm, and the intensity of the 
weak, broad feature increases, becoming more positive around 415 nm and more 
negative at 550 nm, with a zero point at 500 nm giving a negative Cotton effect.   
 
         Chapter 3 
          133 
This change in CD spectra also coincides with a colour change from purple to 
red, consistent with the formation of a tris-catecholate system.  This indications 
a change in mode of binding of H4-17 towards iron(III), with a clear preference 
for the Δ-configuration.   
 
The behaviour of the CD spectra at different to ligand to metal ratios resembles 
that of the amonabactins, but the intensity of the change is more profound with 
H4-17.  This may be due to the distance between the binding catechol groups and 
the stereo-centre in the ligand.  The iron binding catecholamide units of H4-17 
are directly linked to the stereocentre of the siderophore backbone, whereas in 
the amonabactins the catecholamide is linked to the side chain amine of the 
lysine backbone, which has a four carbon spacer between the catecholamide and 
the stereocentre, potentially reducing the influence of the stereocentre upon 
metal binding. 
 
In conclusion, H4-17 binds both in a 1:1 and a 3:2 fashion, with the relative 
concentrations of H4-17 and iron(III) determining the binding mode.  On 
comparison with H4-4-LICAM, the 1:1 binding mode seems to be favoured over 
3:2, influenced by the backbone of the ligand, due to the stereochemistry, or its 
electronic character.  The CD spectra indicate that ferric complexes of H4-17 
preferentially bind in the Δ-configuration, however, when bound in a bis-
catecholate 1:1 ratio, an interchange between the Δ-configuration and the Λ-
configuration is observed.  The coordination chemistry of H4-17 appears similar 
to that of the amonabactins, a family of tetradentate catecholamide siderophores. 
 
3.4 Interactions of the Ferric Complex with CeuE 
 
Following the investigation of the solution behaviour of H4-17 in the presence of 
iron, the aim was to examine how ferric-17 interacts with the ferric-siderophore 
transport PBP CeuE.  No co-crystal structures of enterobactin hydrolysis 
products with a periplasmic binding protein have been determined.  A crystal 
structure of the human protein siderocalin (Scn), a protein associated with the 
innate immune response towards siderophores (but has no structural similarity to 
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CeuE), was co-crystallised with enterobactin and published by Goetz et al. (PDB 
code 1L6M).
39
  The tri-lactone backbone of enterobactin had been partially 
hydrolysed during crystal formation and was therefore modelled as different 
enterobactin hydrolysis products in each of the binding pockets of the three Scn 
chains in the asymmetric unit.  The iron atoms in the binding pocket associated 
with chain A and chain B are fully coordinated with three catechol units, 
modelled as one DHBS and two dihydroxybenzoic acid units, respectively.  The 
binding pocket associated with chain C was modelled as a DHBS and a 
dihydroxybenzoic acid bound as two independent bidentate ligands, leaving two 
free coordination sites (Figure 59).  The nearest amino acid residues are a 
tyrosine and a lysine, which are 4.0 Å and 3.9 Å from the iron centre, 
respectively, therefore too far away from the metal centre for direct 
coordination.  Each of these binding pockets is unique, with different 
arrangements of the three iron(III)-coordinating ligands found in the binding 
pockets of chains A and B.  The cause of the difference in coordination 
geometry of the ferric-complexes for the three different chains in the asymmetric 
unit is unclear.  
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Figure 59 - Ribbon representation of three monomers of Scn co-crystallised with 
ferric-enterobactin.  Key: Chain A (light blue), chain B (gold), chain C (green); ligands 
shown as cylinders, grey - carbon, blue - nitrogen, red - oxygen, coral - iron. PDB code: 
1L6M.
39
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The same research group also deposited a mutant Scn structure in the PDB, 
however, this structure has never been published (PDB code 3I0A).  This 
structure shows ferric-17 and other enterobactin hydrolysis products bound to 
Scn.  This structure is similar to the 1L6M structure as it is found in the same 
space group (P41212), with three Scn monomers in the asymmetric unit, each 
presenting a different ferric-ligand complex in the binding pocket of the protein 
(Figure 60).  To the best of my knowledge, this structure is the only example 
deposited on the PDB which contains H4-17 as a ligand.  Scn has also been co-
crystallised with vibriobactin,
40-41
 carboxymycobatin S and T,
42
 ferric-
dihydroxybenzoic acid,
43
 and ferric catechol,
44
 and a complex of Scn with ferric-
enterobactin has been solved via solution NMR.
45
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Figure 60 - Ribbon representation of three monomers of Scn co-crystallised with 
ferric-enterobactin.  Key: chain A (blue), chain B (gold), chain C (green); ligands 
shown as cylinders, grey - carbon, blue - nitrogen, red - oxygen, coral - iron. PDB code: 
3I0A (unpublished work). 
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The co-crystal structures reported by Goetz et al. highlight difficulties in co-
crystallising ligand prone to hydrolysis under aqueous conditions required for 
proteins, showing that the crystallisation time is required to be shorter than the 
rate of hydrolysis of the ligand in the presence of the protein.   
 
Crystallisation of the CeuE, Ferric-Linear Dimer Complex 
 
Initial attempts to crystallise ferric-17 with CeuE used the same co-
crystallisation method as for ferric-4-LICAM, but crystals of X-ray diffraction 
quality were not obtained.  Soaking was therefore used to introduce ferric-17 
into an apo-CeuE crystal, grown from the PACT crystal screen.  H4-17 and 
iron(III) were added to the crystallisation well, followed by thorough mixing.  2 
μL of the resulting solution containing ferric-17 was added the sitting drop that 
contained the crystal.  The well was re-sealed and time allowed for the ferric-17 
to diffuse through the crystal.  The soaked crystals were collected at a number of 
time points after the introduction of the crystallisation solution containing ferric-
17, frozen in liquid nitrogen, and data collected at the DLS. 
 
Crystals were soaked for 90 minutes (form I, 0.2 M sodium fluoride, 0.1 M Bis 
Tris propane pH 8.5, 20 (w/v) PEG 3350), 24 hours (form II, 0.1 M MMT buffer 
pH 8.0 25% (w/v) PEG 1500) and 11 days (form III, 0.1 M PCB buffer pH 9.0 
25% (w/v) PEG 1500).  As expected each of the crystal structures was in the 
space group P1, with three CeuE chains in the asymmetric unit.  The apo-CeuE 
structure (Chapter 2), excluding water molecules, was used as a starting model.   
 
Form I showed no additional electron density in the CeuE binding pockets, 
indicating that 90 minutes are not enough time for the complex to fully soak into 
the lattice of the apo-CeuE.  In contrast crystal forms II and III, did show density 
in the binding pockets of each of the three independent CeuE chains in the 
asymmetric unit.  Crystal forms II and III were refined using REFMAC5
46
 and 
Coot.
47
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The electron density map of crystal form II clearly shows 17
5-
 bound to the 
iron(III) centre in a 1:1 ratio in CeuE chains A and B.  CeuE chain C was 
modelled with a partially occupied iron centre with no coordinating ligands, due 
to poor electron density in this binding (Figure 61 and Figure 62). 
 
Form III was treated as crystal form II, but the electron density for the backbone 
of H4-17 was weaker than in form II, thus it was not clear whether the di-serine 
backbone had hydrolysed.  Hence, the ligands were initially modelled as 
bidentate DHBS units bound to the iron(III) centres through the catechol 
functionality.  During refinement it was clear that the coordinating groups bound 
to the three iron(III) centres were different.  The binding pocket of chain A 
showed little electron density linking the two DHBS monomers, and as a result 
the modelled coordinating ligands were kept as two DHBS monomers 
representing hydrolysed 17.  Chain B was initially similar to chain A, however 
during refinement, the DHBS monomers showed electron density linking the 
two serine units, and the ligand was re-modelled to be ferric-17.  Chain C was 
similar to chain A, but the coordination of one of the DHBS monomers was 
found in the opposite orientation, with the serine backbone pointing inwards into 
a side pocket of the CeuE chain (Table 9, Figure 63 Figure 64). 
 
The nomenclature of the two crystal forms refers to the number of CeuE 
molecules found within the unit cell, followed by the ligand species bound by 
the three CeuE molecules. 
 
Chain {CeuE3[Fe(17)]2[Fe]} 
Form II 
{CeuE3[Fe(17)][Fe(DHBS)2]2} 
Form III 
A Linear Dimer 2 x DHBS 
B Linear Dimer Linear Dimer 
C Fe 2 x DHBS 
Table 9 - Summary of modelled ligands in the binding pockets of both crystal forms, 
{CeuE3[Fe(17)]2[Fe]} (crystal form II) and {CeuE3[Fe(17)][Fe(DHBS)2]2} (crystal form 
III). 
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Figure 61 - Ribbon representation of the three independent CeuE chains of 
{CeuE3[Fe(17)]2[Fe]} (form II) with colours blended from cyan, N-terminus, to dark 
blue, C-terminus.  His228, Tyr288 and Fe-17 shown as cylinders.  Key: His227 and 
Tyr288; green - carbon, blue - nitrogen, red - oxygen; Fe-17, grey - carbon, blue - 
nitrogen, red - oxygen; Fe - coral. 
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Figure 62 - Cylinder representation of the binding pockets of {CeuE3[Fe(17)]2[Fe]} 
(form II) with electron density map shown as 2Fobs-Fcalc, contoured at 1σ and chemical 
representation showing key interactions of Fe-17.  Key: His227 and Tyr288; green - 
carbon, blue - nitrogen, red - oxygen; Fe-17, grey - carbon, blue - nitrogen, red - 
oxygen; Fe - coral. 
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Figure 63 - Ribbon representation of the three independent CeuE chains of 
{CeuE3[Fe(17)][Fe (DHBS)2]2} (form III) with colours blended from cyan, N-terminus, 
to dark blue, C-terminus.  His227, Tyr288, Fe-17 and Fe-DHBS2 shown as cylinders.  
Key: His228, Tyr288, green - carbon, blue - nitrogen, red - oxygen; Fe-17, grey - 
carbon, blue - nitrogen, red - oxygen; Fe - coral. 
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Figure 64 - Cylinder representation of the binding pockets of 
{CeuE3[Fe(17)][Fe(DHBS)2]2} (form III) with electron density map shown as 2Fobs-
Fcalc, contoured at 1σ and chemical representation showing key interactions of the two 
Fe-DHBS environments.  Key: His227 and Tyr288; green - carbon, blue - nitrogen, red 
- oxygen; Fe-17, grey - carbon, blue - nitrogen, red - oxygen; Fe - coral. 
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 {CeuE3[Fe(17)]2[Fe]} 
Form II 
{CeuE3[Fe(17)][Fe(DHBS)2]2} 
Form III 
Data collection   
Diffraction Source DLS Beamline i04 DLS Beamline i02 
Wavelength / Å 0.976 0.979 
Temperature / K 100 100 
Crystal Data   
Space Group P1 P1 
a, b, c / Å 58.46, 63.02, 67.01 58.07, 63.09, 67.16 
α, β, γ / ° 83.36, 76.57, 78.24 83.09, 76.90, 79.21 
Resolution / Å 65.02 - 1.68 65.2 - 1.68 
Unique Reflections 70279 58556 
Completeness / % 98.1 94.3 
Redundancy 4.4 1.9 
Rmerge 0.09 0.09 
Mean [I/σ (I)] 17.5 5.2 
Refinement 
Statistics 
  
Reflections, working 66562 48582 
Reflections, test 3495 2510 
Resolution Range / 
Å 
65.01 - 1.90 65.19-2.10 
R-factor 0.226 0.223 
Rfree 0.267 0.262 
Mean B Factors / Å
2
 42.3 31.3 
RMS deviation 
from ideal 
  
Bond length / Å 0.015 0.013 
Bond angles / ° 1.782 1.688 
PDB Code - - 
Table 10- Data collection and refinement statistics of {CeuE3[Fe(17)]2[Fe]}.and 
{CeuE3[Fe(17)][Fe(DHBS)2]2} structures. 
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Both crystal form II, {CeuE3[Fe(17)]2[Fe]}, and crystal form III, 
{CeuE3[Fe(17)][Fe(DHBS)2]2}, show that the binding pocket of CeuE chain C is 
distinctly different compared to that of chains A and B.  In crystal form II, there 
is a low occupancy of the iron(III) atom and no clear density to model any other 
coordinating ligands, whereas in crystal form III, two DHBS monomers are 
bound to the iron(III) centre but in a different orientation than expected.  This 
variation reflects different lattice contacts for the three independent binding 
pockets within the crystal.  A crystal packing diagram shows that the apo-CeuE 
crystal lattice is tightly packed, which might suggest that the three binding 
pockets of each of the CeuE chains are likely to have different accessibilities 
(Figure 65).  The binding pockets of chains A and B are open to the surrounding 
solvent, while access to that of chain C is partially blocked by the neighbouring 
N terminus of chain B.  This can be demonstrated by the superposition Fe-17 of 
chain B into the binding pocket of chain C, which demonstrates that 
encroachment of the N terminus of chain B into the binding pocket of chain C 
(Figure 66). 
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Figure 65 - Crystal packing diagram showing symmetry related CeuE molecules in the 
{CeuE3[Fe(17)]2[Fe]} (form II) crystal.  Key {CeuE3[Fe(17)]2[Fe]} shown in gold, 
symmetry related molecules shown in grey.  Image created using Coot.
47 
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Figure 66 - A) Ribbon representation of the crystal packing in the asymmetric unit of 
{CeuE3[Fe(17)]2[Fe]} (form II) with His227, Tyr288, Fe-17 shown as cylinders.  B) 
Ribbon representation of binding pocket of chain C and surface (electrostatic 
representation) of N terminus of chain B, with Fe-17 from chain B superimposed into 
the binding pocket. Key chain A (blue), chain B (gold), chain (dark green); Fe-17, grey 
- carbon, blue - nitrogen, red - oxygen; Fe - coral.; electrostatic, red - negative, blue - 
positive. 
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In both structures, {CeuE3[Fe(17)]2[Fe]} (chains A and B) and 
{CeuE3[Fe(17)][Fe(DHBS)2]2} (chain B) the same binding arrangement of the 
ferric-17 to CeuE is observed, consistent with the {CeuE[Fe-4-LICAM]} 
structure.  Ferric-17 is bound in a 1:1 metal to ligand stoichiometry to a single 
CeuE monomer.  In the {CeuE3[Fe(17)][Fe(DHBS)2]2} chains A and B contain 
the two ferric-DHBS units, which are bound in a 1:2 metal to ligand 
stoichiometry and mimic a tetracoordinate iron centre.  The remaining two free 
coordination sites of the iron centres are occupied by the side chains of two 
amino acid residues, His227 and Tyr288, similarly to the {CeuE[Fe-4-LICAM]} 
structure (Chapter 2). 
 
The bond lengths of the coordinating atoms to the iron centres in CeuE 
monomers A and B in the {CeuE3[Fe(17)]2[Fe]} structure and the bond lengths 
of the coordinating atoms to the iron centres in the 
{CeuE3[Fe(17)][Fe(DHBS)2]2} structure are shown in Table 11 and Table 12 
respectively. 
 
CeuE Chain Atom Bond Length / Å 
A 
 
17O7 - Fe 2.2 
17O8 - Fe 2.1 
17O36 - Fe 2.1 
17O37 - Fe 2.0 
TyrO - Fe 2.0 
HisN - Fe 2.6 
B 
 
17O7 - Fe 1.8 
17O8 - Fe 2.3 
17O36 - Fe 2.0 
17O37 - Fe 2.0 
TyrO - Fe 2.1 
HisN - Fe 2.3 
 
Table 11 - Bond distances between coordinating atoms and the iron centres of 
monomers A and B in the {CeuE3[Fe(17)]2[Fe]} (form II) structure. 
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The bond lengths in both structures range from 1.8-2.4 Å, with the exception of 
the HisN-Fe in monomer A of both structures, which is 2.6 Å and 2.7 Å 
respectively.  These bond lengths are too large to form a formal bond, however, 
the electron density around both histidine residues is poor due to possible 
restricted movement within the crystal upon binding of ferric-17.  The poor 
electron density surrounding the histidine as a result of partial occupancy will 
increase the error on the bond lengths. 
 
CeuE Chain Atom Bond Length / Å 
A 
 
DHBS1O1 - Fe 2.4 
DHBS1O2 - Fe 2.2 
DHBS2O1 - Fe 2.2 
DHBS2O2 - Fe 2.1 
TyrO - Fe 1.9 
HisN - Fe 2.7 
B 
 
17O7 - Fe 1.8 
17O8 - Fe 2.1 
17O36 - Fe 2.1 
17O37 - Fe 2.1 
TyrO - Fe 2.0 
HisN - Fe 2.4 
C DHBS1O1 - Fe 2.1 
DHBS1O2 - Fe 2.4 
DHBS2O1 - Fe 2.0 
DHBS2O2 - Fe 2.4 
TyrO - Fe 2.1 
HisN - Fe 2.4 
 
Table 12 - Bond distances between coordinating atoms and the iron centres for the 
{CeuE3[Fe(17)][Fe(DHBS)2]2} (form III) structure. 
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The ligands in both the A and B chains, in both structures are in a cis, cis 
configuration with regards to the Oortho-Oortho, Ometa-Ometa donor atoms of the two 
catecholate moeities.  The two DHBS monomers in the binding pocket of chain 
C in the {CeuE3[Fe(17)][Fe(DHBS)2]2} structure, are bound in a cis, trans 
configuration, with the serine backbone of DHBS 1 in the opposite direction 
compared to binding pockets A and B (Figure 67). 
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Figure 67 - Coordination environment of the three binding pockets of 
CeuE3[Fe(17)][Fe (DHBS)2]2} (form III). Key; CeuE residues, green - carbon, blue - 
nitrogen, red - oxygen; DHBS and 4, grey - carbon, blue - nitrogen, red - oxygen; Fe - 
coral. 
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The change in coordination environment of the two DHBS monomers in chain C 
has the consequence of directing the serine backbone towards the surface of the 
protein and occupies a pocket adjacent to the binding site of CeuE.  The 
different orientation of the serine backbone in the two DHBS monomers is a 
clear indication that the hydrolysis must have occurred prior to the binding, as 
the carboxylic acid and alcohol groups in the monomers are too far apart to 
linked together by the ester bond. 
 
There are two possible explanations for the change in orientation of the DHBS 
monomers in the CeuE3[Fe(17)][Fe (DHBS)2]2} structure.  The first is the trans 
effect, which can direct certain donor atoms positioning around a metal centre.  
The trans configuration has been shown previously to direct the binding around 
a metal centre due to the different strengths of the trans effect of the ortho and 
meta catecholate oxygen donor atoms.  The difference between these donor 
atoms can direct the binding geometry around a metal centre such as MoO2 with 
catecholamides
48-49
 and 2,3-dihydroxybenzoic acid.
50
  These studies showed that 
the weaker ortho catecholate oxygen would be directed to the trans position of 
the strong oxo ligands on the MoO2 centre in order to minimise the energy of the 
system.  However, the difference in the trans effect between the ortho 
catecholate oxygen and the coordinating tyrosine oxygen is likely to be minimal 
due to their similar pKa values (ortho catecholamide pKa ≈ 7.5, tyrosine pKa ≈ 
10).
51
   
 
The second explanation is the favourable or unfavourable interactions of the 
DHBS serine backbone.  To examine this hypothesis an electrostatic surface was 
generated for CeuE chain C, which shows that the DHBS backbone is positioned 
in a pocket adjacent to the binding site (Figure 68).  The electrostatic surface 
clearly shows the DHBS 1 monomer in the adjacent pocket, with the carbonyl of 
the catecholamide positioned towards a positively charged protein region, while 
the alcohol and carboxylic acid groups of the serine backbone are in a neutral 
region with the alcohol forming a hydrogen bond with the peptide backbone 
Gly117.  As seen in the {CeuE3[Fe(17)]2[Fe]} structure, the surface of chain B is 
found close to the binding pocket of chain C with the surface projecting into the 
region in which the serine backbone of the DHBS monomer would be positioned 
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if orientated in a cis, cis configuration.  It is more likely that the DHBS 
monomer has bound in the cis, trans configuration to avoid this potential steric 
clash to the N-terminus of CeuE chain B, rather than a energy difference 
associated with the change in configuration as a result of the trans effect the iron 
centre. 
 
 
Figure 68 - Surface electrostatic representation of {CeuE3[Fe(17)][Fe(DHBS)2]2}, 
monomers B (translucent surface) and C (solid surface), negative charge shown in red 
and positive charge shown in blue.  Key: DHBS, grey - carbon, blue - nitrogen, red - 
oxygen; Fe - coral.; Hydrogen bond - black dash. 
 
Circular Dichroism and Fluorescence Biophysical Measurements 
 
As outlined in Chapter 2, octahedral complexes with two cis-positioned 
bidentate ligands are chiral.  {CeuE[Fe(4-LICAM)]} adopts the Λ-configuration, 
consistent with the literature for other periplasmic binding proteins and their 
associated substrates.
52-54
  Ferric-17 has a slight preference towards the Δ-
configuration rather than the Λ-configuration, but is able to interchange between 
the two conformations.
8
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In the {CeuE3[Fe(17)]2[Fe]} and {CeuE3[Fe(17)][Fe(DHBS)2]2} in each of the 
occupied binding pockets the ferric-17 and the ferric-DHBS complexes are in 
the Λ-configuration, consistent with the {CeuE[Fe-4-LICAM]} structure.  To 
confirm this behaviour in solution, CD spectra were recorded in the same 
manner as described for {CeuE[Fe(4-LICAM)]} in Chapter 2.  As the previous 
experiments of ferric-17 showed it possessed a preference to bind in the Δ-
configuration, the addition of CeuE was controlled, with spectra recorded every 
0.2 equivalents until 1 equivalent of CeuE was added relative to ferric-17 
(Figure 69). 
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Figure 69 - Circular dichroism spectra of ferric-17 (light grey) with increasing 
increments of 0.2 eq of CeuE, until {CeuE[Fe(17)]} (black) was formed, recorded in 0.1 
M TrisHCl buffer, pH 7.5, 150 mM NaCl. 
 
The spectra recorded show an inversion of configuration and small 
bathochromic shift of the n→π* transition from a positive peak at 320 nm to a 
large negative peak at 330 nm upon addition of one equivalent of CeuE, with an 
isosbestic point at 305 nm.  The weak positive feature between 380-610 nm of 
the LMCT band is also affected, forming a broad negative band with a minimum 
at 395 nm and a positive band with a maximum at 600 nm, giving an overall 
positive cotton effect, with another isosbestic point at 540 nm.  The isosbestic 
points suggest that a simple equilibrium is present in the titration involving the 
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binding of the ferric-17 to CeuE.  The spectrum of {CeuE[Fe(17)]} is 
remarkably similar to that of the {CeuE[Fe(4-LICAM)]} complex.  
Interestingly, the ligand-based n→π* transition also inverts, from a positive 
feature to a negative feature upon binding to CeuE.  This suggests that despite 
ferric-17 being assigned as achiral by Scarrow et al. due to the featureless 
LMCT band showing no clear preference, the strong signal of the n→π* 
transition can be used as an indicator for the metal-centred chirality.  The strong 
n→π* transition therefore suggests that the complex has a preference for the Δ-
configuration, whilst the featureless LMCT band shows that the metal centred 
configuration is able to convert between Δ and Λ-configurations.8  The CD 
spectra show that ferric-17 is in the Λ-configuration when bound to CeuE, and 
despite the slight preference for the Δ-configuration of the complex when free in 
solution, CeuE enforces the Λ-configuration.  This is consistent with CD spectra 
of ferric-enterobactin and ferric-enterobactin bound to FeuA, where the Δ-
configuration of free ferric-enterobactin converts to the Λ-configuration when 
the complex is bound to FeuA.
8, 54
  
 
As outlined in Chapter 2, it is important to determine the affinity of ferric-17 for 
CeuE.  The dissociation constant for ferric-17 and CeuE was determined through 
the same experimental procedure as outlined for ferric-4-LICAM (Chapter 2).  
The data were plotted and fitted using DynaFit (Figure 70 and Table 13).
55
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Figure 70 - Example fluorescence quenching analyses of PBP CeuE with ferric-17.  
Titration recorded with 240 nM CeuE (red) and 170 nM CeuE (blue) in 40 mM TrisHCl 
pH 7.5, NaCl 150 mM.  Recorded data shown as circles; lines give the non-linear least-
squares calculated fits (DynaFit).
55 
 
 Dissociation Constant / nM 
Individual Average of Batch Overall Average 
Batch 1 
(240 nM) 
Run 1 4.8 ± 0.9 
7.5 ± 6.3 
8.4 ± 4.3 
Run 2 16.4 ± 1.8 
Run 3 14.9 ± 3.7 
Batch 2 
(170 nM) 
Run 1 9.8 ± 1.9 
11.3 ± 2.6 Run 2 12.3 ± 2.5 
Run 3 14.9 ± 3.6 
Table 13 - Calculated dissociation constants from non-linear regression analysis of the 
fluorescence quenching data of ferric-17: CeuE titrations.  Error of individual Kd values 
are calculated from non-linear regression fit, and errors of overall and batch calculated 
from standard deviation of the different Kd values within that group. 
 
The dissociation constant of ferric-17 was determined for two batches of CeuE 
as described for  ferric-4-LICAM.  The first batch, at a concentration of 240 nM, 
gave an average dissociation constant of 7.5 ± 6.3 nM, whereas the second 
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batch, at a concentration of 170 nM, gave an average dissociation constant of 
11.3 ± 2.6 nM.  The second batch of CeuE (170 nM) had a higher normalised 
fluorescent signal at the end point of the titration than the first batch at 240 nM.  
The repeat runs within the same batches gave reproducible results; however, the 
difference of the response of the two CeuE batches was consistently different.  
The same observation is seen with the ferric-4-LICAM, showing there is a 
difference in response between batches.  As in the case of  ferric-4-LICAM, the 
dissociation constants obtained from the two different batches gave the same 
result within experimental error. 
 
The average dissociation constant of ferric-17 (8.4 ± 4.3 nM) is lower than that 
of ferric-4-LICAM (29.3 ± 11.7 nM) showing that Fe-17 is bound tighter to the 
binding pocket of CeuE.  This difference in the binding affinity is expected as it 
is known that ferric-enterobactin is bound to CeuE primarily through 
electrostatic interactions to the positively charged binding pocket of CeuE.  
Ferric-4-LICAM, if bound in a 1:1 ligand to metal ratio, would present one 
negative charge, while ferric-17 would have a formal negative charge of two, as 
it has the same binding arrangement through the catechol binding moieties and a 
free carboxylate attached to the backbone that is hydrogen-bonded in the crystal 
structure to the neighbouring Arg249 residue.  The extra negative charge on the 
complex may allow the ferric-17 complex to bind with a greater affinity, and 
therefore give rise to a lower dissociation constant.  
 
The calculated dissociation constant of ferric-17 is close to the quoted range of 
dissociation constants outlined in Chapter 2 for hexadentate catecholate 
siderophores binding to their associated PBPs, which vary between 15-52 nM.
54, 
56-59
  The calculated dissociation constant of ferric-17 is lower than the quoted 
range in the literature, however, as discussed in Chapter 2 it is likely that there 
are larger errors within the quoted dissociation constants due to experimental 
error and different batches of protein expressed and purified, which might 
suggest that the ferric-17 has a dissociation constant of similar strength to that of 
other ferric-catecholate siderophores.  This result is somewhat surprising, due to 
the difference in the binding arrangement between the coordinatively saturated 
hexadentate siderophores and the two coordinatively unsaturated siderophores 
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presented here.  This suggests that the direct coordination of the histidine and 
tyrosine residues compensates for the loss of the third catecholamide arm, 
allowing for the dissociation constant for the tetradentate siderophore binding to 
be in a biological relevant range. 
 
3.5 Summary of Chapter 3 
 
The enterobactin hydrolysis product H4-17 was successfully synthesised, 
characterised and complexed to iron(III).  Ferric-17 can form complexes with 
3:2 and a 1:1 ligand to metal ratios, much like 4-LICAM
4-
, but has a preference 
for a 1:1 ratio.  The 3:2 complex possesses a preference for the Δ-configuration, 
whereas the 1:1 complex has a slight preference for Δ, but can interchange 
between the two configurations. 
 
Structures of {CeuE3[Fe(17)][Fe(DHBS)2]2} and {CeuE3[Fe(17)]2[Fe]} were 
obtained through crystal soaking of ferric-17 into apo-CeuE crystals for varying 
lengths of time.  The ferric-17 was bound in the same configuration as ferric-4-
LICAM, in a 1:1:1 fashion (metal:ligand:protein), with the His227 and Tyr288 
completing the octahedral iron ligation.  The ferric-17 structure in 
{CeuE3[Fe(17)][Fe(DHBS)2]2} was partially hydrolysed, with the DHBS units 
in CeuE chains A and C bound differently to each other in a cis, cis, and a cis, 
trans orientation.  The metal-centred chirality of all of the binding pockets of the 
two crystal structures which had ligands bound was Λ. 
 
Circular dichroism spectroscopy showed an inversion of configuration at the 
metal centre from Δ to Λ once a stoichiometric amount of CeuE had been added.  
The dissociation constant was determined for ferric-17 and CeuE by intrinsic 
fluorescence quenching and was found to be 8.4 ± 4.3 nM.  The complex ferric-
17 shows tighter binding to CeuE compared to ferric-4-LICAM, yet would seem 
to be within a biologically relevant range. 
 
 Chapter 4: A Siderophore 
Mimic for use with Further 
Functional Components 
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Project Aims 
 
The aim of the research outlined in this chapter is the design and synthesis of a 
biomimetic hexadentate catecholamide siderophore that possesses a chemical 
functional group to act as a linker.  This chemical linker can either be used to 
add a second chemical function, e.g. a antimicrobial agent or a fluorescence 
probe, or be left unfunctionalised as a biologically inert group that does not 
affect the ability of the compound to be recognised as a siderophore, e.g. not 
affect the coordination of iron(III) (Figure 71). 
 
 
Figure 71 - Schematic design of a biomimetic hexadentate siderophore that possesses 
a chemical linker. 
 
4.1 Introduction 
 
As outlined in Chapter 1, there are numerous uses for biomimetic models of 
hexadentate siderophores.  Some of these models require chemical linkers, so as 
to introduce a second chemical moiety (e.g. Trojan Horse strategy, or fluorescent 
probes),
1-4
 whilst others only require the strong iron binding function (e.g. iron 
overload therapeutics).
5-7
   
 
The most successful previously reported biomimetic hexadentate catecholamide 
siderophores, were designed as close mimics of enterobactin (see Chapter 1).  
Only four of the many existing biomimetic hexadentate catecholamide 
siderophores contain an obvious chemical functionality that can be reacted 
further in order to covalently attach a chemical tool. 
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The first was reported by Imbert et al. in 2000 and is known as H6-CacCAM.
8
  
The structure is similar to H6-TRENCAM, with an aliphatic three fold 
symmetric backbone.  Instead of connecting through a central tertiary amine, H6-
CacCAM connects through a central quaternary carbon, which is bound to a 
carboxylic acid.  The three iron(III) binding arms possess an extra carbon atom 
in the chain, compared to H6-TRENCAM. 
 
 
 
H6-CacCAM has been linked to an aliphatic carbon linker (C16) to produce an 
amphiphilic iron(III) chelator as a mimic of marine bacterial siderophores.
9
  The 
modified H6-CacCAM(C16) and its ferric complexes are able to self-assemble, 
the iron-free H6-CacCAM(C16) forming micellar assemblies, whilst the ferric-
CacCAM(C16) complex formed spherical assemblies with diameters of 
approximately 130 nm.  This system mimics the behaviour of marine bacterial 
siderophores.
9-10
 
 
The second example is an iron binding dendrimer, synthesised by Zhou et al. as 
a novel approach for the treatment of haemochromatosis (a type of iron 
overload).
11
  Dendrimers are synthetic macromolecules with highly branched 
structures that have been widely studied.
12-17
  The structure of the dendrimer 
allowed the covalent attachment of several hexadentate iron binding moieties to 
one molecule.  For this design, the hexadentate metal binding unit needed a 
functional group to allow a covalent linkage between the metal binder and the 
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dendrimer backbone to be formed.  This was achieved by using compound 35 as 
the branched linker, with the carboxylic acids used for both the growth of the 
dendrimer to the next generation and the attachment of the metal binding 
catechol moieties to give compound H54-36 (Figure 72). 
 
 
Figure 72 - Dendritic catecholate-based iron chelator developed by Zhou et al.11 
 
The structure of H54-36 uses a primary amine, situated on the quaternary carbon 
atom rather than a carboxylic acid, as seen in H6-CacCAM for covalent linkage.  
Consequently, the catechol binding units are not the preferred catecholamide 
functionality.  H54-36 is still able to bind iron(III), but as described in Chapter 1, 
is not recognised and therefore evades the iron uptake system.
18-19
  This is ideal 
for use as an iron(III) chelator for the treatment of haemochromatosis but is not 
suitable for use as a model siderophore. 
 
The third example was recently developed by Ji et al. and incorporates design 
features of both H6-CacCAM and H54-36.
20
  The structure of 37 is similar to H6-
CacCAM, with an aliphatic backbone with three-fold symmetry, and seven atom 
spacers between the catecholamide units.  Interestingly, the catechol groups 
were left protected as acetate groups.  In vivo, the acylated catechol groups were 
expected to avoid potential methylation by a catechol O-methyl-transferase.  
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Compound 37 acts as a prodrug, with hydrolysis leading to the required catechol 
functionality for iron(III) binding.  Compound 37 also includes a succinic acid 
linker, altering the linking functional group from the original amine to a 
carboxylic acid, which could then be used for covalently linking β-lactam 
antibiotics, as required for the Trojan Horse strategy, giving compounds 38 and 
39 (Figure 73).
20
 
 
Figure 73 - Structures of a biomimetic tris-catecholate siderophore and its 
aminopenicillin conjugates.
20 
 
Both compounds 38 and 39 showed improved antibacterial activity against a 
selection of strains of P. aeruginosa compared to the parent antibiotic.
20
  In 
order to ascertain whether the increased antibacterial activity was as a result of 
increased uptake through the iron uptake system, the antimicrobial activity was 
measured in both iron-rich and iron-deficient media.  There was an increase in 
activity when the compounds were tested in iron-deficient medium, where the 
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iron uptake system plays a greater role in active nutrient uptake. This suggests 
that active transport of the conjugates through the siderophore mediated iron 
uptake mechanism plays a significant role in delivering the drug to the 
bacteria.
20
  
 
The fourth example, H6-40,  was developed by Inomata et al and has a similar 
structure to 37, but it contains no acetyl protecting groups and the succinic linker 
is absent.
21
  A self assembled monolayer of ferric-40 was formed and chemically 
bound to a gold surface.  This allowed the adsorption of E. coli onto the 
substrate which was detectable by a quartz crystal micro-balance chip used for 
detection of micro-organisms with the corresponding siderophore uptake 
protein.
21
 
 
 
None of these four mimetics possess both the five atomic linker between the 
catecholamide binding moieties and the correct orientation of the catecholamide 
required for biological recognition.  Thus, the design of the biomimetic 
hexadentate catecholamide siderophore, forming the rest of this chapter, took 
into account the key features of enterobactin, and also the strategies of the 
previously discussed biomimetic siderophores, which possessed a chemical 
linker.  The key features incorporated were: a) the three fold symmetry of the 
backbone, b) the five atom spacer between the catecholamide units and c) the 
removal of the hydrolytically unstable trilactone backbone (Figure 74). 
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Figure 74 - The chemical structure of the designed biomimetic hexadentate 
siderophore.  Key: catecholamide, red - backbone, blue - linker, black. 
 
In the design of H6-41, the linker choice was inspired by the linker used by Ji et 
al. (compound 37), as it could either be incorporated or not, depending on 
requirements. The inclusion of the linker is determined by the probe to be 
synthesised, accounting for the requirements of either an amino or carboxylate 
group for linkage to a functional tool.  The position of the linker at the central 
quaternary carbon has the advantage of directing it away from the iron(III) 
binding catecholamide moieties, and hence should have minimal impact on the 
iron(III) binding of the compound.  For proof-of-concept, the linker was 
included in the synthesis of H6-41 to demonstrate the feasibility of incorporating 
this functionality. 
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4.2 Synthesis 
 
The synthesis of H6-41 can be divided into two sections: firstly the synthesis of 
the catechol units and secondly of the siderophore backbone.  The synthesis of 
the catechol units has been discussed in Chapters 2 and 3 and therefore the 
present Chapter will focus on the siderophore backbone. 
 
Synthesis of a Biomimetic Hexadentate Siderophore 
 
The work outlined within this section was completed with the aid of Amy 
Scorah, a summer placement student working under my supervision (July-
September 2013). 
 
The backbone of H6-41 requires four primary amines in two different 
environments, one located on a central quaternary carbon, whilst the remaining 
three are located on the terminal of each of the three arms. 4-(2-carboxyethyl)-4-
nitroheptanedioic acid, 42, offered a good starting point for the synthesis, as it 
possesses much of the carbon skeleton of the backbone.  The carboxylic acids 
can be converted into the required terminal primary amines via an isocyanate 
intermediate using the Curtius rearrangement.
22
  Once the terminal amines have 
been synthesised, standard protecting group chemistry can be employed to 
enable the reduction of the central nitro group to a primary amine, which can 
then be used to couple a protected linker.  Subsequently, selective deprotection 
of the terminal primary amines allows the introduction of the catecholamide 
moieties onto the backbone.  Standard deprotection chemistry should then yield 
H6-41 (Scheme 11). 
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Scheme 11 - Synthetic route to H6-41.  (a) i) SOCl2, ii) TMS azide, iii) 80 °C, iv) HCl, 
(b) Boc2O, NEt3; (c) H2, Raney®-Nickel 2800 slurry; (d) Glutaric acid monomethyl 
ester chloride, NEt3 ; (e) TFA; (f) 31, DIPEA; (g) NaOH; (h) H2, Pd-C 10%.  
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The backbone of H6-41 was synthesised from 42, using the methodology 
reported by Zhao et al.
23
  The carboxylic acid functional groups were 
transformed into primary amines by conversion to acyl azides, followed by 
Curtius rearrangement to give the corresponding isocyanates.  Next, acid 
catalysed hydrolysis of the isocyanate was carried out to give the required amine 
salt (72% yield) (Scheme 12). 
 
 
Scheme 12 - Synthetic route to compound 43.  (a) SOCl2; (b) TMS azide; (c) 80 °C; 
(d) HCl. 
 
Due to the reactive nature of the intermediates, no attempt was made to isolate 
and characterise these compounds.  However, compound 43 was isolated and 
characterised by mass spectrometry, 
1
H, 
13
C NMR and infra-red spectroscopies.  
Mass spectrometry confirmed the presence of both the [M+H]
+
 and [M+Na]
+
 
ions for a molecular formula of C7H19N4O2 with signals observed at m/z 
191.1499 and m/z 213.1324, respectively.  The 
1
H and 
13
C NMR spectra showed 
that the symmetry of compound 43 had been maintained, with only three signals 
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in the 
1
H NMR spectrum for the three proton environments (including amine 
protons).  The multiplicity of the signals does not resemble the standard triplets 
reported by Zhao et al., possibly due to long range 
14
N coupling as observed in 
ammonium ions (Figure 75).
24
 
 
 
Figure 75 - 1H NMR spectrum of 43 in d6-DMSO shown between 3.00-2.10 ppm 
showing the multiplicity of the resonances assigned to protons H
a
 and H
b
.  Quintet at 
2.50 is the d6-DMSO residual solvent peak. 
 
The 
13
C NMR spectrum shows the expected three signals; one at 89.7 ppm 
consistent with a quaternary carbon atom attached to a nitro group, and two at 
33.8 ppm and 31.8 ppm, respectively for the two aliphatic carbon environments.  
Apart from the unusual 
1
H NMR multiplicity all other characterisation data 
matched that of the literature, and therefore it was concluded that compound 43 
had been successfully synthesised.
23
 
 
Upon repeating the reaction, it became apparent that the reproducibly of the 
yield and purity of compound 43 was difficult to maintain, probably due to the 
nature of the reactive intermediates.  The mechanism of the reaction first 
involves the reaction of the carboxylic acid with thionyl chloride, to give the 
activated acyl chloride, which then reacts with TMS (trimethylsilyl) azide to 
         Chapter 4 
          170 
produce the acyl azide.  Upon heating, acyl azides undergo Curtius 
rearrangement, which involves the evolution of nitrogen gas upon rearrangement 
of the acyl azide into the isocyanate.  Once the isocyanate has formed, acid 
catalysed hydrolysis forms the required amine (Scheme 13).
25
 
 
 
Scheme 13 - Reaction mechanism of reaction of 42 to form 43 with key intermediates, 
acyl chloride, acyl azide and isocyanate highlighted within a box. 
 
The key intermediates in this reaction, the acyl chloride and acyl azide, are 
prone to hydrolysis, creating additional competing side reactions, forming 
undesired by-products.  Due to the three-fold symmetry of the starting material, 
the reaction process must go to completion three times on each molecule to 
produce the target compound.  The procedure was therefore modified to be 
completed under rigorously dry conditions, with a constant nitrogen atmosphere 
utilising a Schlenk line.  This improved the yield to 92%, with characterisation 
data consistent with the previous synthesis, and literature data.
23
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Compound 44 was synthesised by reacting 43 with excess di-tert-butyl 
dicarbonate in the presence of triethylamine using the methodology of Zhao et 
al. (84% yield, Scheme 14).
23
  Compound 44 showed a characteristic singlet at 
1.42 ppm in the 
1
H NMR spectrum, with a relative integration of 27 
corresponding to the three equivalent tert-butyl groups.  Signals in the mass 
spectrum were observed at m/z 491.3068 and m/z 513.2885 consistent with the 
[M+H]
+
 and [M+Na]
+
 ions, respectively, for a molecular formula of 
C22H42N4O8.  All other characterisation data are consistent with the literature.
23
 
 
 
Scheme 14 - Synthesis of 44 using the methodology of Zhao et al.23 
 
Compound 44 was reduced to the corresponding amine 45 by catalytic 
hydrogenation using Raney®-Nickel 2800 slurry as the catalyst.  There have 
been reports in the literature that many reducing conditions, such as platinum, 
palladium and commercially available Raney®-Nickel, give poor yields for 
aliphatic nitro reduction, and that a specialised T-1 Raney®-Nickel is required to 
be synthesised and utilised in order to complete the reaction.
26-27
  However, 
others have claimed to use commercially available Raney®-Nickel to 
successfully reduce a aliphatic nitro group on a quaternary carbon to give a 
primary amine.
28
  Therefore, commercially available Raney®-Nickel (Raney 
Nickel 2800 slurry in H2O active, Sigma-Aldrich) was tried first and found to be 
successful at reducing the nitro group to the amine under a pressurised 
atmosphere of hydrogen (35 bar, Scheme 15).  Successful reduction was 
indicated by mass spectrometry, with signals observed at m/z 461.3356 and m/z 
483.3164 consistent with the [M+H]
+
 and [M+Na]
+
 ions, respectively, for a 
molecular formula of C22H44N4O6 and an upfield shift in the 
13
C NMR spectrum 
of the signal due to the quaternary carbon from 90.4 ppm to 53.8 ppm. 
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Scheme 15 - Synthesis of 45 using commercially available Raney®-Nickel. 
 
The primary amine of 45 was used to attach the linker unit onto the backbone, 
by reacting 45 with glutaric acid monomethyl ester chloride in the presence of 
triethylamine in anhydrous dichloromethane under a dry nitrogen atmosphere to 
yield 46 (76% yield, Scheme 16).  The additional signal due to the amide proton 
in the 
1
H NMR spectrum at 6.57 ppm, and the amide and ester carbonyl signals 
in the 
13
C NMR spectrum at 174.1 and 173.1 ppm, respectively, confirmed the 
addition of the monomethyl linker via the amide linkage.  Mass spectrometry 
confirmed the presence of both the [M+H]
+
 and [M+Na]
+
 ions at m/z 589.3807 
and m/z 611.3645 ppm, respectively, consistent with a molecular formula of 
C28H52N4O9.   
 
Scheme 16 - Synthesis of 46 using the modified methodology of Ji et al.20 
 
Compound 46 represents the protected backbone of the hexadentate siderophore 
with a methyl ester protected linker attached.  The continuation of the synthesis 
of H6-41 first involved the removal of the Boc-protecting groups of 46, which 
was achieved using trifluoroacetic acid in a dichloromethane : methanol (9:1) 
mixture.  The 
1
H NMR spectrum showed the complete removal of the three tert-
butyl signals, while 
13
C NMR confirmed that the ester and amide linkage of 47, 
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173.2 and 172.1 ppm, respectively, had not been affected during the reaction.  
Mass spectrometry gave further confirmation that compound 47 was isolated 
with a signal observed at m/z 289.2247 assigned as the [M+H]
+
 consistent with 
for a molecular formula of C13H28N4O3.  Compound 47 was isolated as a white 
solid in 98% yield (Scheme 17). 
 
 
Scheme 17 - Synthesis of 47 by Boc deprotection of 46 using trifluoroacetic acid.  
 
Compound 31 was utilised for the addition of the catechol functionality to 47, in 
the same manner as in the synthesis of H4-17 (Chapter 3).  The reaction 
proceeded to 48 in 17% yield (Scheme 18), a surprisingly low value, however, it 
was later found that the starting material, 47, was highly hygroscopic, forming a 
clear viscous oil when left open to the atmosphere.  It is believed that this had 
occurred during the set-up of the reaction leading to the introduction of water, 
hydrolysing reagent 31 in a competing reaction, explaining the low yield.  In 
order to confirm this hypothesis the reaction would need to be repeated using 
inert conditions, and the preparation and storage of compound 47 would need to 
be altered to eliminate any water.  Despite the low yield, mass spectrometry 
showed a signal at m/z 1259.5357 assigned as the [M+Na]
+
 ion, consistent with a 
molecular formula of C76H76N4O12.  The 
1
H NMR spectrum shows the addition 
of the aromatic signals between 7.71 and 7.11 ppm, with a total relative 
integration of 39 protons.  Furthermore, two additional singlets at 5.15 ppm and 
5.09 ppm, which both have a relative integration of six protons, are assigned as 
the methylene signals of each of the benzyl protecting groups of the catechol 
moieties. 
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Scheme 18 - Synthesis of 48 using the methodology outlined in Chapter 3. 
 
The methyl ester protecting group of 48 was removed using base hydrolysis, 
employing the methodology outlined by Theodorou et al. by reacting compound 
48 with sodium hydroxide in a dichloromethane : methanol (9:1) mixture, 
yielding compound 49 (94% yield, Scheme 19).
29
  The 
1
H and 
13
C NMR spectra 
showed the complete removal of the signal due to the methyl  protons (
1
H NMR: 
3.65 ppm, 
13
C NMR: 51.9 ppm), with the rest of the resonances in the spectra 
unaffected.  Mass spectrometry confirmed the amide had not been hydrolysed 
during the reaction with a signal found at m/z 1221.5240 assigned as the [M-H]
-
 
ion. 
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Scheme 19 - Synthesis of 49 via methyl ester hydrolysis using the methodology of 
Theodorou et al.
29
 
 
The free carboxylic acid functionality of 49 at this point could be coupled to a 
addition functional component to functionalise the compound.  However, this is 
beyond the scope of this project, and it was therefore left as the free carboxylic 
acid and the reaction scheme was continued towards the target compound, H6-
41. 
 
The benzyl ethers of compound 49 were removed using the same methodology 
as for H4-4-LICAM and H4-17 (Chapters 2 and 3).  Catalytic hydrogenation 
using 10% Pd-C yielded compound H6-41 (92% yield).  Mass spectrometry 
confirmed the presence of H6-41 with a signal observed at m/z 681.2420 
assigned as the [M-H]
-
 ion, consistent with the molecular formula C33H37N4O12. 
The 
1
H and 
13
C NMR spectra confirmed the complete removal of the benzyl 
protecting groups by absence of the methylene signals, (
1
H NMR, 5.13 and 5.07 
ppm, 
13
C NMR, 76.5 and 71.4 ppm).  Furthermore the aromatic region of the 
1
H 
NMR spectrum simplified to three signals (
1
H NMR, 7.19, 6.91 and 6.70 ppm).  
The rest of the resonances in the spectra were unaffected, confirming the 
successful synthesis of compound H6-41. 
 
         Chapter 4 
          176 
 
Scheme 20 - Deprotection of 49 via catalytic hydrogenation to yield siderophore 
mimic H6-41. 
 
4.4 Summary of Chapter 4 
 
A novel catecholamide siderophore mimic that possesses a five-atomic spacer, 
free chemical functionality and a three-fold symmetric axis, was successfully 
designed, synthesised and characterised.  The three carboxylic acid groups 42 
were converted to primary amines via activation with thionyl chloride, followed 
by reaction with TMS azide to produce the acyl azide.  Subsequent 
rearrangement of the acyl azide into the isocyanate allowed for acid catalysed 
hydrolysis to form 43.  Protection of the three terminal primary amines using di-
tert-butyl dicarbonate, allowed the reduction of the nitro group to the central 
primary amine.  This central amine was subsequently coupled to the linker 
completed the synthesis of the protected backbone.  Deprotection, liberated the 
terminal primary amines, and allowed the catecholamide moieties to be 
introduced.  This was followed by deprotection of the methyl ester of the linker 
and benzyl deprotection of the catecholamides to yield the target compound H6-
41 in an overall yield of 10.5% over eight synthetic steps.  All the reactions, 
with exception of the coupling of the catecholamide moieties to the backbone 
proceeded in yields >76%. and therefore if this reaction yield could be improved 
(Section 4.2), to other comparable yields (~60%) then the overall yield to the 
successful synthesis of H6-41 should increase to approximately 30%. 
 Chapter 5: A Natural 
Siderophore with a Further 
Fluorescent Component 
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The work outlined within this Chapter is an ongoing collaboration with Prof 
James Coulton (McGill University, Montreal) and Dr Christoph Baumann 
(Department of Biology, University of York).  
 
Project Aims 
 
The aim of this collaborative research project was the design and synthesis of a 
small molecule-fluorophore conjugate by the modification of ferricrocin for the 
targeting and labelling of the outer membrane receptor, FhuA.  This should 
allow a targeted approach for fluorescently labelling the protein and allow the 
location and mobility to be and characterised within the outer cell membrane. 
 
5.1 Introduction 
 
Along with the use of siderophore mimics as chemical tools (see Chapter 4), 
natural siderophores can also be utilised either for their iron(III) binding ability, 
e.g. the use of H3-desferrioxamine B for the treatment of iron overload, or be 
modified to introduce an additional functional component, e.g. the attachment of 
antimicrobial agents to natural siderophores for use in  Trojan Horse 
antimicrobials.
1-5
  Other applications of functionalised siderophores include the 
delivery of cargos,
6-7
 targeted fluorescent probes,
8-13
 and the investigation of 
iron(III) uptake (see Chapter 1).
14-15
   
 
Ferrichrome is a cyclic hexapeptide, made up of three glycine units and three 
modified ornithine units that act as the iron binding hydroxamate units.  
Ferricrocin is a naturally occurring hexadentate hydroxamate siderophore, 
structurally related to ferrichrome but with the second glycine residue replaced 
by a serine.
16
  Despite E. coli not synthesising either ferrichrome or ferricrocin, 
both siderophores can act as iron suppliers for E. coli and a range of other 
organisms using the hydroxamate uptake system.
17
  Modification of ferricrocin 
to investigate iron(III) uptake in E. coli was previously reported by Coulton et 
al. .
14
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The free alcohol functional group on ferricrocin makes it an ideal hydroxamate 
siderophore for studying the iron uptake mechanism, as the free alcohol 
functionality allows direct coupling of a fluorescent label to the siderophore 
backbone, away from the iron binding region. 
 
 
 
Coulton et al. used this alcohol functional group to covalently link the 
ferricrocin to poly(ethylene glycol) to form the polymer-ferricrocin conjugate.  
First the alcohol of the ferricrocin was reacted with succinic anhydride to yield 
the monoester, ferricrocinyl succinate.  The free carboxylate was then activated 
by the reaction of N-(chloromethylene)-N-methylmethanaminium chloride 
followed by the addition of poly(ethylene glycol) (Mr 7000-8500) to yield the 
covalently linked ferricrocinyl polyethylene glycolyl succinate, 50 (Scheme 
21).
14
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Scheme 21 - Synthesis of high-molecular weight ferricrocinyl polyethylene glycolyl 
succinate by Coulton et al.
14 
 
Coutlon et al. showed that the polymer-ferricrocin conjugate could act as an iron 
source, although at a reduced rate compared to free ferricrocin.  When either free 
ferricrocin or the polymer-linked ferricrocin conjugate was used as the iron 
source, the TonB system was required for growth.  Control experiments 
indicated that the ester linkage of the polymer-ferricrocin conjugate was not 
simply hydrolysing and acting as a source of free ferricrocin, rather that the 
conjugate could itself act as a iron(III) source for the cells.
14
  These results 
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demonstrate the complex nature of the iron(III) uptake mechanism, with many 
different processes all playing their role in the uptake of this essential element. 
 
The characterisation of the location and mobility of integral membrane proteins 
has become of great interest since the discovery of the complex and non-uniform 
nature of cell surfaces.  The lipids and proteins of a cell surface are not 
homogenously distributed in the membrane, but are separated into biochemically 
and biophysically distinct domains.
18
  Highly ordered domains are known as 
lipid rafts, which have implications for protein distributions, diffusion and 
trafficking.
18-21
  The chemical make-up of the lipid rafts make the 
characterisation of these systems difficult as they comprise of complex dynamic 
systems.  Fluorescence microscopy is an ideal technique for the investigation of 
these systems as it can be applied to cell membranes and avoids the fixation of 
integral membrane proteins which can introduce artefacts in organisation.
18, 22
  
The analysis of the localisation and dynamics of membrane proteins can offer 
good insights into the constitution of these complex systems utilising techniques 
such as fluorescence recovery after photobleaching (FRAP), which allows the 
direct observation of the diffusion of fluorescently-tagged membrane proteins 
(Figure 76). 
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Figure 76 - Schematic diagram showing the FRAP experiment. 
 
Due to the low number of FhuA receptors expressed on the cell surface of E. 
coli, a technique which possesses a high signal to noise ratio is required for 
visualisation of single receptors.  Total internal reflection fluorescence (TIRF) 
microscopy is an analytical technique that utilises this physical property to 
observe a thin region of a specimen at the surface. Laser light is used to excite 
the sample, by shining it onto a quartz prism which refracts it through a quartz 
cover slip onto the sample.  As the beam hits the sample it passes from a 
material of high optical density (quartz) to a material of low optical density 
(aqueous medium).  As the angle of incidence is large the laser light is reflected 
back into the quartz prism, forming a evanescent wave at the interface.  This 
wave has a high intensity at the surface, however decays exponentially, 
generating excited fluorophores close to the TIRF surface.  This principle allows 
the selective excitation of surface fluorophores over bulk fluorophores which 
enhances the signal to noise ratio, giving a high sensitivity of the technique 
(Figure 77).
23-24
 
         Chapter 5 
          183 
 
 
Figure 77 - Schematic representation of the TIRFM experimental set-up. A) General 
overview; B) Schematic representation of the evanescent wave formation. 
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5.2 Synthesis 
 
Due to the TIRF experimental set-up, which utilises an argon ion fixed 
wavelength laser source (488 nm), the fluorophore chosen for the design of the 
conjugate was Alexa Fluor® 488 azide (Life Technologies), which possesses an 
intense absorbance band at 488 nm (ε = 76,000 mol-1dm3cm-1) and efficiently 
emits at 519 nm (ϕ = 0.92).  This fluorophore also has a number of other 
desirable properties such as being water soluble, photostable, and pH 
independent between pH 4-10.
25
 
 
 
The fluorophore possesses a six carbon linker to the azide functionality, which 
reduces the likelihood of adverse steric interactions when the target conjugate is 
bound to the FhuA receptor.  The azide functional group allows reaction with an 
alkyne using a copper catalysed 1,3-dipolar-cycloaddition reaction (‘click-
chemistry’).  The required alkyne functionality can be introduced onto 
ferricrocin by forming an ester linkage using the alcohol of ferricrocin and an 
alkyne containing carboxylic acid.  Compound 51 is the purposed structure of 
the target compound. 
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The synthesis starts with the addition of the alkyne functionality to ferricrocin 
(Scheme 22).  Following the synthetic strategy employed by Coulton et al.
14
 it 
was decided to first activate 4-pentynoic acid as an anhydride.  This was 
synthesised through self condensation using DCC as a coupling reagent, 
following a modified methodology described by Ledin et al.
26
  The 4-pentynoic 
acid was first reacted with DCC in anhydrous dichloromethane under a dry 
nitrogen atmosphere.  The activated 4-pentynoic acid subsequently reacted with 
another 4-pentynoic acid molecule producing anhydride 52 and a DCU by-
product.  The DCU was removed whilst remaining under an inert atmosphere via 
cannular filtration.  The ferricrocin was introduced dissolved in dry pyridine and 
allowed to react as described by Coulton et al.
14
  
 
 
Scheme 22 - Synthetic route to 53.  (a) DCC, N2; (b) Ferricrocin, N2. 
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Due to the small scale of the synthesis (< 1 mg) and the  use of ferricrocin which 
contains iron(III), NMR could not be used to characterise 53.  Therefore semi- 
preparative HPLC and mass spectrometry were utilised to purify and 
characterise the product (Figure 78).   
 
 
Figure 78 - HPLC traces (absorbance at 420 nm) of ferricrocin (20 mM) in water, 
injection volume 5 μL (blue) and 53 (0.5 mg in 350 μL of water) injection volume 20 
μL (red); 6-40 % (v/v) acetonitrile/water gradient. 
 
The HPLC traces show that ferricrocin has a retention time of 13 minutes under 
the experimental conditions, whereas the reaction mixture contained both 
ferricrocin and a more intense new species which eluted at 17 minutes.  The 
sample was purified by HPLC and the fraction eluting at 17 minutes was 
collected.  Mass spectrometry confirmed the presence of 53 with signals 
observed at m/z 851.2705 and m/z 873.2541 consistent with [M+H]
+
 and 
[M+Na]
+
 ions, respectively, for a molecular formula of FeC33H48N9O14. 
 
The next step in the synthesis was the addition of the Alexa Fluor® 488 azide 
fluorophore onto 53, using a copper-catalysed 1,3 dipolar-cycloaddition ('click'-
chemistry) reaction (Scheme 23).  This type of reaction is  well established in the 
literature.  It was discovered by Rostovtsev et al.
27
 and has been used 
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extensively since, due to high yields and the wide range of chemical conditions 
in which the reaction can take place.
28
  The copper acts as a catalyst and is first 
introduced into the reaction as a copper(II) salt, which is reduced in situ by 
sodium ascorbate to produce the catalytically active copper(I) form.  The 
reaction is reported to work in a wide pH range and in a number of different 
solvents from aqueous tert-butyl alcohol to neat water.
27-28
 
 
Scheme 23 - Synthetic route to 51. (a) Alexa Fluor® 488 azide, CuSO4, sodium 
ascorbate. 
 
The reaction was conducted using water as the solvent, due to the water 
solubility of the reagents and requirement for the work-up using dialysis.  The 
reaction was allowed to proceed for 6 hours, at room temperature and in the dark 
in order to reduce potential photobleaching.  The reaction mixture was then 
dialysed using a 0.1-0.5 kDa molecular weight cut off dialysis membrane 
(Dialysis Float-A-Lyzer 5 mL, Spectrum labs) in-order to remove any remaining 
copper salts.  The sample was analysed by HPLC under the same conditions as 
for 53 (Figure 79). 
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Figure 79 - HPLC traces of 51 (red) after dialysis and Alexa Fluor® 488 (blue). A) - 
Absorbance data measured at 420 nm.  B) Fluorescence data excited at 500 nm 
emission measured at 520 nm. 
 
The HPLC traces show that free Alexa Fluor® 488 azide has a retention time of 
12 minutes observed by both the absorbance and fluorescence detectors.  The 
reaction mixture has a strongly absorbing species with a retention time of 13 
minutes, but only shows a weak emission intensity, and a weakly absorbing 
species with a large emission intensity at 16 minutes.  The reaction mixture was 
purified using the same semi-preparative HPLC methodology as with 53, 
collecting the band eluting at 16 minutes and mass spectrometry was utilised to 
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confirm that presence of the conjugate 51.  The broad nature of the emission 
peak in the HPLC trace of 51 demonstrated a need to confirm the purity of the 
conjugate.  Therefore LC-MS with an UV-visible detector was used to identify 
any impurities.  Due to the different experimental limitations for the LC-MS, the 
chromatography procedure was different to that used for the semi-preparative 
HPLC in the synthesis.  Control experiments showed that free ferricrocin could 
be detected using both the UV-visible absorbance detector (254 nm) and 
negative mode ESI mass spectrometry.  Therefore a sample of 51 was 
investigated using the same methodology as for free ferricrocin.  There was only 
one peak in the total ion count (TIC) chromatogram, with three features in the 
UV-visible trace (Figure 80). 
 
Figure 80 - LC-MS of 51. A) TIC chromatogram; B) UV absorbance (254 nm) 
chromatogram; C) Mass spectrum associated with the peak eluting after 32 minutes in 
the chromatogram. Peak at 15 min (dashed black line) is calibrant injected into the ESI 
source used for accurate mass calibration. 
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The band  in the chromatograms eluting after 32 minutes is assigned as 51, due 
to the ESI signals observed at m/z 753.1849 and 1507.3876 consistent with the 
doubly charged, (M
2-
) and singly charged (M
-
) molecular ions for a compound 
of molecular formula FeC60H73N15O24S2, respectively.  The other features in the 
UV-visible trace are a broad peak between 0-5 minutes and a sharp negative 
signal followed by a broad positive peak starting at 11 minutes.  These features 
had no detectable ions in the TIC chromatogram, suggesting that the signal is 
due to the void of the column.  This was confirmed by control blank 
chromatograms, with these features always present.  The only species detected 
by either absorbance at 254 nm or mass spectrometry was conjugate 51 showing 
that the semi-preparative HPLC methodology for the purification was 
successful. 
 
To further characterise 51, the UV-visible, emission and excitation spectra were 
recorded (Figure 81).  The profile of the UV-visible spectrum is similar to that 
of the Alexa Fluor® 488, as it is the most dominate chromophore in the 
molecule.  Conjugate 51 does possess a larger absorbance than that of the Alexa 
Fluor® 488 chromophore between 380-420 nm due to the LMCT band of the 
ferricrocin component of the conjugate.  Ferricrocin was found not to be 
fluorescent and therefore the profiles of the emission and excitation spectra of 51 
match that of the Alexa Fluor® 488 fluorophore. 
 
Due to the small scale of the synthesis an accurate mass could not be obtained 
for 51.  The final yield was therefore calculated from the UV-visible absorbance 
spectrum using the molar absorption coefficient of the Alexa Fluor® 488 azide 
(λ488, ε = 76,000 mol
-1
dm
3
cm
-1
), to be 4.2x10
-9
 mol (6.3 μg). 
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Figure 81 - A) UV-visible absorbance spectra of Alexa Fluor® 488 azide (1.3x10-5 
moldm
-3
), 51 and ferricrocin (2.0x10
-4
 moldm
-3
); B) Emission spectra of Alexa Fluor® 
488 azide and 51, excited at 488 nm; C) Excitation spectra of Alexa Fluor® 488 azide 
and 51, monitoring at 525 nm.  All spectra recorded in water. 
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5.3 Conjugate-Protein Interactions 
 
The work outlined within this section was conducted by Dr Christoph Baumann, 
Department of Biology, University of York. 
 
To determine if 51 will selectivity bind to the outer membrane receptor FhuA as 
outlined in the introduction, TIRF microscopy was utilised.  Two strains of E. 
coli were grown and used for this experiment, a ΔfhuA strain and a ΔtonB strain.  
The ΔfhuA strain provided a negative control: due to the lack of FhuA receptors 
expressed, conjugate 51 should not bind to these cells.  The ΔtonB strain 
provided the positive control as 51 should bind to the FhuA receptor but not be 
internalised into the cell and hence remains detectable under the TIRF 
microscopy experimental conditions.   
 
A sample of each cell culture was taken and centrifuged, the supernatant was 
removed and the cells subsequently resuspended in M9 medium containing 10 
nM of conjugate 51.  The cells were incubated in the dark for 20 minutes, before 
being centrifuged to remove any supernatant, before resuspended in fresh M9 
medium containing no 51.  The cells where then immobilised onto a poly-lysine 
slip and images recorded under the TIRF microscope (Figure 82). 
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Figure 82 - Initial TIFM images.  A) 10 nM 51 and E. coli ΔfhuA cells (sum of 500 
video frames); B) 10 nM 51 and E. coli ΔtonB cells (sum of 5 video frames). 
 
The TIRFM images show the successful labelling of the E. coli cells that 
contained the FhuA receptor.  To further test the hypothesis of the specific 
labelling of the receptor, the experiments were repeated, but with a third 
experimental condition.  This time the ΔtonB cells were incubated with 5 μM of 
ferricrocin, before the incubation of 10 nM of conjugate 51.  The unlabelled 
ferricrocin, should bind and block the FhuA receptors from 51 resulting in a 
weak fluorescence signal (Figure 83). 
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Figure 83 - Repeat TIRFM images containing 10 nM 51, E. coli ΔfhuA, ΔtonB cells 
and ΔtonB cells with 5 μM ferricrocin.  A) sum of 10 video frames; B) sum of 200 
video frames; C) Profile plot of grey value of pixels across highlighted cell (yellow).  
Analysis performed using ImageJ.
29 
 
The repeat TIRFM images show the ferricrocin block reduces the fluorescence 
of the E. coli cells, showing that conjugate 51 specifically binds to the FhuA 
outer membrane receptor.  The intensity of the fluorescence signal, however, is 
weaker than expected, possibly due to quenching of the fluorophore by the 
ferricrocin moiety.  As a result, the planned FRAP work could not be completed 
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as the conjugate would not be compatible with the confocal microscope 
equipment required for the experiment. 
 
5.4 Summary of Chapter 5 
 
The ferricrocin-Alexa Fluor® 488 conjugate 51 was successfully synthesised in 
a two step procedure.  First ferricrocin was reacted with 4-pentynoic anhydride, 
followed by click-chemistry to react the alkyne group with the commerically 
available Alexa Fluor® 488 azide fluorophore.  Characterisation by LC-MS, 
UV-visible and fluorescence spectroscopies confirmed the successful formation 
of 51.  Due to the small scale of the synthesis yields were not obtainable.  
Conjugate 51 was incubated with two E. coli strains, ΔfhuA and ΔtonB and 
analysed using TIRF microscopy.  The ΔfhuA strain showed a weak 
fluorescence, whereas the ΔtonB strain showed observable fluorescence under 
these experimental conditions, indicating compound 51 is selectivity binding to 
cells which possess the outer membrane transporter FhuA.   
 
 Chapter 6: Conclusions and 
Future Work 
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6.1 Conclusions and Future Work 
Interactions of Tetradentate Siderophores with CeuE (Chapters 2 and 3) 
 
The simple bis(catecholamide) biomimetic model, H4-4-LICAM was the first 
tetradentate ligand to be characterised, complexed with iron(III) and co-
crystallised with a PBP, leading to the discovery of a novel binding mode of 
CeuE.  Ferric-4-LICAM was found to be present as a 1:1 complex in the binding 
pocket of CeuE, with residues His227 and Tyr288 coordinating directly to the 
iron centre, thus completing its coordination sphere.  Sequence alignment 
revealed that these two residues are conserved among a number of related 
proteins from different bacteria.  In the absence of CeuE, it was found that 4-
LICAM
4-
 is capable of forming complexes with a ligand to metal ratio of both 
3:2 and 1:1 in equilibrium, however, only the 1:1 complex is found bound if the 
complex is co-crystallised with CeuE.  The chirality of the iron centre in the 
{CeuE[Fe(4-LICAM)]} structure was found to be Λ, both in the solid state (X-
ray diffraction analysis) and in solution (CD spectroscopy).  The dissociation 
constant was determined by intrinsic fluorescence quenching to be 29.3 ± 11.7 
nM, which is the first time a ferric-tetradentate siderophores dissociation 
constant has been determined. 
 
To confirm if the binding mode of the mimetic is biologically important, the 
successful total synthesis of the natural siderophore enterobactin linear dimer 
was carried out.  It was shown that the linear dimer preferentially binds iron(III) 
in a 1:1 complex in solution, unlike 4-LICAM
4-
, and that the basic arrangement 
within the binding pocket of CeuE in the crystal is the same.  The dissociation 
constant was determined to be 8.4 ± 4.3 nM.  The similarity between the 
dissociation constants of PBPs with ferric-4-LICAM, ferric-linear dimer and 
other characterised hexadentate siderophores, suggest that the tyrosine and 
histidine residues act as an adapter for the protein, enabling the binding of both 
tetradentate and hexadentate ligands with minimal impact on the binding mode 
(e.g. dissociation constant and metal centred chirality). 
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Future work should first involve determination of the dissociation constant of 
ferric-enterobactin towards CeuE, which would reveal whether the ferric-4-
LICAM and ferric-linear dimer Kd values are within a biologically relevant 
range for CeuE or not.  Selective mutagenesis could be used to confirm the 
importance of the His227 and Tyr288 residues, with determination of the mutant 
dissociation constants indicating the relative contribution to the Kd value for 
each residue.  Beyond these experiments, expanding the research to include 
PBPs from other organisms, as well as other proteins in the uptake system would 
be of great interest. 
 
Development of a Siderophore Mimic for use with Further Functional 
Components (Chapter 4) 
 
The second area of research involved the development of a novel catecholamide 
hexadentate siderophore mimic that possesses a linker for the attachment of a 
secondary chemical functional group.  The successful synthesis used 4-(2-
carboxyethyl)-4-nitroheptanedioic acid as a starting material, in eight synthetic 
steps to produce the final compound, with an overall yield of 10.5%.  
 
Future work would include full optimisation of the synthetic route, particularly 
the coupling of the catecholamide groups to the backbone, which is likely to be 
hampered by hydrolysis of the acid chloride.  After full optimisation, the 
iron(III) binding abilities of H6-41 could be investigated.  In addition, a second 
functional component could be covalently attached via the free carboxylate, to 
enable evaluation of its effect on the iron(III) binding of the siderophore moiety.  
Once the ligand-metal interactions are understood, the interactions between the 
protein and the ferric siderophore could be investigated, using CeuE as a model 
protein.  Determination of the metal-centred chirality and the dissociation 
constant of the CeuE-ferric-41 complex would provide useful insight into the 
protein recognition of ferric-41, and how this compares to ferric-enterobactin 
and other siderophore models.  The second functional component attached could 
be either: a fluorophore, for use as a novel fluorescent probe to target 
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enterobactin receptors or an anti-microbial agent for use in the Trojan Horse 
Strategy. 
 
Modification of Ferricrocin with a Fluorescent Component (Chapter 5) 
 
The final area of research involved modification of a natural siderophore, 
ferricrocin, by the attachment of the Alexa Fluor® 488 fluorophore.  This was 
completed by the attachment of an alkyne to the free alcohol functionality of the 
ferricrocin, followed by a 1,3 dipolar-cycloaddition ('click'-chemistry) reaction 
to introduce the Alexa Fluor® 488 fluorophore via the azide group.  The 
conjugate was characterised by LC-MS, UV-visible and fluorescence 
spectroscopies.  In collaborative experiments conjugate 51 was incubated with 
two strains of E. coli, ΔfhuA and ΔtonB and analysed using TIRF microscopy.  
The ΔfhuA strain showed a weak fluorescence, whereas the ΔtonB strain showed 
a stronger fluorescence signal, indicating selective binding of 51 to cells which 
possess the outer membrane transporter FhuA.  However, the fluorescence 
signal was not considered intense enough for the intended FRAP experiments. 
 
Future work would involve change from the current conjugate 51.  Increasing 
the link length between the ferricrocin and the fluorophore may reduce the 
impact of the quenching, or alternative fluorophores could be coupled with 
ferricrocin using similar synthetic strategies. 
 Chapter 7: Experimental 
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7.1 General Remarks 
Materials 
All materials were obtained from commercial suppliers (Acros, Alfa-Aesar, 
Fisher Chemicals, Fisher Scientific, Fluka, Sigma-Aldrich) and used as supplied 
unless otherwise stated. 
Instrumentation 
1
H, 
13
C{
1
H}, DEPT 135, HSQC, COSY, HMBC NMR spectra were recorded on 
a Jeol EX and ES 400 MHz instruments (
1
H NMR 400 MHz, 
13
C NMR 100.6 
MHz).  DOSY spectra were recorded on a Bruker 500 MHz instrument (
1
H 
NMR 500 MHz) and the experiments were carried out by Ms. Heather Fish.  
Multiplicity abbreviations are as follows; s for singlet, d for doublet, t for triplet, 
q for quartet quin for quintet, dd for double doublet, td triple doublet, ddd for 
doublet of doublet of doublets, m for multiplet, br for broad and app for 
apparent.  All NMR assignments were aided by  DEPT 135, HSQC experiments, 
with additional COSY and HMBC experiments used as required.  Electro-spray 
ionisation mass spectrometry (ESI-MS) was recorded on a Bruker microTOF 
Electrospray mass spectrometer by Mr. K. Heaton and Ms. H. Robinson.  Infra-
red spectra were recorded on a Thermo Nicolet Avatar 370 FT-IR 
spectrophotometer (KBr), or on a Perkin Elmer FT-IR Spectrum Two 
spectrometer (ATIR) in the region of 4000-500 cm
-1
.  Elemental analysis was 
carried out by Dr. G. McAllister on an Exeter CE-440 elemental analyser and 
results are within ± 0.4 %.  TLC was performed on Merck silica gel 60 F254 
aluminium backed plates and visualised under a Chromato-vue Model CC-10 
UV lamp, unless otherwise stated.  Melting points were recorded on a Stuart 
Scientific SMP3 instrument.  Electronic absorbance spectra were recorded on a 
Shimadzu UV-1800 spectrophotometer, with kinetic data recorded on a Hewlett 
Packard 8452A diode array spectrophotometer with a thermostated cell holder.  
Fluorescence spectra were recorded on a Hitachi F-4500 fluorescence 
spectrophotometer.  The specific rotation was recorded on a Jasco DIP-370 
digital polarimeter.  The circular dichromism spectroscopic measurements were 
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performed on a Jasco J810 CD spectropolarimeter at 20 °C under constant 
nitrogen flush. 
 
7.2 Synthesis 
 
The order of the experimental details of each molecule is shown in Table 14. 
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Compound Number (Target Compound) Chapter of 
Thesis 
Page Number 
12 (Catechol Synthesis) 2 204 
13 (Catechol Synthesis) 2 205 
16 (H2-EBA Synthesis) 2 206 
15 (H2-EBA Synthesis) 2 208 
14 (H4-4-LICAM Synthesis) 2 209 
H4-4-LICAM (H4-4-LICAM Synthesis) 2 211 
22 (H4-17) 3 212 
24 (H4-17) 3 214 
25 (H4-17) 3 215 
29 (H4-17) 3 217 
30 racemic (H4-17) 3 219 
31 (Catechol Synthesis) 3 221 
32 (H4-17) 3 221 
33 (H4-17) 3 223 
34 (H4-17) 3 225 
30 ʟ/ʟ (H4-17) 3 226 
H4-17 (H4-17) 3 228 
43 (H6-41) 4 230 
44 (H6-41) 4 231 
45 (H6-41) 4 232 
46 (H6-41) 4 234 
47 (H6-41) 4 235 
48 (H6-41) 4 237 
49 (H6-41) 4 239 
H6-41 (H6-41) 4 240 
53 (51) 5 242 
51 (51) 5 243 
Table 14 - Ordering of synthetic experimental details. 
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2,3-Bis(phenylmethoxy)benzoic acid, 12 
 
 
 
Prepared as in accordance to the literature.
1
 
 
Yield:  
10.01 g, 29.9 mmol, 80% 
Mp:  
124.1-125.9 °C 
Rf:  
Chloroform : MeOH (8:1) : Rf : 0.51 
m/z (ESI):  
357.1097 ([M+Na]
+
, 97%), 335.1289 ([M+H]
+
, 13%) 
HRMS (ESI): 
Calc for [C21H18O4] + H
+
  = 335.1278 Found 335.1289 (-3.3 ppm error) 
Calc. for [C21H18O4] + Na
+
  = 357.1097  Found 357.1097 (0.1 ppm error)  
1
H NMR: (d6-DMSO, 400 MHz) δH 
12.93 (1H, s, H-9), 7.49 (2H, d, J = 7.3 Hz, Har), 7.42-7.29 (9H, m, Har), 7.22 
(1H, dd, J = 7.8, 1.5 Hz, H-1/3), 7.15 (1H, t, J = 7.8 Hz, H-2), 5.19 (2H, s, H-
11/17), 5.00 (2H, s, H-11/17) 
 
13
C{
1
H} NMR: (d6-DMSO, 100 MHz) δC   
168.2 (C-7), 152.9 (C-4/5), 147.2 (C-4/5), 137.9 (Car), 137.3 (Car), 128.9 (Car), 
128.7 (Car), 128.6 (Car), 128.5 (Car), 128.3 (Car), 128.2 (Car), 124.7 (Car), 121.9 
(Car), 117.5 (Car), 74.9 (C-11/17), 70.3 (C-11/17) 
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IR (KBr cm
-1
):  
3431 weak (O-H), 3032 weak (C-H), 1692 strong (C=O, acid), 1577 strong (C-C 
ar) 
The characterisation data are consistent with those reported. 
 
2,3-Bis(phenylmethoxy)-benzoic acid 2,5-dioxo-pyrrolidinyl ester, 13 
 
 
 
Prepared as in accordance to the literature.
2
 
 
Yield:  
2.58 g, 5.98 mmol, 72% 
Mp:  
115.7 – 116.9 °C 
Rf:  
Chloroform : Ethyl Acetate (4:1) : Rf : 0.47 
m/z (ESI):  
454.1248 ([M+Na]
+
, 100%) 
HRMS (ESI): 
Calc. for [C25H21NO6] + Na
+
 = 454.1261  Found 454.1248 (2.9 ppm error)  
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1
H NMR: (d6-DMSO, 400 MHz) δH 
7.61-7.29 (13H, m, Har), 5.25 (2H, s, H-15/21), 5.04 (2H, s, H-15/21), 2.89 (4H, 
s, H-13) 
13
C{
1
H} NMR: (d6-DMSO, 100 MHz) δC   
171.2 (C-11), 161.5 (C-7), 153.2 (C-4/5), 148.6 (C-4/5), 137.2 (Car), 136.9 (Car), 
129.0 (Car), 128.9 (Car), 128.6 (Car), 128.6 (Car), 128.5 (Car), 128.5 (Car), 125.4 
(Car), 122.6 (Car), 121.0 (Car), 120.5 (Car), 75.3 (C-15/21), 70.6 (C-15/21), 25.5 
(C-13) 
IR (KBr cm
-1
):  
1768 strong (C=O), 1738 strong (C=O), 1499 medium (C-C ar) 
Elemental Analysis: 
Calculated for [C25H21NO6]: %C 69.60, %H 4.91, %N 3.25 
Measured for [C25H21NO6]: %C 69.21, %H 4.92, %N 3.23 
The characterisation data are consistent with those reported. 
 
2,3-Bis(phenylmethoxy)-N-ethylbenzamide, 16 
 
 
 
Compound 13 (0.203 g, 0.47 mmol) was dissolved in 10 mL of THF.  To this 
stirred solution, triethylamine (85 L, 0.6 mmol) was added, followed by 300 
L of a 2.0 M solution of ethylamine in THF.  The solution was stirred at room 
temperature for 4 hours.  The volatiles were then removed in vacuo before the 
residue was taken up in 50 mL of dichloromethane.  The organic layer was 
washed with 15 mL 0.1 M HCl, followed by 15 mL saturated NaHCO3 and 3 x 
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20 mL water.  The organic layer was dried over MgSO4, before the 
dichloromethane was removed in vacuo, to yield the product as an oil. 
Characterisation data consistent with literature.
3
 
 
Yield:  
0.1243 g, 0.34 mmol, 72 % 
Rf:  
Chloroform : Ethyl Acetate (4:1) : Rf : 0.64 
m/z (ESI):  
362.1745 ([M+H]
+
, 100%), 384.1561 ([M+Na]
+
, 37%) 
HRMS (ESI): 
Calc for [C23H23NO3]+H
+
 = 362.1751 Found 362.1745 (1.7 ppm error) 
Calc. for [C23H23NO3]+Na
+
  = 384.1570 Found 384.1561 (2.3 ppm error)  
1
H NMR: (d6-DMSO, 400 MHz) δH 
7.92 (1H, br t, J = 5.0 Hz, H-9), 7.77-7.74 (1H, m, Har), 7.50-7.14 (12H, m, Har), 
5.16 (2H, s, H-14/28), 5.07 (2H, s, H-14/28), 3.32 (2H, dq, J = 7.0, 5.0 Hz, H-
10), 0.99 (3H, t, J = 7.0 Hz, H-11) 
13
C{
1
H} NMR: (d6-DMSO, 100 MHz) δC 
165.3 (C-7), 152.1 (C-4/5), 147.1 (C-4/5), 136.7 (Car), 136.6 (Car), 129.1 (Car), 
128.9 (Car), 128.5 (Car), 127.9 (Car), 127.7 (Car), 124.6 (Car), 123.5 (Car), 116.9 
(Car), 76.3 (C-14/28), 71.2 (C-14/28), 34.2 (C-10), 14.0 (C-11) 
IR (KBr cm
-1
):  
3385 medium (N-H), 2932 weak (C-H), 1652 strong (C=O, amide), 1526 strong 
(C-C ar) 
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N-ethyl-2,3-dihydroxybenzamide, 15 
 
 
 
All glassware used was soaked in 6M HCl for at least 2 hours before use, in 
order to remove iron adsorbed on the surface of the glassware. 
 
Compound 16 (4.1 mmol, 1.480 g) was dissolved in 35 mL of dry ethanol.  To 
the solution, one small spatula tip of Pd-C 10% was added and a balloon of 
hydrogen gas was passed through the solution to purge the system.  After the 
system is purged a second balloon of hydrogen gas was added which allowed the 
reaction to proceed for 3 days under a positive pressure of hydrogen.  After the 
reaction was completed the catalyst was filtered off and the product was isolated 
by removing the solvent in vacuo.  The product was purified by sublimation at 
10
-2
 mbar at 80 °C to yield a white crystalline solid.  Characterisation data 
consistent with literature.
4
  
 
Yield:  
0.547 g, 3.02 mmol, 74 % 
Mp:  
78.2-78.8 °C 
Rf:  
Chloroform : Ethyl Acetate (4:1) : Rf : 0.38 
m/z (ESI):  
182.0810 ([M+H]
+
, 50%), 204.0624 ([M+Na]
+
, 100%) 
HRMS (ESI): 
Calc for [C9H11NO3]+H
+
  = 182.0812 Found 182.0810 (1.2 ppm error) 
Calc. for [C9H11NO3]+Na
+
  = 204.0631 Found 204.0624 (3.5 ppm error)  
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1
H NMR: (d6-DMSO, 400 MHz) δH 
13.94 (1H, br s, H-12/13), 9.13 (1H, br s, H-12/13), 8.80, (1H, t, J = 5.2 Hz, H-
9), 7.27 (1H, dd, J = 8.0, 1.5 Hz, H-1/3), 6.90 (1H, dd, J = 8.0, 1.5 Hz, H-1/3), 
6.66 (1H, app t, J = 8.0 Hz, H-2), 3.31(2H, dq, J = 7.2, 5.5 Hz, H-10), 1.13 (3H, 
t, J = 7.5 Hz, H-11). 
13
C{
1
H} NMR: (d6-DMSO, 100 MHz) δC 
170.3 (C-7), 150.4 (C-4/5), 146.8 (C-4/5), 119.2 (Car), 118.3 (Car), 117.5 (Car), 
115.3 (Car), 38.6 (C-10), 26.3 (C-11). 
IR (KBr cm
-1
):  
3350 medium (O-H), 3223 medium (N-H), 2982 weak (C-H), 1641 medium 
(C=O, amide), 1575 medium (C-C ar) 
Elemental Analysis: 
Calculated for [C9H11NO3]: %C 59.66, %H 6.12, %N 7.73 
Measured for [C9H11NO3]: %C 59.62, %H 6.23, %N 7.69 
 
N,N'-[bis(2,3-bis(phenylmethoxy)benzoyl]-1,4-diaminobutane, 14 
 
 
 
1,4-diaminobutane, 50 μL (0.5 mmol) was dissolved in 5 mL acetone also 
containing triethylamine, 350 μL (2.5 mmol) and stirred.  To this stirred 
solution, compound 13 (0.431 g, 1.0 mmol), dissolved in 5 mL of acetone was 
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slowly added and the resulting mixture was stirred at ambient temperature for 18 
hours.  The solvent was removed in vacuo.  The solid formed was dissolved in 
chloroform and washed with 0.05 M HCl.  The organic layer was washed with 
saturated NaHCO3 and H2O until the aqueous washes were neutral.  The organic 
layer was dried over MgSO4, filtered, and the solvent removed in vacuo to yield 
the crude product.  The crude product was purified via flash column 
chromatography on silica 4:1 CHCl3:EtOAc, with the solvent system changing 
to 9:1 CHCl3:MeOH to elute the product yielding an off white solid. 
 
Yield:  
0.336 g, 0.47 mmol, 94% 
Mp:  
122.1-124.9 °C 
Rf:  
Chloroform : Ethyl Acetate (1:1) : Rf : 0.43 
m/z (ESI):  
721.3268 ([M+H]
+
, 100%), 743.3090 ([M+Na]
+
, 60%) 
HRMS (ESI): 
Calc for [C46H44N2O6]+H
+
  = 721.3272 Found 721.3268 (0.6 ppm error) 
Calc. for [C46H44N2O6]+Na
+
  = 743.3092 Found 743.3090 (0.2 ppm error)  
1
H NMR: (d6-DMSO, 400 MHz) δH 
8.17 (2H, t, J = 6.0 Hz, H-9), 7.51 (4H, d, J = 8.0 Hz, Har), 7.43-7.27 (18H, m, 
Har), 7.14-7.12 (4H, m, Har), 5.20 (4H, s, H-13/19), 5.01 (4H, s, H-13/19), 3.14 
(4H, br q, J = 5.6 Hz H- 10), 1.40-1.36 (4H, br m, H-11) 
13
C{
1
H} NMR: (d6-DMSO, 100 MHz) δC   
166.1 (C-7), 152.2 (C-1/2), 145.7 (C-1/2), 131.5 (Car), 128.9 (Car), 128.7 (Car), 
128.6 (Car), 128.5 (Car), 128.4 (Car), 128.3 (Car), 124.6 (Car), 121.7 (Car), 116.2 
(Car), 75.3 (C-13/19), 70.4 (C-13/19), 38.7 (C-10), 26.4 (C-11) 
IR (KBr cm
-1
):  
3394 medium (N-H), 2933 weak (C-H), 1659 strong (C=O, amide), 1529 strong 
(C-C ar) 
Elemental Analysis: 
Calculated for [C46H44N2O6]: %C 76.64, %H 6.15, %N 3.89 
Measured for [C46H44N2O6]: %C 76.29, %H 6.19, %N 3.83 
         Chapter 7 
          211 
 
H4-4-LICAM 
 
 
 
Compound 14, 0.0564 g (0.078 mmol) was dissolved in 2 mL of dry toluene 
before 50 mL of dry ethanol was added.  To this stirred solution one small 
spatula tip of Pd-C 10% was added.  The mixture was purged with hydrogen and 
allowed to react for 18 hours under a positive pressure of hydrogen.  After the 
reaction was completed the catalyst was filtered off and the product was isolated 
by removing the solvent in vacuo, to yield a beige solid. Characterisation data 
consistent with literature.
5
  
 
Yield:  
0.0267 g, 0.074 mmol, 95% 
Mp:  
Decomposed approx 195 °C 
m/z (ESI):  
361.1391 ([M+H]
+
, 10%), 383.1216 ([M+Na]
+
, 24%) 
HRMS (ESI): 
Calc for [C18H20N2O6]+H
+
  = 361.1394 Found 361.1391 (0.9 ppm error) 
Calc. for [C18H20N2O6]+Na
+
  = 383.1214 Found 383.1216 (-0.7 ppm error)  
1
H NMR: (d6-DMSO, 400 MHz) δH 
12.88 (2H, br s, H-23/24), 9.14 (2H, br s, H-23/24), 8.81 (2H, t, J = 5.5 Hz, H-
9), 7.29 (2H, dd, J = 8.5, 1.2 Hz, H-2/4), 6.90 (2H, dd, J = 8.0, 1.2 Hz, H-2/4), 
6.68 (2H, dd, J = 8.5, 8.0 Hz, H-3), 3.30-3.25 (4H, m, H-10), 1.59-1.54 (4H, m, 
H-11). 
13
C{
1
H} NMR: (d6-DMSO, 100 MHz) δC   
170.4 (C-7), 150.3 (C-1/6), 146.8 (C-1/6), 119.2 (Car), 118.3 (Car), 117.5 (Car), 
115.3 (Car), 38.6 (C-10), 26.3 (C-11). 
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IR (KBr cm
-1
):  
3415 medium (O-H), 3390 medium (N-H), 1643 medium (C=O, amide), 1590 
medium (C-C ar) 
Elemental Analysis 
Calculated for [C18H20N2O6.0.8H2O]: %C 57.69, %H 5.81, %N 7.47 
Measured for [C18H20N2O6.0.8H2O]: %C 57.78, %H 5.94, %N 7.46 
 
ʟ-Serine-N-[2,3-bis(phenylmethoxy)benzoyl]-O-(phenylmethyl)-ether, 22 
 
 
 
To a stirred suspension of ʟ-serine benzyl ester hydrochloride (0.70 g, 3 mmol) 
in acetonitrile (75 mL), triethylamine (0.50 mL, 3.6 mmol) was added and 
allowed to stir for a short time before, a solution of compound 13 (1.29 g, 3 
mmol) in acetonitrile (25 mL) was added and the mixture and left to stir 
overnight. After 18 hours, the solvent was removed in vacuo and the resulting 
oil dissolved in chloroform 100 mL. This was washed with HCl (50 mL, 0.1 M), 
saturated NaHCO3 (50 mL) and water (4 x 50 mL) until the aqueous layer was at 
neutral pH. The organic layer was then dried over MgSO4, filtered and the 
solvent removed in vacuo, yielding an off white solid. Characterisation data 
consistent with literature.
6
 
 
Yield: 
1.40 g, 2.74 mmol, 91.0% 
Melting point:  
76.4 – 79.6 °C 
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Rf: 
Chloroform : Ethyl Acetate (1:1) : Rf : 0.53 
m/z (ESI): 
534.1874 ([M+Na]
+
, 100 %), 512.2056 ([M+H]
+
, 91.5 %) 
HRMS (ESI): 
Calc for [C31H29NO6] + H
+
  = 512.2068 Found 512.2056 (2.3 ppm error) 
Calc for (C31H29NO6] + Na
+
  = 534.1887 Found 534.1874 (2.4 ppm error) 
1
H NMR: (CDCl3, 400 MHz) δH 
8.86 (1H, d, J = 7.0 Hz, H-9), 7.71 (1H, dd, J = 7.0, 2.5 Hz, H-2/4), 7.47-7.15 
(17H, m, Har), 5.21 (1H, d, J = 10.0 Hz, H-16/22/28), 5.19 (2H, s, H-16/22/28), 
5.15 (2H, s, H-16/22/28), 5.07 (1H, d, J = 10.0 Hz, H-16/22/28), 4.78 (1H, ddd, 
J = 7.5, 4.0, 4.0 Hz, H-10), 3.90 (1H, dd, J = 11.2, 4.4 Hz, H-11/11*), 3.85 (1H, 
dd, J = 11.2, 4.0 Hz, H-11/11*) 
13
C{
1
H} NMR: (CDCl3, 100 MHz) δC   
170.2 (C-13), 165.8 (C-7), 151.9 (Car), 147.2 (Car), 136.4 (Car), 136.4 (Car), 
135.4 (Car), 129.2 (Car), 128.8 (Car), 128.7 (Car), 128.7 (Car), 128.6 (Car), 128.5 
(Car), 128.4 (Car), 128.3 (Car), 127.9 (Car), 126.7 (Car), 124.5 (Car), 123.4 (Car), 
117.7 (Car), 76.4 (C-16/22/28), 71.5 (C-16/22/28), 67.5 (C-16/22/28), 63.7 (C-
11), 55.6 (C-10) 
IR (KBr cm
-1
): 
3358 strong (N-H), 3036 medium (C-H ar), 2956 medium (C-H), 1743 strong 
(C=O, ester), 1627 strong (C=O, amide) 
Elemental Analysis: 
Calculated for [C31H29NO6.0.2H2O]: %C 72.27, %H 5.75, %N 2.72 
Measured for [C31H29NO6.0.2H2O]: %C 72.18, %H 5.66, %N 2.78 
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ʟ-Serine-N-[2,3-bis(phenylmethoxy)benzoyl]-O-methyl ester, 24 
 
 
 
To a stirred solution of ʟ-serine methyl ester hydrochloride (1.74 g, 11.2 mmol) 
in acetonitrile (75 mL), triethylamine (3.83 mL, 27.5 mmol) was added and 
allowed to stir for a short time before, a solution of compound 13 (4.31 g, 9.89 
mmol) in acetonitrile (25 mL) was added and the mixture and left to stir 
overnight. After 18 hours, the solvent was removed in vacuo and the resulting 
oil dissolved in chloroform (100 mL).  This was washed with HCl (50 mL, 0.1 
M), saturated NaHCO3 (50 mL) and water (4 x 50 mL) until the aqueous layer 
was at neutral pH. The organic layer was then dried over MgSO4, filtered and 
the solvent removed in vacuo, yielding an off white solid.  
 
Yield: 
3.40 g, 7.8 mmol, 78%  
Melting point: 
110.3 – 111.2 °C 
Rf: 
Chloroform : Ethyl Acetate (1:1) : Rf : 0.37 
m/z (ESI): 
458.1581 ([M+Na]
+
, 100 %), 436.1766 ([M+H]
+
, 11.3 %)  
HRMS (ESI): 
Calc for [C25H25NO6] + H
+
  = 436.1755 Found 436.1766 (-2.6 ppm error) 
Calc for [C25H25NO6] + Na
+
  = 458.1574 Found 458.1581 (-1.6 ppm error) 
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1
H NMR: (CDCl3, 400 MHz) δH 
8.86 (1H, d, J = 7.3 Hz, H-9), 7.72 (1H, dd, J = 7.0, 2.5 Hz, H-2/4), 7.26-7.48 
(10H, m, Har), 7.14-7.20 (2H, m, Har), 5.26 (1H, d, J = 10.5 Hz, H-
18/18*/24/24*), 5.24 (2H, s, H-18/24), 5.19 (1H, d, J = 10.5 Hz, H-
18/18/24/24*), 4.85 (1H, ddd, J = 7.5, 4.0, 4.0 Hz, H-10), 3.98 (1H, dd, J = 11.5, 
4.5 Hz, H-11), 3.92 (1H, dd, J = 11.5, 4.0 Hz, H-11), 3.80 (3H, s, H-16) 
13
C{
1
H} NMR: (CDCl3, 100 MHz) δC 
171.1 (C-13), 166.0 (C-7), 152.1 (Car), 147.4 (Car), 136.6 (Car), 136.6 (Car), 
129.3 (Car), 128.9 (Car), 128.8 (Car), 128.7 (Car), 128.5 (Car), 128.0 (Car), 126.8 
(Car), 124.6 (Car), 123.5 (Car), 117.7 (Car), 76.2 (C-18/24), 71.3 (C-18/24), 63.4 
(C-11), 55.1 (C-10), 52.4 (C-16) 
IR (KBr cm
-1
): 
3335 strong (N-H), 3064 medium (C-H ar), 2935 medium (C-H), 1747 strong 
(C=O, ester), 1643 strong (C=O, amide)  
 
ʟ-Serine-N-[2,3-bis(phenylmethoxy)benzoyl]-O-(tetrahydro-pyran-2-yloxy)-
O-methyl ester, 25 
 
 
 
Pyridinium p-toluenesulfonate (0.75 g, 3 mmol) was added to a stirred solution 
of 24 (3.34 g, 7.66 mmol) in DCM (100 mL) at room temperature. To this, 3,4-
Dihydro-2H-pyran (1.75 mL, 19 mmol) was added and the solution was left to 
stir.  After 18 hours, the DCM was removed in vacuo to yield an oil which was 
subsequently dissolved in diethyl ether (150 mL) and washed with water (3 x 50 
mL) and saturated NaHCO3 solution (50 mL).  After removal of the solvent in 
vacuo, the product is isolated as a viscous oil of diastereomers in an equal ratio. 
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Yield:  
3.44 g, 6.62 mmol, 86% 
Rf: 
Chloroform : Ethyl Acetate (1:1) : Rf : 0.52 
m/z (ESI): 
542.2139 ([M+Na]
+
, 100 %), 520.2344 ([M+H]
+
, 3.0 %)  
HRMS (ESI): 
Calc for [C30H33NO7] + H
+
  = 520.2330 Found 520.2344 (-2.7 ppm error) 
Calc for [C30H33NO7] + Na
+
  = 542.2149 Found 542.2139 (1.9 ppmq error) 
1
H NMR: (d6-DMSO, 400 MHz) δH 
8.80 (2H, d, J = 7.5 Hz, H-9, 9’), 7.52-7.18 (26H, m, Har, Har’), 5.21 (4H, s, H-
24/30, 24’/30’), 5.12-4.98 (4H, m, H-24/30/24*/30*, 24’/30’/24*’/30*’), 4.85-
4.79 (1H, m, H-10/10’), 4.78-4.73 (1H, m, H-10/10’), 4.50-4.47 (1H, m, H-
13/13’), 4.43-4.41 (1H, m, H-13/13’), 4.00 (1H, dd, J = 10.5, 4.5 Hz, H-
11/11*/11’/11*’), 3.89-3.85 (1H, m, H-11/11*/11’/11*’), 3.74 (1H, dd, J = 10.5, 
4.5 Hz, H-11/11*/11’/11*’), 3.67 (3H, s, H-22/22’), 3.66 (3H, s, H-22/22’), 
3.61-3.53 (3H, m, H-11/11*/11’/11*’, 17/17’), 3.46-3.30 (2H, m, H-17/17’)ǂ, 
1.49-1.28 (12H, m, H-14/14’, 15/15’, 16/16’) 
ǂObscured by water signal 
13
C{
1
H} NMR: (d6-DMSO, 100 MHz) δC 
170.4 (C-19/19’), 170.2 (C-19/19’), 164.6 (C-7/7’), 163.3 (C-7/7’), 151.5 (Car), 
145.7 (Car), 145.6 (Car), 136.4 (Car), 136.4 (Car), 136.4 (Car), 136.3 (Car), 128.4 
(Car), 128.3 (Car), 128.3 (Car), 127.9 (Car), 127.9 (Car), 127.9 (Car), 127.9 (Car), 
127.8 (Car), 127.3 (Car), 124.3 (Car), 124.2 (Car), 121.5 (Car), 121.3 (Car), 116.8 
(Car), 116.7 (Car), 98.2 (C-13/13’), 97.2 (C-13/13’), 93.0 (C), 75.1 (C-
24/30/24/30’), 75.0 (C-24/30/24’/30’), 70.2 (C-24/30/24’/30’), 70.2 (C-
24/30/24’/30’), 66.3 (C-11/11’), 65.9 (C-11/11’), 64.9 (C), 64.7 (C), 61.3 (C), 
60.6 (C), 52.7 (C-10/10’), 52.3 (C-10/10’), 51.9 (C-22/22’), 51.9 (C-22/22’), 
29.9 (C), 29.7 (C), 29.3 (C), 24.8 (C), 24.6 (C), 24.5 (C), 18.9 (C), 18.6 (C), 18.4 
(C) 
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ʟ-Serine-N-[2,3-bis(phenylmethoxy)benzoyl]-O-(phenylmethyl)-ether, 29 
 
 
 
Triethylamine (0.50 mL, 3.6 mmol) was added to a stirred solution of O-benzyl 
ʟ-serine (0.70 g, 3 mmol) in acetonitrile (75 mL). To this, a solution of 
compound 13 (1.29 g, 3 mmol) in acetonitrile (25 mL) was added and the 
mixture left to stir overnight. After 18 hours, the solvent was removed in vacuo 
and the resulting oil dissolved in chloroform 100 mL. This was washed with 
HCl (50 mL, 0.1 M) and water (4 x 50 mL) until the aqueous layer was at 
neutral pH. The organic layer was then dried over MgSO4, filtered and the 
solvent removed in vacuo, yielding an off white solid. Characterisation data 
consistent with literature.
1
 
 
Yield: 
1.28 g, 2.50 mmol, 84% 
Melting point: 
116.2 - 117.9 °C 
m/z (ESI): 
512.2082 ([M+H]
+
, 13 %), 534.1880 ([M+Na]
+
, 100 %) 
HRMS (ESI): 
Calc for [C31H29NO6] + H
+
  = 512.2068 Found 512.2082 (-2.8 ppm error) 
Calc for [C31H29NO6] + Na
+ 
= 534.1887 Found 534.1880 (1.6 ppm error) 
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1
H NMR: (CDCl3, 400 MHz) δH 
9.01 (1H, d, J = 7.0 Hz, H-9), 7.74 (1H, dd, J = 7.0 Hz, 2.5 Hz, H-2/4), 7.48-
7.22 (17H, m, Har), 5.16 (2H, s, H-22/28), 5.11 (1H, d, J = 10.5 Hz, H-
22/28/22*/28*), 5.09 (1H, d, J = 10.5 Hz, H-22/28/22*/28*), 4.87 (1H, ddd, J = 
7.5, 4.0, 4.0 Hz, H-10), 4.37 (2H, s, H-13), 3.86 (1H, dd, J = 9.5, 4.5 Hz, H-
11/11*), 3.66 (1H, dd, J = 9.5, 4.0 Hz, H-11/11*) 
13
C{
1
H} NMR: (CDCl3, 100 MHz) δC 
173.6 (C-18), 166.2 (C-7), 152.0 (Car), 147.3 (Car), 137.4 (Car), 136.4 (Car), 
136.2 (Car), 129.3 (Car), 128.9 (Car), 128.6 (Car), 128.6 (Car), 128.5 (Car), 128.5 
(Car), 128.0 (Car), 127.9 (Car), 127.9 (Car), 126.4 (Car), 124.6 (Car), 123.4 (Car), 
117.8 (Car), 76.4 (C-22/28), 73.4 (C-13), 71.5 (C-22/28), 68.8 (C-11), 53.4 (C-
10) 
IR (KBr cm
-1
): 
3353 strong (N-H), 3060 medium broad (O-H acid), 2919 medium (C-H ar) 
1757 strong (C=O, acid), 1636 strong (C=O, amide)  
Elemental Analysis: 
Calculated for [C31H29NO6]: %C 72.78, %H 5.71, %N 2.74 
Measured for [C31H29NO6]: %C 72.64, %H 5.69, %N 2.80 
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ʟ-Serine-N-[2,3-bis(phenylmethoxy)benzoyl]-O-(phenylmethyl)-ester-O-ʟ/ᴅ-
serine, N-[2,3-bis(phenylmethoxy)benzoyl]-O-(phenylmethyl)-ether, 30 (ʟ/ᴅ, 
ʟ/ʟ) 
 
 
Compound 29 (0.231 g, 0.45 mmol), compound 22 (0.262 g, 0.51 mmol) and 
HOBt (0.122 g, 0.9 mmol) were suspended in 30 mL dry chloroform.  DCC 
(0.138 g, 0.67 mmol) was added slowly over 10 minutes, and the reaction was 
stirred overnight at room temperature.  The solution was then washed with 20 
mL water, 15 mL saturated NaHCO3 solution, 20 mL 0.1 M HCl, followed by 3 
x 20 mL water.  The organic layer was dried over MgSO4 before the solvent was 
removed in vacuo.  The crude product was purified via column chromatography, 
9:1 dichloromethane : ethyl acetate, followed by a second column eluting with 
9:2 dichloromethane : ethyl acetate to yield a colourless oil.  
 
Yield: 
0.072 g, 0.07 mmol, 16 % 
Rf: 
Dichloromethane : Ethyl Acetate (9:2) : Rf : 0.7 
m/z (ESI): 
1005.3917 ([M+H]
+
, 100 %), 1027.3743 ([M+Na]
+
, 6 %) 
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HRMS (ESI): 
Calc for [C62H56N2O11] + H
+
  = 1005.3957 Found 1005.3917 (4.0 ppm error) 
Calc for [C62H56N2O11] + Na
+
 = 1027.3776 Found 1027.3743 (3.2 ppm error) 
1
H NMR: (CDCl3, 400 MHz) δH 
The 
1
H NMR is comprised of two diastereomers in solution.  The ratio between 
the two diastereomers is 5/4. 
8.83-8.76 (2H, m, H-9/31), 7.73-7.66 (2H, m, Har), 7.45-6.92 (34H, m, Har), 
5.22-4.96 (10H, m), 4.65, (1H, ddd, J = 7.6, 3.6, 3.2 Hz, H-10/22)), 4.57-4.53 
(1H, m), 4.34 (1H, dd, J = 11.2, 3.6 Hz, H-11/11*/21/21*), 4.31 (1H, dd, J = 
11.2, 4.0 Hz, H-11/11*/21/21*), 4.20 (1H, d, J = 12.0 Hz, Hbenzyl), 4.16 (1H, d, J 
= 12.0 Hz, Hbenzyl), 3.53 (1H, dd, J = 9.6, 3.6 Hz, H-11/11*/21/21*), 3.44 (1H, 
dd, J = 9.2, 3.2 Hz, H-11/11*/21/21*) 
 
8.83-8.76 (2H, m, H-9/31), 7.73-7.66 (2H, m, Har), 7.45-6.92 (34H, m, Har), 
5.22-4.96 (12H, m), 4.60-4.52 (2H, m), 4.07 (2H, s, Hbenzyl), 3.27 (1H, dd, J = 
9.6, 3.6 Hz, H-11/11*/21/21*), 3.18 (1H, dd, J = 9.6, 3.6 Hz, H-11/11*/21/21*) 
13
C{
1
H} NMR: (CDCl3, 100 MHz) δC 
Certain signals in the 
13
C NMR spectrum overlap 
170.1 (C-18/18*/23/23*), 170.1 (C-18/18*/23/23*), 169.6 (C-18/18*/23/23*), 
169.5 (C-18/18*/23/23*), 165.6 (C-7/7*/32/32*), 165.6 (C-7/7*/32/32*), 165.4 
(C-7/7*/32/32*), 165.4 (C-7/7*/32/32*), 152.3 (Car), 152.2 (Car), 152.1 (Car), 
147.4 (Car), 147.4 (Car), 147.4 (Car), 147.3 (Car), 137.7 (Car), 137.7 (Car), 136.6 
(Car), 136.6 (Car), 136.6 (Car), 136.6 (Car), 136.5 (Car), 136.5 (Car), 136.5 (Car), 
135.5 (Car), 135.4 (Car), 129.6 (Car), 129.4 (Car), 129.4 (Car), 128.9 (Car), 128.9 
(Car), 128.9 (Car), 128.8 (Car), 128.8 (Car), 128.7 (Car), 128.6 (Car), 128.6 (Car), 
128.5 (Car), 128.5 (Car), 128.5 (Car), 128.4 (Car), 128.4 (Car), 128.4 (Car), 128.4 
(Car), 128.3 (Car), 128.2 (Car), 128.1 (Car), 128.1 (Car), 127.9 (Car), 127.7 (Car), 
127.6 (Car), 127.6 (Car), 127.1 (Car), 127.1 (Car), 126.9 (Car), 124.6 (Car), 124.6 
(Car), 124.5 (Car), 123.5 (Car), 123.4 (Car), 123.4 (Car), 117.6 (Car), 117.4 (Car), 
117.3 (Car), 76.1 (Cbenzyl), 76.0 (Cbenzyl), 76.0 (Cbenzyl), 72.9 (Cbenzyl), 72.6 
(Cbenzyl), 71.2 (Cbenzyl), 71.2 (Cbenzyl), 69.1 (Cbenzyl), 68.6 (Cbenzyl), 67.6 (Cbenzyl), 
67.4 (C-11/11*/21/21*), 64.9 (C-11/11*/21/21*), 64.5 (C-11/11*/21/21*), 60.3 
(C-11/11*/21/21*), 52.9 (C-10/10*/22/22*), 52.8 (C-10/10*/22/22*), 51.9 (C-
10/10*/22/22*), 51.5 (C-10/10/22/22*) 
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2,3-bis(benzyloxy)benzoyl chloride, 31 
 
 
 
Prepared as in accordance to the literature and used crude.
7
 
 
ʟ-Serine-N-[(1,1-dimethylethoxy)carbonyl]-O-(phenylmethyl)-ester, 32 
 
 
 
To a stirred suspension of ʟ-serine benzyl ester hydrochloride (1.15 g, 5 mmol) 
in acetonitrile (20 mL), triethylamine (0.60 mL, 6.0 mmol) was added and the 
resulting solution was allowed to stir for 10 minutes.  Di-tert-butyl dicarbonate 
(1.15 g, 5 mmol) was then added and the mixture and left to stir for three hours 
at reflux.  Once the reaction was completed, the solvent was removed in vacuo 
and the resulting oil dissolved in dichloromethane, 50 mL. The solution was 
washed with formic acid (15 mL, 0.1 M) and water until the aqueous layer was 
at neutral pH (3 x 25 mL minimum). The organic layer was then dried over 
MgSO4, filtered and the solvent removed in vacuo, yielding a white solid. 
Characterisation data consistent with literature.
8
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Yield: 
1.382 g, 4.68 mmol, 94% 
Melting point: 
66.8-68.2 °C 
Rf: 
Dichloromethane : Methanol (9:1) : Rf : 0.63 
m/z (ESI): 
318.1305 ([M+Na]
+
, 80 %), 296.1482 ([M+H]
+
, 10 %) 
HRMS (ESI): 
Calc for [C15H21NO5] + H
+
  = 296.1492 Found 296.1482 (3.4 ppm error) 
Calc for [C15H21NO5] + Na
+
  = 318.1312 Found 318.1305 (2.3 ppm error) 
1
H NMR: (CDCl3, 400 MHz) δH 
7.39-7.34 (5H, m, Har), 5.51 (1H, br, d, J = 5.0 Hz, H-6), 5.22 (1H, d, J = 12.5 
Hz, H-13/13*), 5.20 (1H, d, J = 12.5 Hz, H-13/13*), 4.42 (1H, br s, H-7), 3,98 
(1H, dd, J = 11.0, 4.0 Hz, H-8), 3,90 (1H, dd, J = 11.0, 4.0 Hz, H-8) 1.43 (9H, s, 
H-1) 
13
C{
1
H} NMR: (CDCl3, 100 MHz) δC 
171.2 (C-10), 156.1 (C-4), 135.2 (Car), 128.8 (Car), 128.7 (Car), 128.4 (Car), 80.2 
(C-2), 67.5 (C-13), 63.3 (C-8), 55.7 (C-7), 27.9 (C-1) 
IR (KBr cm
-1
): 
3419 medium (O-H), 3365 medium (N-H), 2980 weak (C-H), 1760 strong 
(C=O), 1669 strong (C=O), 1526 medium (C-C ar) 
Elemental Analysis: 
Calculated for [C15H21NO5]: %C 61.00, %H 7.17, %N 4.74 
Measured for [C15H21NO5]: %C 61.14, %H 7.12, %N 4.63 
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ʟ-Serine-N-[(1,1-dimethylethoxy)carbonyl]-O-(phenylmethyl)-ester-O-ʟ-
serine, N-[(1,1-dimethylethoxy)carbonyl]-O-(phenylmethyl)-ether, 33 
 
 
 
Boc-O-benzyl-ʟ-serine (1.89 g, 6.4 mmol), compound 32 (1.72 g, 5.8 mmol) and 
HOBt (1.23 g, 9.1 mmol) were suspended in 10 mL dry acetonitrile and the 
mixture was stirred on ice.  Once the mixture was cooled, EDC (1.41 g, 7.4 
mmol) was added to the suspension, followed by the addition of 15 mL 
acetonitrile and allowed to stir for two hours on ice, followed by 48 hours at 
room temperature.  The volatiles were removed in vacuo, and the remaining oil 
dissolved in 100 mL dichloromethane.  The organic solution and washed with 50 
mL brine and 10 mL sat NaHCO3 solution, followed by 2 x 50 mL brine.  The 
organic layer was dried over MgSO4 before the solvent was removed in vacuo.  
The crude product was purified via column chromatography, 9:1 chloroform : 
acetonitrile to yield a pure white solid.  Characterisation data consistent with 
literature.
6
 
 
Yield: 
2.032 g, 3.55 mmol, 60% 
Melting point: 
80.1-82.2 °C 
Rf: 
Chloroform : Acetonitrile (4:1) : Rf : 0.47 
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m/z (ESI): 
595.2602 ([M+Na]
+
, 100 %), 573.2782 ([M+H]
+
, 62 %) 
HRMS (ESI): 
Calc for [C15H21NO5] + H
+
  = 573.2807 Found 573.2782 (4.4 ppm error) 
Calc for [C15H21NO5] + Na
+ 
 = 595.2626 Found 595.2602 (4.0 ppm error) 
1
H NMR: (CDCl3, 400 MHz) δH 
7.37-7.27 (10H, m, Har), 5.50 (1H, br, d, J = 8.8 Hz, H-6/28), 5.29 (1H, br, d, J = 
8.8 Hz, H-6/28), 5.21 (1H, d, J = 12.4 Hz, H-10/10*), 5.17 (1H, d, J = 12.0 Hz, 
H-10/10*), 4.68-4.56 (3H, m, H-7/19,8/8*/18/18*,23/23*), 4.49-4.43 (2H, m, H-
8/8*/18/18*,23/23*), 4.35-4.31 (1H, m, H-7/19), 3.72 (1H, dd, J = 9.6, 3.6 Hz, 
H-8/8*/18/18*), 3.58 (1H, dd, J = 9.6, 3.2 Hz, H-8/8*/18/18*) 1.43 (9H, s, H-
1/33), 1.40 (9H, s, H-1/33) 
13
C{
1
H} NMR: (CDCl3, 100 MHz) δC 
170.6 (C-15/20), 170.0 (C-15/20), 155.8 (C-4/29), 155.7 (C-4/29), 137.6 (Car), 
135.4 (Car), 128.9 (Car), 128.8 (Car), 128.7 (Car), 128.6 (Car), 128.2 (Car), 128.0 
(Car), 127.8 (Car), 80.2 (C-2/32), 80.1 (C-2/32), 73.2 (C-8/18/23), 69.6 (C-
8/18/23), 67.5 (C-10), 65.0 (C-8/18/23), 53.8 (C-7/19), 53.0 (C-7/19), 28.0 (C-
1/33), 27.9 (C-1/33) 
IR (KBr cm
-1
): 
3459 medium (N-H), 2978 weak (C-H), 1744 strong (C=O), 1713 strong (C=O), 
1505 medium (C-C ar) 
Elemental Analysis: 
Calculated for [C30H40N2O9]: %C 62.92, %H 7.04, %N 4.89 
Measured for [C30H40N2O9]: %C 63.92, %H 7.04, %N 4.86 
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ʟ-Serine-O-(phenylmethyl)-ester-O-ʟ-serine-O-(phenylmethyl)-ether 
trifluoroacetic acid salt, 34 
 
 
Compound 33 (0.1078 g, 0.18 mmol) was dissolved in 4 mL of dichloromethane 
and the flask was purged with nitrogen.  Trifluoroacetic acid (1 mL) was then 
added to the stirred solution and the reaction was allowed to proceed at room 
temperature, monitored by TLC (~2 hours).  The volatiles were removed in 
vacuo to yield a pale yellow oil, which was taken up in 5 mL toluene, which was 
subsequently removed in vacuo.  This process was repeated two more times to 
remove traces of TFA and yield a white solid material. 
 
Yield: 
0.0908 g, 0.16 mmol, 89% 
Melting point: 
64.3.1-67.7 °C 
m/z (ESI): 
373.1753 ([M+H]
+
, 63 %) 
HRMS (ESI): 
Calc for [C20H24N2O5] + H
+
 = 373.1758 Found 373.1753 (1.2 ppm error) 
1
H NMR: (MeOD, 400 MHz) δH 
7.46-7.27 (10H, m, Har), 5.35 (1H, d, J = 11.5 Hz, H-5/5*), 5.27 (1H, d, J = 11.5 
Hz, H-5/5*), 4.63 (1H, d, J = 12.5 Hz, H-19/19*), 4.54 (1H, d, J = 12.5 Hz, H-
19/19*), 4.28 (1H, dd, J = 4.0, 3.2 Hz, H-2/14), 4.17 (1H, dd, J = 4.0, 3.2 Hz, H-
2/14), 4.02 (1H, dd, J = 12.0, 4.4 Hz, H-3/3*/13/13*), 3.95 (1H, dd, J = 12.0, 4.4 
Hz, H-3/3*/13/13*), 3.95 (1H, dd, J = 12.0, 4.4 Hz, H-3/3*/13/13*), 3.83 (1H, 
dd, J = 12.0, 4.4 Hz, H-3/3*/13/13*) 
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13
C{
1
H} NMR: (MeOD, 100 MHz) δC 
168.8 (C-10/16), 168.2 (C-10/16), 138.9 (Car), 136.8 (Car), 130.5 (Car), 130.5 
(Car), 130.3 (Car), 130.2 (Car), 130.1 (Car), 130.1 (Car), 129.8 (Car), 129.8 (Car), 
129.7 (Car), 74.8 (C-19), 69.3 (C-5), 68.1 (C-3/13), 60.9 (C-3/13), 56.3 (C-2/14), 
54.6 (C-2/14) 
IR (KBr cm
-1
): 
3005 weak (C-H), 1764 medium (C=O), 1745 medium (C=O), 1668 strong 
(C=O), 1538 medium (C-C ar) 
Elemental Analysis: 
Calculated for [C24H24F6N2O7.0.5TFA]: %C 47.86, %H 4.29, %N 4.55 
Measured for [C24H24F6N2O7.0.5TFA]: %C 48.16, %H 3.96, %N 4.49 
 
ʟ-Serine-N-[2,3-bis(phenylmethoxy)benzoyl]-O-(phenylmethyl)-ester-O-ʟ-
serine, N-[2,3-bis(phenylmethoxy)benzoyl]-O-(phenylmethyl)-ether, 30 (ʟ/ʟ) 
 
 
 
Compound 34 (0.5779 g, 1.0 mmol) was dissolved in 5 mL anhydrous 
dichloromethane.  Alternating amounts of DIPEA (15 mmol. 2.6 mL) and crude 
compound 31, (3.0 mmol) dissolved in 10 mL dichloromethane was added.  The 
resulting mixture was stirred for 10 minutes.  The mixture was subsequently 
diluted with 30 mL dichloromethane, followed by the addition of 20 mL 0.1 M 
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formic acid (aqueous).  The organic layer was separated, washed with 2 x 20 mL 
water, before drying over MgSO4..  The organic layer was then filtered and dried 
in vacuo yielding a crude product.  The product was purified via column 
chromatography using 9:1 dichloromethane: acetonitrile as the solvent system to 
yield an off white solid material 
 
Yield: 
0.4575 g, 0.455 mmol, 44% 
Melting point: 
45.2-46.9 °C 
Rf: 
Dichloromethane : Acetonitrile (9:1) : Rf : 0.48 
m/z (ESI): 
1005.3922 ([M+H]
+
, 100 %) 
HRMS (ESI): 
Calc for [C62H56N2O11] + H
+
 = 1005.3957 Found 1005.3922 (3.4 ppm error) 
1
H NMR: (CDCl3, 400 MHz) δH 
8.82 (1H, d, J = 8.4 Hz, H-9/31), 8.81 (1H, d, J = 7.6 Hz, H-9/31), 7.73-7.71 
(2H, m, Har), 7.45-6.91 (34H, m, Har), 5.24 (1H, d, J = 12.0 Hz, Hbenzyl), 5.22 
(1H, d, J = 12.0 Hz, Hbenzyl), 5.15-5.08 (7H, m, Hbenzyl, 10/22), 5.02 (2H, dd, J = 
10.4, 3.6 Hz, Hbenzyl), 4.56-4.52 (2H, m, H-11/11*/21/21*, 10/22), 4.35 (1H, dd, 
J = 11.6, 3.6 Hz, H-11/11*/21/21*), 4.08 (2H, s, H-26), 3.28 (1H, dd, J = 9.6, 
3.2 Hz, H-11/11*/21/21*), 3.18 (1H, dd, J = 9.6, 3.2 Hz, H- 11/11*/21/21*) 
13
C{
1
H} NMR: (CDCl3, 100 MHz) δC 
170.1 (C-18/23), 169.6 (C-18/23), 165.5 (C-7/32), 165.4 (C-7/32), 152.2 (Car), 
152.2 (Car), 147.4 (Car), 147.3 (Car), 137.7 (Car), 136.6 (Car), 136.5 Car), 136.4 
(Car), 135.5 (Car),129.6 (Car), 129.5(Car), 129.4 (Car), 128.9 (Car), 128.9 (Car), 
128.8 (Car), 128.8 (Car), 128.7 (Car), 128.7 (Car), 128.6 (Car), 128.5 (Car), 128.5 
(Car), 128.4 (Car), 128.3 (Car), 128.3 (Car), 128.2 (Car), 128.1 (Car), 127.9 (Car), 
127.6 (Car), 127.0 (Car), 126.8 (Car), 124.6 (Car), 124.5 (Car), 123.4 (Car), 123.3 
(Car), 117.4 (Car), 117.2 (Car), 76.0 (Cbenzyl), 75.9 (Cbenzyl), 72.6 (C-26), 71.2 
(Cbenzyl), 71.1 (Cbenzyl), 68.6 (C-11/21), 67.6 (Cbenzyl), 64.9 (C-11/21), 52.8 (C-
10/22), 51.4 (C-10/22) 
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IR (ATIR cm
-1
): 
3362 weak (N-H), 3032 weak (C-H), 1747 strong (C=O, ester), 1658 strong 
(C=O, amide), 1575 strong (C=C) 
Elemental Analysis: 
Calculated for [C62H56N2O11.0.25H2O]: %C 73.76, %H 5.64, %N 2.77 
Measured for [C62H56N2O11.0.25H2O]: %C 73.46, %H 5.51, %N 2.79 
 
Enterobactin Linear Dimer, 17 
 
 
 
Compound 30, 0.359 g (0.35 mmol) was dissolved in 8 mL of dry toluene before 
42 mL of dry ethanol was added.  To this stirred solution one small spatula tip of 
Pd-C 10% was added.  The mixture was purged with hydrogen and allowed to 
react for 18 hours under a positive pressure of hydrogen.  After the reaction was 
completed the catalyst was filtered off and the product was isolated by removing 
the solvent in vacuo, to yield a white solid. Characterisation data consistent with 
literature.
9
 
 
Yield: 
0.165 g, 0.32 mmol, 91% 
Melting point: 
124.4 °C - Foamed; 197.4-200.1 °C - Film melted 
m/z (ESI): 
463.0094 ([M-H]
-
, 100%) 
HRMS (ESI): 
Calc. for [C20H19N2O11]
-
 = 463.0994  Found 463.0994 (0.1 ppm error)  
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1
H NMR: (d6-DMSO, 400 MHz) δH 
9.00-8.96 (2H, m, H-11,23), 7.38 (1H, dd, J = 8.4, 1.6 Hz, H-4/27), 7.34 (1H, 
dd, J = 8.0, 1.2 Hz, H-4/27), 6.96 (1H, dd, J = 4.4, 1.2 Hz, H-2/29), 6.93 (1H, 
dd, J = 4.8, 1.2 Hz, H-2/29), 6.74-6.68 (2H, m, H-3,28), 4.81-4.76 (1H, m, H-
12/19), 4.61 (1H, dd, J = 11.2, 4.4 Hz , H-13/13*/18/18*), 4.58-4.55 (1H, m, H-
12/19), 4.41 (1H, dd, J = 11.2, 6.4 Hz , H-13/13*/18/18*), 3.83(1H, dd, J = 11.6, 
6.4 Hz , H-13/13*/18/18*), 3.77(1H, dd, J = 11.2, 4.0 Hz , H-13/13*/18/18*), 
3.44 (2.79H, q, J = 7.2 Hz, H-EtOH CH2)ǂ, 1.05 (2.75H, t, J = 7.2 Hz, H-EtOH 
CH3) 
ǂObscured by water signal 
13
C{
1
H} NMR: (d6-DMSO, 100 MHz) δC 
171.1 (C-9/15/20/24), 170.7 (C-9/15/20/24), 169.5 (C-9/15/20/24), 169.3 (C-
9/15/20/24), 149.3 (C-1/6/30/31), 148.9 (C-1/6/30/31), 146.7 (C-1/6/30/31), 
146.6 (C-1/6/30/31), 119.4 (Car), 119.3 (Car), 119.1 (Car), 118.7 (Car), 118.7 
(Car), 118.6 (Car), 116.4 (Car), 116.0 (Car), 63.9 (C-13/18), 60.9 (C-13/18), 56.1 
(C-EtOH CH2), 55.4 (C-12/19), 51.8 (C-12/19), 18.4 (C- EtOH CH3) 
IR (ATIR cm
-1
): 
3343 weak broad (O-H), 1737 strong (C=O, ester), 1639 medium (C=O, amide), 
1532 strong (C=C) 
Elemental Analysis: 
Calculated for [C20H20N2O110.9EtOH.1.1H2O]: %C 49.81, %H 5.29, %N 5.33 
Measured for [C20H20N2O11.0.9EtOH.1.1H2O]: %C 49.52, %H 4.94, %N 5.27 
Specific Rotation: 
[]D (Methanol, conc. 0.1 g/100 mL) +15.8 
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3-(2-Amino-ethyl)-3-nitro-pentane-1,5-diamine-trihydrochloride, 43 
 
 
 
A schlenk tube was charged with nitromethane-trispropanoic acid (2.27 g, 8.2 
mmol) and placed under a nitrogen atmosphere.  To this two drops of DMF was 
added, followed by thionyl chloride (15 mL, 77 mmol).  The suspension was 
allowed to stir overnight under a postive pressure of nitrogen.  Once the solution 
was clear the excess thionyl chloride was removed in vacuo, followed by the 
replacement of the nitrogen atmosphere.  The residue was dissolved in 15 mL 
anhydrous 1,4-dioxane, followed by the slow addition of trimethylsilyl azide 
(3.5 mL, 26.6 mmol).  This solution was slowly heated over an hour to 70 °C 
behind a blast shield under an atmosphere of nitrogen.  Gas evolution can be 
observed upon heating (caution: after addition of the trimethylsilyl azide the 
reaction has the capability to form a thermal runaway reaction, producing 
dinitrogen, potentially becoming expolsive).  After the gas evolution slows the 
solution is allowed to cool to 45 °C.  Once at temperature 10 mL of acetone is 
added, followed by the addition of 6 mL of 6M hydrochloric acid dropwise.  The 
solution turns cloudy and gas evolution can be observed upon the addition of the 
acid.  Once all the acid was added the flask was opened to the atmosphere and 
the suspension was stirred for an hour.  The solid was collected by filtration and 
washed with ice cold acetone (100 mL) to yield an off white solid.  
Characterisation data consistent with literature.
10
  
 
Yield:  
2.27g, 7.58 mmol, 92% 
Melting point: 
Decomposed 225 °C 
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m/z (ESI):  
191.1499 ([M+H]
+
, 100%), 213.1324 ([M+Na]
+
, 20%) 
HRMS (ESI): 
Calc for [C7H19N4O2]+H
+
 = 191.1503 Found 191.1499 (1.9 ppm error) 
1
H NMR: (d6-DMSO, 400 MHz) δH 
8.31 (9H, br s, H-4), 2.86-2.77 (6H, m, H-3), 2.35-2.28 (6H, m, H-2) 
13
C{
1
H} NMR: (d6-DMSO, 100 MHz) δC 
89.7 (C-1), 33.8 (C-2/3), 31.8 (C-2/3) 
IR (KBr cm
-1
):  
3437 strong (N-H), 3015 strong (C-H), 1543 medium (NO2asymm), 1457 weak 
(NO2symm) 
 
Tert-butyl-N-(5-{[(tert-butoxy)carbonyl]amino}-3-(2-{[(tert-
butoxy)carbonyl]amino}ethyl)-3-nitropentyl)carbamate, 44 
 
 
 
Prepared as in accordance to the literature.
10
 
 
Yield:  
0.563 g, 1.15 mmol, 84% 
Melting point: 
56.8-57.4 °C 
Rf:  
Ethyl Acetate : Rf : 0.6 (permanganate stain) 
m/z (ESI):  
491.3068 ([M+H]
+
, 7%), 513.2885 ([M+Na]
+
, 100%) 
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HRMS (ESI): 
Calc for [C22H42N4O8]+H
+
 = 491.3075 Found 491.3068 (1.5 ppm error) 
Calc. for [C22H42N4O8]+Na
+
  = 513.2895 Found 513.2885 (1.9 ppm error)  
1
H NMR: (CDCl3, 400 MHz) δH 
4.84 (3H, br s, H-4), 3.18-3.10 (6H, br m, H-3), 2.18 (6H, t, J = 7.5 Hz, H-2), 
1.42 (27H, s, H-7) 
13
C{
1
H} NMR: (CDCl3, 100 MHz) δC 
156.3 (C-5), 90.6 (C-1), 79.7 (C-6), 35.6 (C-2/3), 35.3 (C-2/3), 28.1 (C-7) 
IR (KBr cm
-1
):  
3356 weak (N-H), 2978 weak (C-H), 1696 strong (C=O, carbamate), 1543 
strong (NO2asymm) 
Elemental Analysis: 
Calculated for [C22H42N4O8]: %C 53.86, %H 8.63, %N 11.42 
Measured for [C22H42N4O8]: %C 53.46, %H 8.37, %N 11.32 
 
Tert-butyl-N-(3-amino-5{[tert-butoxy)carbonyl]amino}-3-(2-{[(tert-
butoxy)carbonyl]amino}ethyl)pentyl)carbamate, 45 
 
 
 
Compound 44, 1.651 g (3.36 mmol) was dissolved in 80 mL of ethanol.  To this 
stirred solution one spatula tip of Raney®-Nickel 2800 slurry in water was 
added.  The mixture was first purged with hydrogen before reacting for 18 hours 
under a hydrogen atmosphere of 35 bar.  After the reaction had completed the 
reaction mixture was filtered through Celite and washed with ethanol, ensuring 
the catalyst was never allowed to dry.  The product was isolated from the filtrate 
by removing the solvent in vacuo, yielding an off white solid.  Characterisation 
data consistent with literature.
10
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Yield:  
1.50 g, 3.26 mmol, 97% 
Melting point: 
61.7-62.9 °C 
m/z (ESI):  
461.3356 ([M+H]
+
, 100%), 483.3164 ([M+Na]
+
, 6%) 
HRMS (ESI): 
Calc for [C22H44N4O6]+H
+
 = 461.3334 Found 461.3356 (-5.0 ppm error) 
Calc. for [C22H44N4O6]+Na
+
  = 483.3153 Found 483.3164 (-2.2 ppm error)  
1
H NMR: (CDCl3, 400 MHz) δH 
5.17-5.12 (3H, br m, H-4), 3.18 (6H, q, J = 6.5 Hz, H-3), 1.62 (6H, t, J = 7.5 Hz, 
H-2), 1.42 (27H, s, H-7) 
13
C{
1
H} NMR: (CDCl3, 100 MHz) δC 
156.3 (C-5), 79.3 (C-6), 53.3 (C-1), (38.8 (C-2/3), 35.8 (C-2/3), 28.1 (C-7) 
IR (KBr cm
-1
):  
3370 strong (N-H), 2978 weak (C-H), 1696 strong (C=O, carbamate), 1521 
strong (N-H) 
Elemental Analysis: 
Calculated for [C22H44N4O60.5H2O]: %C 56.27, %H 9.66, %N 11.93 
Measured for [C22H44N4O60.5H2O]: %C 56.22, %H 9.40, %N 11.80 
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Methyl-4-{[1,5-bis({[tert-butoxy)carbonyl]amino})-3-(2-{[tert-
butoxy)carbonyl]amino}ethyl)pentan-3-yl]carbamoyl}butanoate, 46 
 
 
Compound 45 (1.461 g, 3.17 mmol) was dissolved in 15 mL dichloromethane 
followed by the addition of triethylamine (860 μL, 6 mmol).  The solution was 
cooled on ice before the addition of glutaric acid monomethyl ester chloride 
(750 μL, 5.4 mmol) and allowed to reaction for 1 hour on ice followed by 1 hour 
at room temperature.  The volatiles were subsequently removed in vacuo and the 
resulting oil dissolved in 50 mL ethyl acetate. This was washed with water (3 x 
50 mL).  The aqueous layer was then washed with ethyl acetate (2 x 50 mL), and 
the two organic layers combined.  The organic solution was then dried over 
MgSO4, filtered and the solvent removed in vacuo, yielding the crude product.  
The crude product was purified via column chromatography, 4:1 chloroform : 
ethyl acetate to yield a pure white solid. 
 
Yield:  
1.422 g, 2.42 mmol, 76% 
Rf:  
Chloroform : Ethyl Acetate (4:1) : Rf : 0.39 (permanganate stain) 
m/z (ESI):  
589.3807 ([M+H]
+
, 37%), 611.3645 ([M+Na]
+
, 37%) 
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HRMS (ESI): 
Calc for [C28H52N4O9]+H
+
 = 589.3807 Found 589.3807 (0.1 ppm error) 
Calc. for [C28H52N4O9]+Na
+
  = 611.3645 Found 611.3645 (-3.0 ppm error)  
1
H NMR: (CDCl3, 400 MHz) δH 
6.57 (1H, br s, H-8), 4.84 (3H, t, J = 5.0 Hz, H-4), 3.65 (3H, s, H-14), 3.09 (6H, 
q, J = 6.5 H-3), 2.35 (2H, t, J = 7.5 Hz, H-10/12), 2.20 (2H, t, J = 7.0 Hz, H-
10/12), 1.93-1.88 (8H, m, H-2,11), 1.40 (27H, s, H-7) 
13
C{
1
H} NMR: (CDCl3, 100 MHz) δC 
174.1 (C-9/13), 173.1 (C-9/13) 155.6 (C-5), 79.3 (C-6), 56.2 (C-1),  51.4 (C-14), 
(35.8 (C-2/3), 35.8 (C-10/12) 35.6 (C-2/3), 33.0 (C-10/12), 28.1 (C-7), 20.5 (C-
11) 
IR (ATIR cm
-1
):  
3331 medium (N-H), 2978 medium (C-H), 1690 strong (C=O, carbamate), 1662 
medium (C=O, amide), 1513 strong (N-H) 
 
Tris(trifluoroacetic acid) methyl 4-{[1,5-diamino-3-(2-aminoethyl)pentan-3-
yl]carbamoyl}butanoate, 47 
 
 
 
Compound 46 (1.359 g, 2.31 mmol) was dissolved in 50 mL 9:1 
dichloromethane : methanol and stirred.  To this stirred solution 5 mL of 
trifluoroacetic acid was added and allowed to react.  The reaction was followed 
via TLC (ethyl acetate) and allowed to complete (~24 hours).  The volatiles were 
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removed in vacuo to yield a pale yellow oil, which was taken up in 5 mL dry 
ethanol, which was subsequently removed in vacuo.  This process was repeated 
two more times to remove traces of TFA and yield a white hydroscopic solid 
material. 
 
Yield:  
1.440 g, 2.28 mmol, 98% 
m/z (ESI):  
289.2247 ([M+H]
+
, 100%) 
HRMS (ESI): 
Calc for [C13H28N4O3]+H
+
 = 289.2234 Found 289.2247 (-4.5 ppm error) 
1
H NMR: (d6-DMSO, 400 MHz) δH 
7.89 (9H, br s, H-4), 7.53 (1H, s, H-5), 3.58 (3H, s, H-11), 2.78-2.68 (6H, br m, 
H-3), 2.30 (2H, t, J = 7.5 Hz H-7/9), 2.13 (2H, t, J = 7.5 Hz H-7/9), 1.96-1.88 
(6H, m, H-2), 1.73 (2H, app quin, J = 7.5 Hz, H-8) 
13
C{
1
H} NMR: (d6-DMSO, 100 MHz) δC 
173.2 (C-10), 172.1 (C-6), 158.9 (q, J 35 Hz, C-12), 115.9 (q, J 290 Hz, C-13), 
54.4.6 (C-1), 51.4.1 (C-11), 34.7 (C-7/9), 34.2 (C-3), 32.8 (C-7/9), 31.8 (C-2), 
20.7 (C-8) 
IR (ATIR cm
-1
):  
3059 weak, broad (N-H), 2943 weak, broad (C-H), 1668 strong, broad (C=O, 
amide) 
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4-{[1,5-diamino-3-(2-aminoethyl)-3-amide]butanoate}-N,N,N-[-[2,3-
bis(phenylmethoxy)benzoyl]-methyl ester, 48 
 
 
 
Compound 47 (1 mmol, 0.630 g) was suspended in 10 mL dry acetonitrile and 
placed on ice.  To the stirred solution DIPEA (15 mmol, 2.6 mL) was added, and 
the system was placed under an atmosphere of nitrogen.  Compound 31 was 
dissolved in 6 mL dry acetonitrile and slowly added and allowed to stir 
overnight at room temperature.  The solution was diluted with 50 mL 
dichloromethane and washed with 30 mL water followed by 20 mL 0.1M HCl, 
20 mL; saturated NaHCO3; and H2O until the aqueous washes were neutral.  The 
organic layer was dried over MgSO4, filtered, and the solvent removed in vacuo 
to yield the crude product.  The crude product was purified via flash column 
chromatography on silica 4:1 EtOAc : dichloromethane, yielding an off white 
solid. 
 
Yield:  
0.1902 g, 0.154 mmol, 17% 
Rf:  
Ethyl Acetate : Rf : 0.40 
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m/z (ESI):  
1259.5357 ([M+Na]
+
, 100%) 
HRMS (ESI): 
Calc for [C76H76N4O12]+Na
+
 = 1259.5352 Found 1259.5357 (-0.4 ppm error) 
1
H NMR: (CDCl3, 400 MHz) δH 
8.04 (3H, t, J = 5.5 Hz, H-4), 7.73-7.69 (3H, m, H-14/15/16), 7.50-7.11 (36H, 
m, Har), 5.15 (6H, s, H-19/20), 5.09 (6H, s, H-19/20), 3.65 (3H, s, H-11), 3.18 
(6H, dt, J = 9.6, 6 Hz, H-3), 2.36 (2H, t, J = 7.0 Hz, H-7/9), 2.26 (2H, t, J = 7.5 
Hz, H-7/9), 1.94 (2H, app quin, J = 7.2 Hz , H-8), 1.79-1.73 (6H, m, H-2) 
13
C{
1
H} NMR: (CDCl3, 100 MHz) δC 
174.1 (C-6/10), 172.6 (C-6/10), 165.7 (C-12), 152.0 (Car), 147.2 (Car), 136.7 
(Car), 136.5 (Car), 129.2 (Car), 129.0 (Car), 128.9 (Car), 128.9 (Car), 128.5 (Car), 
127.9 (Car), 127.4 (Car), 124.5 (Car), 123.4 (Car), 117.3 (Car), 76.3 (C-19/20), 
71.2 (C-19/20), 55.9 (C-1), 51.3 (C-11), (35.8 (C-7/9), 35.1 (C-3) 34.9 (C-2), 
33.1 (C-7/9), 20.5 (C-8) 
IR (ATIR cm
-1
):  
3362 weak (N-H), 3031 weak (C-H), 2949 weak (C-H), 1734 medium (C=O, 
ester), 1650 strong (C=O, amide), 1575 strong (C=C) 
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4-{[1,5-diamino-3-(2-aminoethyl)-3-amide]butanoic}-N,N,N-[-[2,3-
bis(phenylmethoxy)benzoyl]-acid, 49 
 
 
 
Compound 48 (46.8 mg, 0.038 mmol) was dissolved in 9:1 mL of dry 
dichloromethane : methanol and stirred.  To this stirred solution, 150 μL of a 2M 
methanolic sodium hydroxide solution was added and the solution.  The reaction 
was followed via TLC (ethyl acetate) and allowed to complete (~18 hours).  The 
solution was then diluted with 40 mL dichloromethane and washed with 2 x 30 
mL 0.1 M formic acid.  The organic layer was dried with MgSO4, filtered and 
dried in vacuo yielding a clear glass foamed product. 
 
Yield:  
43.4 mg, 0.035 mmol, 94% 
Melting point: 
68.9-69.7 °C 
m/z (ESI):  
1221.5240 ([M-H]
-
, 47%) 
HRMS (ESI): 
Calc for [C75H73N4O12]
-
 = 1221.5230 Found 1221.5240 (-0.8 ppm error) 
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1
H NMR: (CDCl3, 400 MHz) δH 
8.08 (3H, t, J = 5.5 Hz, H-4), 7.70-7.66 (3H, m, H-14/15/16), 7.47-7.09 (36H, 
m, Har), 6.96 (1H, br s, H-5), 5.13 (6H, s, H-19/20), 5.07 (6H, s, H-19/20), 3.16 
(6H, dt, J = 9.2, 6 Hz H-3), 2.42 (2H, t, J = 7.0 Hz, H-7/9), 2.29 (2H, t, J = 7.0 
Hz, H-7/9), 1.94 (2H, app quin, J = 6.8 Hz , H-8), 1.72-1.65 (6H, m, H-2) 
13
C{
1
H} NMR: (CDCl3, 100 MHz) δC 
175.4 (C-10), 172.9 (C-6), 165.7 (C-12), 151.8 (Car), 147.0 (Car), 136.5 (Car), 
136.3 (Car), 129.0 (Car), 128.9 (Car), 128.9 (Car), 128.8 (Car), 128.4 (Car), 127.8 
(Car), 127.0 (Car), 124.5 (Car), 123.3 (Car), 117.4 (Car), 76.5 (C-19/20), 71.4 (C-
19/20), 56.4 (C-1), 35.9 (C-7/9), 35.2 (C-2/3) 35.1 (C-2/3), 34.0 (C-7/9), 21.0 
(C-8) 
 
4-{[1,5-diamino-3-(2-aminoethyl)-3-amide]butanoic}-N,N,N-[2,3-
dihydroxybenzamide]-acid, 41 
 
 
Compound 49, (32.4 mg, 0.026 mmol) was dissolved in 5 mL of dry toluene 
before 45 mL of dry ethanol was added.  To this stirred solution one small 
spatula tip of Pd-C 10% was added.  The mixture was purged with hydrogen and 
allowed to react for 18 hours under a positive pressure of hydrogen.  After the 
reaction was completed the catalyst was filtered off and the product was isolated 
by removing the solvent in vacuo, to yield a off-white film. 
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Yield:  
16.6 mg, 0.024 mmol, 92% 
m/z (ESI):  
681.2420 ([M-H]
-
, 26%) 
HRMS (ESI): 
Calc for [C33H37N4O12] = 681.2413 Found 681.2420 (-0.9 ppm error) 
1
H NMR: (CDCl3, 400 MHz) δH 
7.19 (3H, dd, J = 8.4, 1.2 Hz, H-14/16), 6.91 (3H, dd, J = 8.0, 1.2 Hz, H-14/16), 
6.70 (3H, t, J = 8.2 Hz, H-15), 3.55-3.48 (6H, m, H-3), 2.33 (2H, t, J = 7.2 Hz, 
H-7/9), 2.25 (2H, t, J = 7.6 Hz, H-7/9), 2.20-2.13 (6H, m, H-2), 1.88 (2H, app 
quin, J 7.4 Hz, H-2) 
13
C{
1
H} NMR: (MeOD, 100 MHz) δC 
176.1 (C-10), 174.0 (C-6), 170.2 (C-12), 149.0 (C-17/18), 145.9 (C-17/18), 
118.3 (Car), 118.2 (Car), 117.3 (Car), 115.3.9 (Car), 56.4 (C-1), 35.5 (C-7/9), 34.4 
(C-2/3) 34.1 (C-2/3), 33.2 (C-7/9), 21.0 (C-8) 
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Ferric-{8,11,14-tris[3-(N-hydroxyacetamido)propyl]-3,6,9,12,15,18-hexaoxo-
1,4,7,10,13,16-hexaazacyclooctadecan-2-yl}methyl pent-4-ynoate, 53 
 
 
 
To a stirred solution of pent-4-ynoic acid (98.7 mg, 1.01 mmol), in dry 
dichloromethane (10 mL), DCC (107.6 mg, 0.52 mmol) was added and the flask 
and placed under an atmosphere of nitrogen.  The resulting solution was stirred 
for three hours at room temperature.  The solution was then placed in an ice bath 
for one hour, and the resulting precipitation was filtered using a cannula filter, to 
yield crude anhydride in dichloromethane.  Ferricrocin (14.6 mg, 0.019 mmol) 
was dissolved in dry pyridine (3 mL) and added to the solution of crude 
anhydride dissolved in dichloromethane (5 mL), which was stirred for three 
hours at room temperature.  The solution was then dried in vacuo to yield a 
brown solid.  This solid was then purified via LH-20 size exclusion 
chromatography (1:1 CHCl3:MeOH), to yield a brown solid. 
 
HPLC: 
HPLC was performed on a reversed phase column, using MeCN:H2O gradient 
(6-40 %), from 0-20 minutes.  Retention time found to be 17 min. 
m/z (ESI):  
873.2541 ([M+Na]
+
, 33%), 851.2705 ([M+H]
+
, 17%) 
HRMS (ESI): 
Calc for [FeC33H48N9O14]+H
+
 = 851.2743 Found 851.2705 (4.4 ppm error) 
Calc for [FeC33H48N9O14]+Na
+
 = 873.2563  Found 873.2541 (2.5 ppm error) 
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Ferric-2-(6-amino-3-imino-4,5-disulfo-3H-xanthen-9-yl)-5-[(6-{4-[3-oxo-3-
({8,11,14-tris[3-(N-hydroxyacetamido)propyl]-3,6,9,12,15,18-hexaoxo-
1,4,7,10,13,16-hexaazacyclooctadecan-2-yl}methoxy)propyl]-1H-1,2,3-
triazol-1-yl}hexyl)carbamoyl]benzoic acid, 51 
 
 
 
The Alexa488 Azide dye was dissolved in HPLC grade water (2 mL) and added 
to a stirred solution of 53 in HPLC grade water (3 mL).  To this reaction 
mixture, sodium ascorbate (6 μL of 10 mM stock solution) was added, followed 
by CuSO4.5H2O (3 μL of a 5 mM stock solution).  The resulting solution was 
stirred at room temperature for six hours in the dark and then placed in a 5 mL 
0.1-0.5 MW dialysis bag and dialysed for 90 minutes.  The solution was then 
dried in vacuo. 
 
LC-MS 
Synergi Hydro column, 4.6mm x 250mm; Mobile phase solvent A = H2O 
solvent B = MeCN; Gradient Profile (0-30 min 94% A, 6% B to 60% A, 40% B, 
20-40 min held at 60% A, 40% B; Flow rate 0.3 mLmin
-1
; UV wavelength 295 
nm.  
Retention time: 31.5 min 
Calc for [C60H72FeN15O24S2]
2-
 = 753.1839 Found 753.1849 (-1.3 ppm error) 
Calc for [C60H72FeN15O24S2]
-
 = 1507.3749 Found 1507.3876 (-8.3 ppm error) 
m/z (MALDI:  
1478.46111 ([M-Fe+5H+Na]
+
, 100%), 1456.46872 ([M-Fe+6H]
+
, 90%), 
1494.41644 ([M-Fe+5H+K]
+
, 65%), 1500.44920 ([M-Fe+4H+2Na]
+
, 64%), 
1516.42003 ([M-Fe+4H+Na+K]
+
, 50%) 
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HRMS (MALDI): 
Calc for [C60H72N15O24S2] + 6H
+
 = 1456.46872 
Found 1456.46872 (1.79 ppm mean error) 
Calc for [C60H72N15O24S2] + 5H
+
 + Na
+
 = 1478.45995 
Found 1478.46111 (-0.62 ppm mean error) 
Calc for [C60H72N15O24S2] + 5H
+
 + K
+
 = 1494.43389 
Found 1494.41644 (10.63 ppm mean error) 
Calc for [C60H72N15O24S2] + 4H
+
 + 2Na
+
 = 1500.44190 
Found 1500.44920 (-8.38 ppm mean error) 
Calc for [C60H72N15O24S2] + 4H
+
 + Na
+
 + K
+
 = 1516.41583 
Found 1516.42003 (-6.79 ppm mean error) 
UV-vis: 
λmax(H2O) / 494 nm (ε : Not determined: Unable to record a mass) 
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7.3 Protein Production and Crystallisation Trials 
 
The CeuE coding sequence was cloned from genomic DNA.  The PCR 
amplification of the sequence was performed in a 50 μL reaction containing Kod 
Hot start polymerase (1 μL), PCR buffer 10x (5 μL), dNTP’s (5 μL), MgSO4
 
(2 
μL), genomic DNA (0.5 μL, 500 μg / mL), forward primer, (5’-
CCAGGGACCAGCAATGTTGCCTATTAGTATGAGCGATGAG-3’) (1 μL, 
20 μM), reverse primer, (5’-
GAGGAGAAGGCGCGTTATTATTTTACAGCGTTTTTGATTTC-3’) (1 μL, 
20 μM), made up to 50 μL with mQ grade water.  The PCR cycle performed 
consisted of 95 °C for two minutes and 30 cycles of 95 °C for 20 seconds, 48 °C 
for 30 seconds and 72 °C for 37 seconds.  The PCR product was inserted into 
pET-YSBLIC 3C vector.  The CeuE was then expressed in E. coli BL-21 cells.  
Single colonies were used to inoculate 500 mL cultures of Luria-Bertani broth 
containing 30 μg/mL of the antibiotic kanamycin.  When the OD600 reached 
approximately 0.8, CeuE expression was induced with the addition of 1 mM 
isopropyl β-D-1-thiogalactopyranoside.  The samples were then incubated at 37 
°C for four hours and then harvested by centrifugation.  The cells were then 
resuspended in 50 mM TrisHCl pH 7.5, 500 mM NaCl, 10 mM imidazole, with 
C-complete protease inhibitor cocktail EDTA-free present, and sonicated to 
disrupt the cells.  The insoluble portion was separated from the solution phase 
using centrifugation, and the crude supernatant was loaded onto a 5 mL nickel-
agarose affinity column.  The His-tagged CeuE was eluted with an increasing 
gradient (10-500 mM) imidazole in buffer, and fractions analysed by SDS-
PAGE.  Fractions containing CeuE were pooled, and subjected to dialysis at 4 
°C for 48 hours in the presence of C-protease (100:1).  The mixture after dialysis 
was analysed by SDS-PAGE found that all the His-tags had not been removed.  
Therefore the sample was subjected to C-protease again (50:1) and mixed at 4 
°C overnight.  The SDS-PAGE confirmed all of the His-tags had now been 
removed.  The mixture was loaded onto a 5 mL nickel-agarose affinity column, 
and eluted with the same buffer gradient as previous.  The fractions collected 
were pooled and concentrated, then applied to a gel filtration column 
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(equilibrated in 20 mM TrisHCl pH 8.0, 150 mM NaCl).  The fractions  were 
checked by SDS-PAGE, pooled and concentrated to 18 mg/mL.  The protein 
solution was then divided into 50 μL aliquots and shock frozen in liquid nitrogen 
and stored at -80 °C until required. 
 
Crystallisation. The CeuE stock as described above was used for the crystal 
screening.  All initial screening was carried out using a Mosquito Crystal Robot 
and Hampton and PACT commercial crystal screens.  These screens used 150 
nL of protein and 150 nL of screening solution in the crystallisation drop. The 
best apo-CeuE crystals were obtained with 0.1 M MIB buffer, pH 5, 25% (w/v) 
PEG 1500.  
 
For the {CeuE[Fe(4-LICAM)]} complex a stock solution of ferric 4-LICAM 
was prepared by mixing 3 mg of H4-4-LICAM in 1 mL of methanol with 35 μL 
of a 0.16 M stock of FeCl3, and stirring for 2 hours. The methanol was removed 
in vacuo to yield a purple solid.  The solid (1.3 mg) was dissolved in 11 μL 
DMF to yield a 100 mM stock assuming the complex to be a 3:2 triple stranded 
complex.  The CeuE stock (57 μL) was mixed with this solution (3 μL) which 
caused precipitation.  The purple precipitate was removed by centrifugation 
yielding the pale purple ferric 4-LICAM CeuE stock solution used for 
crystallisation.  Initial screening was carried out as described for apo-CeuE.  The 
best crystals were obtained with 0.2 M sodium nitrate, 0.1 M Bis Tris propane, 
pH 7.5, 20% (w/v) PEG 3350. 
 
For the {CeuE[Fe(17)} crystals were obtained through crystal soaking 
experiments.  A crystal was grown from the PACT crystal screen and Fe-17 was 
introduced by the addition of H4-17 (2 μL, 1x10
-2
 M in DMSO) and Fe(NTA) (2 
μL, 1x10-2 M, aqueous) to the condition reservoir, followed by thorough mixing.  
2 μL of the resulting solution was added the sitting drop that contained the 
crystal.  The well was re-sealed and time allowed for the ferric-17 to diffuse 
through the crystal. 
 
Data Collection, Structure Solution and Refinement. The {CeuE[Fe(4-
LICAM)]} crystal was coated with a cryoprotectant solution consisting of the 
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mother liquor with 20% PEG 1.5 K before flash-cooling in liquid nitrogen and 
storage for data collection.  All other crystal data collection reported within this 
thesis were flash-cooled in liquid nitrogen without the use of cryoprotectant.  
Crystal X-ray diffraction data was collected at the Diamond Light Source 
synchrotron.  The structure was determined by molecular replacement using one 
domain from the ferric-MECAM structure (PDB code 2CHU) as a search model 
using MOLREP
11
 in the CCP4
12
 software package.  Model building was carried 
out using Coot
13
 and refinement using REFMAC
14
. 
 
7.4 Job Plot Method 
 
A series of aqueous solutions containing the ligand of interest and Fe(NTA) 
were prepared such that the sum of the concentrations of both remained constant 
(400 µM) in 0.1 M TrisHCl pH 7.5, 5% DMSO.  The ratio of ligand and metal 
was varied from 100% ligand to 100% metal.  The absorbance of interest for the 
system was plotted against the ligand-to-metal ratio. 
 
110 mM TrisHCl pH 7.5.  Tris(hydroxymethyl)aminomethane, (27.5 mmol, 
3.334 g) was dissolved in approximately 200 mL distilled water.  The pH was 
adjusted to 7.5 with 2.5M HCl.  The volume of the solution was made up t 250 
mL with distilled water. 
 
Ligand Solution.  A stock solution of 10 mM of each ligand was prepared in 
DMSO. 
 
Fe(NTA) Solution.  Nitrilotriacetic acid trisodium salt (0.1 mmol) was 
dissolved in 0.0179 mol dm
-3
 standard Fe(NO3)3 solution (5.587 mL).  This 
solution was then made up to 10 mL with distilled water, leaving a final solution 
of 0.01 mol dm
-3
 Fe(NO3)3 with 0.01 mol dm
-3
 NTA. 
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7.5 Circular Dichroism 
 
Circular dichroism spectra were recorded using a Jasco J-810 spectropolarimeter 
with a Peltier temperature control unit at 20 °C under constant nitrogen flush.  
The instrument was operated with the following parameters: range: 300-700 nm, 
data pitch: 0.5 nm, scanning mode: continuous, scanning speed: 100 nm/min, 
response: 2 seconds, bandwidth: 2 nm, accumulation: 5, pathlength: 1 cm. 
 
{CeuE[Fe(4-LICAM)]}.  The sample consisted of 550 μL of CeuE stock 
solution (18 mg/mL in 20 mM TrisHCl pH 8.0, 10 mM NaCl), 50 μL of a ferric 
4-LICAM (2.55 x 10
-3
 M in 50 mM TrisHCl pH 7.5, 25% DMSO) and 1400 μL 
20 mM TrisHCl pH 8.0. The ferric 4-LICAM spectrum was then recorded with a 
solution containing 50 μL of a ferric 4-LICAM stock solution (2.55 x 10-3 M in 
50 mM TrisHCl pH 7.5, 25% DMSO) and 1950 μL 20 mM TrisHCl pH 8.0.  
The blank spectrum was subtracted from both data sets to give the spectra 
shown. 
 
Fe-17.  The samples consisted of a total concentration of [L]+[M] of 0.4 mM, 
recorded in 100 mM TrisHCl pH 7.5, 150 mM NaCl, 5% DMSO, with ligand to 
metal ratios recorded at 1:0, 3:2, 1:1, 2:3, 0:1.  The blank spectrum was 
subtracted from all spectra. 
 
{CeuE[Fe(17)]}.  The samples consisted of 50 μM Fe-17, 0.1 M TisHCl pH 7.5, 
150 mM NaCl (1000 μL) titrating in 20 μL aliquots of a CeuE stock solution 
(17.5 mg/mL in 20 mM TrisHCl pH 8.0, 10 mM NaCl).  The blank spectrum 
was subtracted from all spectra. 
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7.6 Fluorescence Quenching Titration 
 
Intrinsic fluorescence spectroscopy was carried out at room temperature.  The 
excitation slit width of 10 nm and an emission slit width of 20 nm, scan speed 60 
nm/min with an automatic response.  The detector voltage was set at 950 V.  
CeuE was excited at 280 nm and the emission spectrum was recorded from 285 
nm to 415 nm.  For each measurement a protein solution of 240 nM in 2000 L, 
40 mM TrisHCl (pH 7.5) NaCl 150 mM was placed in a 1 cm quartz cuvette, 
and titrated stepwise with concentrated ferric-ligand stock solution.  After each 
addition the solution was thoroughly mixed and allowed to rest for one minute.  
The integrated emission (corrected for PMT response) at from 305 nm to 380 
nm was used for plotting and binding constant calculation, using the fitting 
program DynaFit.
15
  The non-linear regression fit assumes there is no pre-
equilibrium of the ligand and iron(III), and the ferric-ligand complex is a single 
stable molecule.  The scripts for DynaFit can be found in the appendix and on 
the compact disc attached to the thesis.  For each titration, the task and 
mechanism fields of the script remain the same.  The final concentration of 
CeuE in the cuvette is required under the concentraton field and a initial esitmate 
of the Kd value is required in the constant field, both in μM.  The responses are 
required to be changed for each indivual titration, with the CeuE response being 
the initial normallised fluroscent signal divided by the final concentration of 
CeuE in the cuvette, and the CeuE.FeLD response is the end normallised 
fluroscent signal divided by the final concentration of CeuE.  Under the 
equilibria field the location of the .TXT file containing the titration data must be 
located, and the output field must be filled in in order for DynaFit to write the 
output data. 
 
40 mM TrisHCl pH 7.5, 150 mM NaCl.  Tris(hydroxymethyl)aminomethane, 
(0.02 mol, 2.423 g) and sodium chloride (7.5 mmol, 4.383 g) was dissolved in 
approximately 400 mL distilled water.  The pH was adjusted to 7.5 with 2M 
HCl.  The volume of the solution was made up to 500 mL with distilled water. 
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Fe-Ligand Solution.  M stock solution of ferric-ligand was prepared by 
pipetting 2 L of the ligand stock solution and 2 L of the Fe(NTA) stock 
solution into 1696 L of 40 mM TrisHCl pH 7.5, 150 mM NaCl and thoroughly 
mixed. 
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Appendix I. Fluorescent Quenching Analysis of CeuE 
 
Figure 84 - Run 1 fluorescence quenching analyses of PBP CeuE with ferric-4-
LICAM.  Titration recorded with 240 nM CeuE (red) and 170 nM CeuE (blue) in 40 
mM TrisHCl pH 7.5, NaCl 150 mM.  Recorded data shown as circles; lines give the 
non-linear least-squares calculated fits (DynaFit). Kd = 25.1± 1.3 nM (240 nM), 44.9 ± 
2.5 nM (170 nM). 
 
Figure 85- Run 2 fluorescence quenching analyses of PBP CeuE with ferric-4-
LICAM.  Titration recorded with 240 nM CeuE (red) and 170 nM CeuE (blue) in 40 
mM TrisHCl pH 7.5, NaCl 150 mM.  Recorded data shown as circles; lines give the 
non-linear least-squares calculated fits (DynaFit). Kd = 30.3± 0.9 nM (240 nM), 40.8 ± 
3.8 nM (170 nM). 
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Figure 86 - Run 3 fluorescence quenching analyses of PBP CeuE with ferric-4-
LICAM.  Titration recorded with 240 nM CeuE (red) and 170 nM CeuE (blue) in 40 
mM TrisHCl pH 7.5, NaCl 150 mM.  Recorded data shown as circles; lines give the 
non-linear least-squares calculated fits (DynaFit). Kd = 14.9± 2.7 nM (240 nM), 19.9 ± 
5.3 nM (170 nM). 
 
Figure 87 - Run 1 fluorescence quenching analyses of PBP CeuE with ferric-17.  
Titration recorded with 240 nM CeuE (red) and 170 nM CeuE (blue) in 40 mM TrisHCl 
pH 7.5, NaCl 150 mM.  Recorded data shown as circles; lines give the non-linear least-
squares calculated fits (DynaFit). Kd = 4.8± 0.9 nM (240 nM), 9.8 ± 1.9 nM (170 nM). 
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Figure 88 - Run 2 fluorescence quenching analyses of PBP CeuE with ferric-17.  
Titration recorded with 240 nM CeuE (red) and 170 nM CeuE (blue) in 40 mM TrisHCl 
pH 7.5, NaCl 150 mM.  Recorded data shown as circles; lines give the non-linear least-
squares calculated fits (DynaFit). Kd = 16.4 ± 1.8 nM (240 nM), 12.3 ± 2.5 nM (170 
nM). 
 
Figure 89 - Run 3 fluorescence quenching analyses of PBP CeuE with ferric-17.  
Titration recorded with 240 nM CeuE (red) and 170 nM CeuE (blue) in 40 mM TrisHCl 
pH 7.5, NaCl 150 mM.  Recorded data shown as circles; lines give the non-linear least-
squares calculated fits (DynaFit). Kd = 14.9± 3.7 nM (240 nM), 14.9 ± 3.6 nM (170 
nM). 
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RAW DATA 
Batch 1 - 240 nM 
Conc Fe-4-LICAM/ uM 
Run 1 Run 2 Run 3 
INTEGRATION 
(305-380NM) 
INTEGRATION 
(305-380NM) 
INTEGRATION 
(305-380NM) 
0 1400 1217 857 
0.0476 1206 1030 733 
0.0952 1042 904 634 
0.1428 930 821 558 
0.1904 840 708 494 
0.238 754 649 451 
0.2856 709 597 417 
0.3332 678 554 400 
0.3808 653 525 385 
0.4284 626 517 376 
0.476 606 492 368 
0.5236 596 478 362 
0.5712 587 467 359 
0.6188 574 469 355 
0.6664 572 454 355 
0.714 569 454 350 
0.952 553 442 349 
1.19 549 440 340 
    
NORMALISED 
Conc Fe-4-LICAM/ uM 
Run 1 Run 2 Run 3 
INTEGRATION 
(305-380NM) 
INTEGRATION 
(305-380NM) 
INTEGRATION 
(305-380NM) 
0 1 1 1 
0.0476 0.861428571 0.846343468 0.855309218 
0.0952 0.744285714 0.742810189 0.739789965 
0.1428 0.664285714 0.674609696 0.651108518 
0.1904 0.6 0.581758422 0.576429405 
0.238 0.538571429 0.533278554 0.526254376 
0.2856 0.506428571 0.490550534 0.486581097 
0.3332 0.484285714 0.455217749 0.466744457 
0.3808 0.466428571 0.431388661 0.44924154 
0.4284 0.447142857 0.424815119 0.43873979 
0.476 0.432857143 0.404272802 0.429404901 
0.5236 0.425714286 0.392769104 0.422403734 
0.5712 0.419285714 0.383730485 0.418903151 
0.6188 0.41 0.38537387 0.414235706 
0.6664 0.408571429 0.37304848 0.414235706 
0.714 0.406428571 0.37304848 0.4084014 
0.952 0.395 0.363188168 0.407234539 
1.19 0.392142857 0.361544782 0.396732789 
Table 15 - Raw and normalised fluorescence data for the ferric-4-LICAM CeuE 
titration at 240 nM. 
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RAW DATA 
Batch 2 - 170 nM 
Conc Fe-4-LICAM/ 
uM 
Run 1 Run 2 Run 3 
INTEGRATION 
(305-380NM) 
INTEGRATION 
(305-380NM) 
INTEGRATION 
(305-380NM) 
0 991 965 634 
0.0476 831 809 525 
0.0952 733 698 449 
0.1428 651 639 405 
0.1904 600 594 376 
0.238 545 552 365 
0.2856 525 539 351 
0.3332 503 512 343 
0.3808 490 505 341 
0.476 465 488 331 
0.5236 446 472 321 
0.5712 439 473 323 
0.6188 441 463 317 
0.6664 433 448 315 
0.714 437 457 311 
0.952 419 433 302 
1.19 398 410 297 
    
    
NORMALISED 
Conc Fe-4-LICAM/ 
uM 
Run 1 Run 2 Run 3 
INTEGRATION 
(305-380NM) 
INTEGRATION 
(305-380NM) 
INTEGRATION 
(305-380NM) 
0 1 1 1 
0.0476 0.838546922 0.838341969 0.82807571 
0.0952 0.739656912 0.723316062 0.708201893 
0.1428 0.65691221 0.662176166 0.638801262 
0.1904 0.605449041 0.615544041 0.593059937 
0.238 0.549949546 0.572020725 0.575709779 
0.2856 0.529767911 0.558549223 0.55362776 
0.3332 0.507568113 0.530569948 0.541009464 
0.3808 0.49445005 0.523316062 0.53785489 
0.476 0.469223007 0.505699482 0.522082019 
0.5236 0.450050454 0.489119171 0.506309148 
0.5712 0.442986882 0.49015544 0.509463722 
0.6188 0.445005045 0.479792746 0.5 
0.6664 0.436932392 0.464248705 0.496845426 
0.714 0.440968718 0.47357513 0.490536278 
0.952 0.422805247 0.448704663 0.476340694 
1.19 0.401614531 0.424870466 0.468454259 
Table 16 - Raw and normalised fluorescence data for the ferric-4-LICAM CeuE 
titration at 170 nM. *Note missing data point of Fe-4-LICAM concentration at 0.4284. 
 
   
          256 
 
RAW DATA 
Batch 1 - 240 nM 
Conc Fe-4-LICAM/ 
uM 
Run 1 Run 2 Run 3 
INTEGRATION 
(305-380NM) 
INTEGRATION 
(305-380NM) 
INTEGRATION 
(305-380NM) 
0 1115 1181 813 
0.0476 959 1039 750 
0.0952 851 909 669 
0.1428 742 795 591 
0.1904 627 695 509 
0.238 547 610 434 
0.2856 490 534 386 
0.3332 475 482 356 
0.3808 463 467 339 
0.4284 452 467 341 
0.476 464 449 344 
0.5236 458 450 339 
0.5712 448 444 334 
0.6188 464 439 328 
0.6664 453 439 331 
0.714 451 436 330 
0.952 452 428 332 
1.19 455 428 329 
    
NORMALISED 
Conc Fe-4-LICAM/ 
uM 
Run 1 Run 2 Run 3 
INTEGRATION 
(305-380NM) 
INTEGRATION 
(305-380NM) 
INTEGRATION 
(305-380NM) 
0 1 1 1 
0.0476 0.860089686 0.879762913 0.922509225 
0.0952 0.7632287 0.769686706 0.822878229 
0.1428 0.665470852 0.67315834 0.726937269 
0.1904 0.562331839 0.588484335 0.626076261 
0.238 0.49058296 0.516511431 0.533825338 
0.2856 0.439461883 0.452159187 0.474784748 
0.3332 0.426008969 0.408128704 0.437884379 
0.3808 0.415246637 0.395427604 0.41697417 
0.4284 0.405381166 0.395427604 0.419434194 
0.476 0.416143498 0.380186283 0.423124231 
0.5236 0.410762332 0.381033023 0.41697417 
0.5712 0.401793722 0.375952583 0.410824108 
0.6188 0.416143498 0.371718882 0.403444034 
0.6664 0.406278027 0.371718882 0.407134071 
0.714 0.404484305 0.369178662 0.405904059 
0.952 0.405381166 0.362404742 0.408364084 
1.19 0.408071749 0.362404742 0.404674047 
Table 17 - Raw and normalised fluorescence data for the ferric-17 CeuE titration at 
240 nM. 
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RAW DATA 
Batch 2 - 170 nM 
Conc Fe-4-LICAM/ 
uM 
Run 1 Run 2 Run 3 
INTEGRATION 
(305-380NM) 
INTEGRATION 
(305-380NM) 
INTEGRATION 
(305-380NM) 
0 865 855 707 
0.0476 751 735 643 
0.0952 658 616 571 
0.1428 561 535 501 
0.1904 513 470 451 
0.238 490 455 417 
0.2856 488 435 400 
0.3332 483 444 394 
0.3808 478 438 384 
0.4284 472 415 392 
0.476 459 409 390 
0.5236 466 417 384 
0.5712 451 415 380 
0.6188 455 412 375 
0.6664 454 399 375 
0.714 452 398 386 
0.952 453 390 397 
1.19 433 380 397 
    
NORMALISED 
Conc Fe-4-LICAM/ 
uM 
Run 1 Run 2 Run 3 
INTEGRATION 
(305-380NM) 
INTEGRATION 
(305-380NM) 
INTEGRATION 
(305-380NM) 
0 1 1 1 
0.0476 0.868208092 0.859649123 0.909476662 
0.0952 0.760693642 0.720467836 0.807637907 
0.1428 0.648554913 0.625730994 0.708628006 
0.1904 0.593063584 0.549707602 0.637906648 
0.238 0.566473988 0.532163743 0.589816124 
0.2856 0.56416185 0.50877193 0.565770863 
0.3332 0.558381503 0.519298246 0.5572843 
0.3808 0.552601156 0.512280702 0.543140028 
0.4284 0.54566474 0.485380117 0.554455446 
0.476 0.530635838 0.478362573 0.551626591 
0.5236 0.538728324 0.487719298 0.543140028 
0.5712 0.521387283 0.485380117 0.53748232 
0.6188 0.526011561 0.481871345 0.530410184 
0.6664 0.524855491 0.466666667 0.530410184 
0.714 0.522543353 0.465497076 0.545968883 
0.952 0.523699422 0.456140351 0.561527581 
1.19 0.500578035 0.444444444 0.561527581 
Table 18 - Raw and normalised fluorescence data for the ferric-17 CeuE titration at 
170 nM. 
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[task] 
 data = equilibra 
 task = fit 
 
[mechanism] 
 CeuE + FeLD <==> CeuE.FeLD : Kd dissoc. 
 
[concentrations] 
 CeuE = 0.24 ; Concentration of CeuE in cuvette in uM / approx 5.00 mgmL-1 3 
uL  
 
[constants] 
 Kd = 0.02 ? 
 
[Responses] 
 CeuE = 4.16 ? ; Initial fluorescence divided by amount of CeuE i.e. (1/0.24) 
 CeuE.FeLD = 1.70 ? ; End fluorescence divided by amount of FeLD.CeuE i.e. 
(0.408/0.24) 
 
[equilibria] 
 variable FeLD 
 file ./CeuE/FeLD/FULLDATA/Dan1/FeLD.txt 
 
[output] 
 directory ./CeuE/FeLD/FULLDATA/Dan1/Output 
 
[end] 
 
Figure 90 - Script used for Dynafit v3. 
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[task] 
 data = equilibria 
 task = fit 
 
[mechanism] 
 CeuE + FeLD <==> CeuE.FeLD : Kd dissoc 
 
[concentrations] 
 CeuE = 0.17 ; Concentration of CeuE in cuvette in uM / approx 5.00 mgmL-1 3 
uL 
 
[constants] 
 Kd = 0.02 ? ; uM 
 
[responses] 
 CeuE = 5.88 ? , CeuE.FeLD = 3.3 ? ; Initial fluorescence divided by amount of  
 
CeuE i.e. (1/0.17); End fluorescence divided by amount of FeLD.CeuE i.e.  
 
(0.561/0.17) 
 
[data] 
 variable FeLD 
 file ./CeuE/FeLD/FULLDATA/Adam4/FeLD.txt 
 
[output] 
 directory ./CeuE/FeLD/FULLDATA/Adam4/Output 
 
[end] 
 
Figure 91 - Script used for Dynafit v4. 
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Abbreviations 
 
° degrees 
°C degrees Celsius 
Å Angstroms 
Amo amonabactin 
aro aromatic residue 
B. subtilis Bacillus subtilis 
Boc tert-butyloxycarbonyl 
Boc2O di-tert-butyl dicarbonate 
c (prefix) centi 
C. jejuni Camoylobacter jejuni 
CD circular dichroism 
CDI 1,1'-carbonyldiimidazole 
D2O deuterium oxide 
d6-DMSO  deuterated dimethyl sulfoxide 
Da Dalton 
dATP deoxyadenosine triphosphate 
DCC dicyclohexylcarbodiimide 
DCU dicyclohexylurea 
DFO desferrioxamine-B 
DGE diglucosylated enterobactin 
DHBS  dihydroxybenzolyserine 
DIPEA N-N'-diisopropylethylamine 
DLS Diamond Light Source 
DMAP 4-dimethylaminopyridine 
DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
DOSY  diffusion ordered spectroscopy 
E. coli Escherichia coli 
EDC 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
Ent enterobactin 
ESI electrospray ionisation 
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EtOH ethanol 
FRAP fluorescence recovery after photobleaching 
Fur ferric-iron uptake regulation 
g grams 
gly glycine 
H. influenzae Haemophilus influenzae 
HBTU N,N,N',N'-tetramethyl-O-(1H-benzotriazol-1-yl)uronium 
 hexafluorophosphate 
His histidine 
HOBt hydroxybenzotriazole 
HPLC high peformance liquid chromatgraphy 
IPTG isopropyl β-D-1-thiogalactopyranoside 
K Kelvin 
L ligand (complexation) 
L litre 
LB lysogeny broth 
LC liquid chromatrography 
LICAM linear Catechol Amide 
LMCT ligand to metal charge transfer 
Lys  lysine 
M metal (complexation) 
m metre 
M molar 
m (prefix) milli 
m/z mass/charge 
Maq-Br 2-bromomethylanthraquinone 
MeOH methanol 
MIB sodium malonate, imidazole and boric acid 
Mr relative molecular mass 
MS mass spectrometry 
MW molecular weight 
n (prefix) nano 
NEt3 triethylamine 
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nm nanometer 
NMR nuclear magnetic resonance 
NTA nitrilotriacetic acid 
OD600 optical density at 600 nm 
P. aeruginosa Pseudomonads aeruginosa 
Pa Pascal 
PBP periplasmic binding protein 
PCR  polymerase chain reaction 
PEG polyethylene glycol 
ppm parts per million 
RMS root mean square 
RNA ribonucleic acid 
rpm revolutions per minute 
s second 
SDS PAGE sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SGC serine-glycine-catechol 
TFA trifluoroacetic acid 
THP tetrahydropyran 
TIC total ion count 
TIRF total interal reflection fluorescence 
TLC thin layer chromatography 
TMS trimethylsilyl 
TrisHCl tris(hydroxymethyl)aminomethane hydrochloride 
Trp tryptophan 
Tyr tyrosine 
UV-visible ultra violet-visible 
V potential Difference 
λmax wavelength of maximum absorbance 
μ (prefix) micro 
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